Duquesne University

Duquesne Scholarship Collection
Electronic Theses and Dissertations

2010

Development of Multivariate Powder X-ray
Diffraction Techniques and Total Scattering
Analyses to Enable Informatic Calibration of Solid
Dispersion Potential
Michael Moore

Follow this and additional works at: https://dsc.duq.edu/etd
Recommended Citation
Moore, M. (2010). Development of Multivariate Powder X-ray Diffraction Techniques and Total Scattering Analyses to Enable
Informatic Calibration of Solid Dispersion Potential (Doctoral dissertation, Duquesne University). Retrieved from
https://dsc.duq.edu/etd/944

This Immediate Access is brought to you for free and open access by Duquesne Scholarship Collection. It has been accepted for inclusion in Electronic
Theses and Dissertations by an authorized administrator of Duquesne Scholarship Collection. For more information, please contact
phillipsg@duq.edu.

DEVELOPMENT OF MULTIVARIATE POWDER X-RAY DIFFRACTION
TECHNIQUES AND TOTAL SCATTERING ANALYSES TO ENABLE
INFORMATIC CALIBRATION OF SOLID DISPERSION POTENTIAL

A Dissertation
Submitted to the Graduate School of Pharmaceutical Sciences

Duquesne University

In partial fulfillment of the requirements for
the degree of Doctor of Philosophy

By
Michael D. Moore

December 2010

Copyright by
Michael D. Moore

2010

DEVELOPMENT OF MULTIVARIATE POWDER X-RAY DIFFRACTION
TECHNIQUES AND TOTAL SCATTERING ANALYSES TO ENABLE
INFORMATIC CALIBRATION OF SOLID DISPERSION POTENTIAL

By
Michael D. Moore

Approved August 10, 2010

Peter L. D. Wildfong, Ph.D
Associate Professor of Pharmaceutics
Graduate School of Pharmaceutical Sciences
(Committee Chair)

David A. Engers, Ph.D.
Research Director
SSCI, a division of Aptuit, Inc.
(Committee Member)

Carl A. Anderson, Ph.D.
Associate Professor of Pharmaceutics
Graduate School of Pharmaceutical Sciences
(Committee Member)

Ira S. Buckner, Ph.D.
Assistant Professor of Pharmaceutics
Graduate School of Pharmaceutical Sciences
(Committee Member)

Jennifer A. Aitken, Ph.D.
Associate Professor
Department of Chemistry and Biochemistry
Bayer School of Natural and Environmental
Sciences
(Committee Member)

James K. Drennen, III, Ph.D.
Associate Professor of Pharmaceutics
Associate Dean for Graduate Programs and
Research
Mylan School of Pharmacy
(Committee Member)

J. Douglas Bricker, Ph.D.
Dean, Mylan School of Pharmacy and the
Graduate School Pharmaceutical Sciences

iii

ABSTRACT

DEVELOPMENT OF MULTIVARIATE POWDER X-RAY DIFFRACTION
TECHNIQUES AND TOTAL SCATTERING ANALYSES TO ENABLE
INFORMATIC CALIBRATION OF SOLID DISPERSION POTENTIAL

By
Michael D. Moore
December 2010

Dissertation supervised by: Peter L.D. Wildfong, Ph.D.
The objective of this work was to introduce a novel method for predicting solid
dispersion potential enabled by the ability to differentiate phase-separated co-solidified
products from amorphous molecular solid dispersions. The central hypothesis states that
a combination of materials properties exists that defines the propensity of an active
pharmaceutical ingredient to form a binary amorphous molecular solid dispersion with
polyvinylpyrrolidone:vinyl acetate copolymer using a melt-quench procedure. Testing
this hypothesis required execution of specific aims directed to address issues inherent to
characterizing amorphous materials. The work herein is presented with respect to two
separate subjects: (1) analytical development and (2) theoretical applications. In the first
few chapters, advanced powder X-ray diffraction data processing techniques are explored
and adapted to composite pharmaceutical systems. Specific emphasis will be placed on
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total scattering data manipulations and their benefits over traditional practices. The
concluding part of this work is devoted to illustrating the use of materials informatics in
modeling solid dispersion potential, ultimately afforded by implementing the materials
characterization methodologies developed in the initial stages. Molecular descriptors,
commonly employed in quantitative structure-property relationship assessment, were
tested for correlation to dispersion potential across a library of small molecule organic
compounds. The final model accurately predicted dispersion potential for all 12
calibration compounds and three test compounds.
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Chapter 1: Introduction
1.1 Statement of Problem
The development of small molecule organic (SMO) new chemical entities (NCE)
for use in therapeutic products is a complex process involving effort from a diverse
multidisciplinary scientific team. Charged with the formidable task of formulating
chemically/physically stable, manufacturable, and bioavailable dosage forms, scientists
have traditionally relied on highly empirical tactics for solving the most daunting
developmental issues. Instances where first-principles approaches are not available for
troubleshooting problematic materials-based deterrents seldom precipitate empiricallyderived predictive models largely due to analytical limitations. As a result, innovation in
the areas of pharmaceutical pre-formulation and formulation development are often
precluded by advancements in materials characterization.
In the area of solid oral dosage form development, solubility of a solid material in
the aqueous environment of the gastrointestinal fluid and subsequent permeability of
active pharmaceutical ingredient (API) molecules through epithelial cellular membranes
are two principal biopharmaceutical properties given significant consideration when
deciding the fate of a NCE in the pharmaceutical development process. Molecules
having acceptable aqueous solubility and permeability, i.e., biopharmaceutical
classification system1 (BCS) I compounds, are desirable owing to typically higher in
vitro-in vivo correlation (IVIVC), but are encountered less frequently among emerging
NCEs. Therefore, modifications to APIs intended to improve biopharmaceutical
properties inherent to successful development are becoming routinely necessary.
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Tactics commonly employed in permeability enhancement of NCEs often require
alteration of intramolecular functional groups, thereby manipulating properties, including
reduction of ionization potential under physiological conditions and lipophilicity. These
modified functional groups, however, often influence other physicochemical and
pharmacological properties, such as aqueous solubility and receptor binding efficiency.
Consequently, molecules that lack adequate permeability (BCS Class III, IV) are often
dismissed as viable development candidates. As aqueous solubility enhancing
approaches are developed, BCS Class II compounds (low aqueous solubility, high
permeability) exhibit greater potential for successful development. With the decline in
“blockbuster” drug development in the last decade, methods for optimizing
biopharmaceutical properties of SMO compounds are becoming increasingly important.
The solubilization of a solid material in an aqueous medium is a complex,
equilibrium process that can be broken down into three general steps. The first step
involves removing a molecule from the bulk solute particle. This is achieved by
breaking/overcoming the cohesive inter-molecular non-bonded interactions (NBI)
responsible for maintaining the crystal lattice. Half of the work committed in this process
is regained from “closing” the hole created from the departure of the molecule. The
second step is called pre-solvation and is the work of breaking cohesive solvent:solvent
interactions to create a “hole” sufficient to accommodate the solute molecule. The final
step, solvation, is the insertion of the solute molecule into the solvent “hole” and
subsequent formation of adhesive interactions. The final step represents an overall gain
in work (or decrease in potential energy) due to: (1) the formation of adhesive
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interactions between the solute molecule and surrounding solvent molecule(s); and (2)
the “hole” created in step two is sealed.2
Techniques that may be used to enhance the aqueous solubility and/or dissolution
rate of NCEs can be broken down into two subgroups: (1) chemical and (2) physical
modifications. Conventional chemical modifications include prodrug development3 and
salt screening/selection.4,5 Though successfully applied to commercially available
therapeutic agents,2 these methods have their shortcomings. Synthesizing an appropriate
prodrug through the addition of an optimal physiologically cleavable functional group is
not trivial. Further, chemical modifications also possess the potential to unpredictably
alter other biopharmaceutical properties, such as permeability, toxicological potential and
pharmacological action. Specifically, a molecular modification resulting in the greatest
aqueous solubility enhancement may increase the toxicity of the molecule, e.g., in the
case of quaternary ammonium prodrugs of tertiary amine containing compounds.6
Further, salt formation of a compound is only a viable option when the NCE possesses an
ionizable group, and oftentimes results in a material that has sub-optimal physical
properties for manufacturing and stability.
Physical modifications, on the other hand, are more generally applied in the
pharmaceutical industry relative to their chemical counterparts. From classical
dissolution theory, such as Noyes-Whitney,7 various materials properties can be altered,
theoretically resulting in enhanced aqueous dissolution. The inverse relationship between
particle size and dissolution rate has enabled the exploitation of particle size reduction as
a method of enhancing aqueous dissolution.8 Impact mills and fluid-energy mills are
commonly used for reduction of particle size, however, the high-energy input of these
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methods imparts the ability to induce phase changes (i.e., polymorphism,9
amorphization,10,11 etc.,) with implications of physical instability.12
Other physical strategies, such as the formation of non-covalent inclusion
complexes using cyclodextrins, provide solubility advantages over the un-manipulated
drug.13 The prediction of solubilization potential with cyclodextrins, however, remains
highly empirical, and is limited to appropriately sized, chemically compatible molecules.
Solubility enhancement can be achieved through the use of formulation additives such as
surfactants, however, drug:excipient compatibility becomes an issue.14 Despite the extent
of viable options described herein, it has still been estimated that more than 40% of
highly potent NCEs fail to reach clinical trials owing to their poor aqueous solubility.15
Therefore, alternative methods need to be rigorously explored, and more fundamentally
understood.
Controlled solid state modifications comprise an additional tactic for aqueous
solubility enhancement on the principle that different solid forms have different
physicochemical properties. Adoption of metastable forms, however, is limited by their
potential to convert to a more thermodynamically stable form in pharmaceuticallyrelevant time-frames.12 Formation of binary amorphous molecular solid dispersions
offers a method for physically stabilizing the amorphous phase of a drug substance.
Generally speaking, amorphous molecular solid dispersions are formed by the cosolidification of a drug and polymer, in a specific ratio, producing an overall amorphous
phase displaying short-range order unique from that of either amorphous component.
These systems, coupled with other composite entities (e.g. eutectics and solid solutions)
are commonly implemented in manufacturing in the areas of metallurgy,16
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microelectronics, and superconductor technology, where their controlled formation is
well understood in the optimization of specific materials properties (other than solubility
enhancement).17,18
The application of composite systems to pharmaceuticals is highly empirical,
where solid dispersion potential screening may involve multiple concentration points (i.e.
drug to excipient ratios), various excipient (e.g. polymers) materials, and different
methods of preparation. The raw material requirement involved with this assessment in
early drug development stages remains an impediment for producing viable dosage forms
from this technology. Given this, the commercial availability of these systems in
currently marketed pharmaceutical dosage forms is limited.8,19
Predicting drug:polymer solid dispersion compatibility/stability presents a
difficult task, which suffers from the absence of universally applicable rules describing
the molecular requirements for physically stabilizing amorphous therapeutic agents.
Attempts to empirically model solid dispersed systems have yielded conflicting accounts,
which are seemingly due to the dependency of specific stabilization effects on the
particular components in the system, as well as inconsistencies in analytical
characterization. The insensitivity to structure at the short-range order level frequently
impedes identification of miscible products from phase-separated products. Additionally,
variable reports on the presence of adhesive drug:excipient interactions oftentimes
prevents accurate modeling/calibration of dispersion potential.
The random orientation of molecules in a molecularly dispersed system, as well
as the indiscriminate specific/non-specific bonding schemes, implies that miscibilityindicating features may be specifically related to properties of the individual molecules.
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Through in silico modeling, various molecular properties and descriptors can be
calculated from the compound’s atomic crystallographic coordinates. With the enormous
number of molecular properties available for modeling, a method for sorting through
multi-dimensional data is required. Materials informatics provides a statistically-robust
method for surveying multi-scale data to seek specific structure-property relationships
through linear/non-linear modeling. Coupled with identification of successful amorphous
molecular dispersion formation, this may ultimately provide an answer to determining
molecular requirements for successful formation of amorphous molecular solid
dispersions. The ability to predict the miscibility between a drug and polymer and
thereby limit the overall resource burden would significantly enhance the appeal of solid
dispersion technology.

1.2 Hypothesis and Objectives
The central hypothesis of this dissertation is that a combination of materials
properties exists that defines the propensity of an API to form a binary amorphous
molecular solid dispersion with polyvinylpyrrolidone:vinyl acetate (PVPva) copolymer
using the melt-quench process. In order to test this hypothesis, the following specific
aims were proposed and executed:
1. Due to the considerable complexity of composite materials relative to single
component systems, the quantitative ability of multivariate PXRD techniques
will be compared with traditional univariate methods to support the use of
full-pattern analyses on composite samples.
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2. The sensitivity of the PDF transform to subtle alterations in interatomic
distances of an API:excipient composite mixture induced by high compaction
pressures will be demonstrated with the goal of illustrating the potential of
finite phase differentiation using the short-range structural order.
3. A statistically-relevant method for interpreting PDF difference plots based on
the propagation of an initial PXRD error estimate will be derived and applied
to classification schemes for solid dispersion systems.
4. An informatics calibration from a molecular descriptor database will be
created to predict the potential of a compound to form an amorphous
molecular solid dispersion with a given polymeric carrier using a single
preparation method.
The purposes of the previous specific aims are: (1) to support the use of advanced
analytical techniques to improve the characterization of complex pharmaceutical systems;
and (2) to replace traditional empirical methodologies with advanced in silico modeling.

1.3 Literature Survey
1.3.1 Powder X-ray Diffraction
The discovery of X-radiation occurred in 1895 by W.C. Röntgen. It was not until
1912 when Max von Laue confirmed the wave character of X-rays from his single crystal
diffraction experiments that the birth of the X-ray crystallography field commenced.
Following von Laue’s three-vector dot-product description of X-ray diffraction, William
Henry Bragg and his son William Lawrence Bragg derived a simpler method for
understanding and predicting this phenomenon, thereby arriving at the well-known Bragg
equation (Equation 1.1):
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nλ = 2d sin θ

(1.1)

where λ is the wavelength of X-radiation, n is the integer value of wavelength
displacement satisfying constructive interference criteria, d is the interplanar spacing
between a pair of Miller indices, θ is equal to 2θ/2 and 2θ is the angle between incidence
and diffracted beams.20
According to Equation 1.1, when a particular set of molecular planes is oriented
toward an X-ray beam, X-rays will be diffracted at an angle (2θ) satisfying a particular
distance between planes. Although initially derived for single crystal samples,
applications of X-ray crystallography principles to powders (i.e. polycrystalline material)
provide the ability to study structural order without isolating a single crystal specimen.
The powder diffraction pattern arises from the assumption that a large number of
polycrystalline aggregates have crystallites in all possible orientations permitting the Xray beam to see all intermolecular planes. Powder X-ray diffraction (PXRD) has become
particularly useful practically, as structure-sensitive analyses may be applied to samples
obtained from all stages of various manufacturing unit operations.
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Figure 1.1. Example PXRD focusing arrangements (after Zevin and Kimmel21, with
modifications): (a) diverging incident radiation converges upon diffraction in reflectance
geometry; (b) converging incident radiation diverges upon diffraction in reflectance
geometry; (c) diverging incident radiation diverges upon diffraction in transmission
geometry; and (d) converging incident radiation converges upon diffraction in
transmission geometry.
Fundamentally, there are two primary geometric modes of PXRD analysis: (1)
reflectance and (2) transmission. Differences between the two setups involve the
convergence-divergence of the X-ray beam. In reflectance, the sample itself either: (a)
changes a divergent beam into a convergent beam or (b) changes a convergent beam into
a divergent beam. In transmission mode, an incident diverging beam remains divergent
upon diffraction and vise versa. From these definitions, four types of focusing
arrangements may be envisioned. The first scheme involves a reflectance orientation
where incident X-rays diverge with subsequently diffracted convergence and is
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commonly referred to as Bragg-Brentano parafocusing geometry (Figure 1.1a). The
second reflectance setup produces converging incident X-radiation with subsequent
diffracted divergence and is known as Seeman-Bohlin focusing geometry (Figure 1.1b).
The first transmission mode produces converging X-rays that display convergence upon
diffraction and is named for Guinier (Figure 1.1d). The second transmission mode,
which is much less common relative to the Guinier geometry, is divergent incident
radiation with subsequent divergent diffracted radiation (Figure 1.1c).21 Both reflectance
and transmission geometries have their own advantages and disadvantages that may be
ultimately reconciled into instrumental and chromatic effects.
The most commonly employed focusing scheme, Bragg-Brentano reflectance,
suffers from both instrumental and chromatic aberrations. Each error source has
scattering angle dependence, where instrumental effects decrease with increasing
scattering angle and chromatic effects increase with increasing scattering angle. There
are four inherent instrumental errors of particular significance that are largely a
consequence of the geometrically-imposed parafocusing circle. They include the axialdivergence error, flat specimen error, sample transparency error, and sample
displacement error, where the latter two are closely related.
The axial-divergence error arises from the divergence of X-rays within the plane
of the specimen, orthogonal to the theta angle. This anomaly produces asymmetric
broadening of Bragg diffraction peaks in the low two-theta direction. Additionally, it
introduces a decreasing negative error in two-theta up to 90°, then an increasingly
positive error beyond. To combat this issue, collimator slits comprised of a metal (i.e.
molybdenum for copper radiation), cut to a specific length, and evenly spaced apart are
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placed in between the source and sample, as well as, the sample and detector, to axially
focus the X-ray beam.20
The flat-specimen error, as indicated by the name, is due to the inability of the
entire irradiated sample to be co-concentric with the parafocusing circle. The sample
surface forms a tangent to the circle, where a different apparent irradiation distance for
specimen extremities results in diffraction at an angle lower than expected. The overall
pattern aberration is a broadening of Bragg peaks due to a distortion of the average radius
of the parafocusing circle. Assuming a fixed incident divergence slit, the magnitude of
the error is highly dependent on scattering angle, where decreasing divergent slit sizes
result in smaller errors.20
The principles associated with errors from sample transparency and sample
displacement are very similar, where both are a result of instances where the effective
diffraction surface lies above/below the focusing circle. Pharmaceutically-relevant SMO
compounds are effectively “transparent” to X-radiation, as the mass-attenuation of atoms
comprising these molecules is relatively low. The specimen-transparency error arises
when X-rays penetrate to layers below the surface with subsequent diffraction from
planes well below the focusing circle. It has been reported that decreasing linear
attenuation coefficients result in as much as a tenth of a degree peak shift and substantial
angular asymmetry.22 Practical difficulties associated with placing a specimen directly
co-concentric to the focusing circle lead to sample-displacement errors. Pattern
aberrations attributable to this error include low two-theta asymmetric peak broadening
and absolute peak shifts equivalent to 0.01°2θ for every 15 μm displacement.20
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To understand chromatic aberrations, an explanation of X-ray generation is
warranted. The production of X-rays is a highly inefficient process with respect to both
substantial heat generation and emission of polychromatic radiation. Copper X-radiation
is produced as a result of the displacement of electrons from its inner electron shell and
the concurrent replacement of those electrons from an outer electron shell. The demoted
electron releases energy equivalent to the energy difference between each orbital, which
is on the order of the wavelength of X-radiation. Typically, high current voltage is
passed through a tungsten filament, which is encased in a glass housing that possesses an
overall negative potential. As high current passes through the filament, electrons are
generated and subsequently directed towards the copper anode. When they collide with
the copper anode, electrons are displaced from the inner electron shell (normally 1s) and
subsequently replaced by an electron from an outer shell (2p→1s). This particular
transition produces Kα radiation. Also, a transition of electrons from the 3p shell (3p→1s)
results in radiation (termed Kβ) of shorter wavelength. Depending on the combination of
the angular quantum number and spin quantum number of the electron which transitions
from the outer shell, different wavelengths of radiation may be produced (Kα1/ Kα2 or Kβ1/
Kβ3).23
Nickel has an absorption edge at 1.488Å with mass attenuation coefficients for Kβ
and Kα radiation of 286 cm2/g and 49.2 cm2/g, respectively. By controlling the thickness
of a Ni filter in the path of incident/diffracted X-rays, considerable attenuation of Kβ
radiation with minimal affect on Kα intensity is possible. It is common practice to use Ni
filters, where 15 μm results in an integrated intensity ratio of Kα / Kβ = 50:1.20 Given this,
the bulk of chromatic aberrations are due to the inability to discriminate between Kα1 and
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Kα2. At large scattering angles, the Kα1/Kα2 doublet results in significant Bragg peak
broadening unless otherwise resolved. The use of a monochromator to remove Kα2
radiation is the most effective method; however, mathematical “stripping” may be carried
out through data processing, having knowledge of each respective profile (i.e. shape,
magnitude).24 Inaccuracies associated with the estimation of each wavelength’s
contribution to the overall diffraction peak when mathematically stripping Kα2, however,
may result in the introduction of substantial error into the data.
The transmission technique where a constant specimen-detector distance is
employed creates an analog similar to the back-reflection of the aforementioned BraggBrentano scheme. Given the conceptual similarities, it may be envisioned that a certain
likeness exists between errors encountered using Bragg-Brentano and transmission
schemes. Generally speaking, both instrumental and chromatic aberrations are much
lower in transmission geometry relative to reflectance, largely due to the focusing circle
placement at θ - 90°. This emulates back-reflection characteristics, and as previously
discussed, is approximately where instrumental aberrations decrease in Bragg-Brentano
setups. Chromatic aberrations are largely eliminated due to competitive dispersion
elements arising from the specimen and/or the mechanism used for incident X-ray
convergence, e.g. elliptical mirror. These factors largely reduce the separation between
the Kα1 and Kα2 components.21 In addition to lower instrumental and chromatic
aberrations, constant depth-of-penetration in transmission geometry results in increased
robustness to particle size, preferred orientation, and stress/strain aberrations relative to
traditional Bragg-Brentano reflectance, where depth of penetration varies with diffraction
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angle thereby amplifying these effects. When significant sample absorption is not an
issue, transmission geometry affords superior performance.
1.3.1.1 Quantitative Powder X-ray Diffraction
Ranging from univariate to full-pattern approaches, quantitative powder X-ray
diffraction (qPXRD) techniques have long been plagued with errors attributable to the
physical characteristics of the sample. Paramount to the list is the issue of sample
absorbance, where the electron density of the atoms comprising the specimen may result
in considerable radiation attenuation. The implementation of full-pattern multivariate
quantitative modeling will be discussed, specifically in the context of the aforementioned
instrumental and chromatic pattern aberrations.
The interaction between the radiation and matter is fairly complex, where
“absorbed” radiation may have been subjected to various other transformations. Total
absorption or energy loss as a function of passing through matter is due to a combination
of scattering and the photoelectric effect. General scattering occurs when radiation
interacts with matter, retains the initial energy/wavelength, but scatters at an angle not
defined by Bragg’s law (Equation 1.1). An instance where a decrease in energy of the
radiation occurs in addition to the previously described situation is commonly referred to
as Compton scattering. Radiation can be absorbed by atoms according to the
photoelectric effect, where the atom is excited and an electron is ejected. When the atom
returns to its ground state, another electron (Auger effect) or fluorescent radiation can be
emitted.25 The methods for absorption corrections in qPXRD applications range from
first principles estimations to empirical assessments with respect to a reference
material(s). The principles originally developed by Alexander and Klug26 for quantitative
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analysis of powder mixtures with respect to the absorptive properties of the sample are
the foundation for the forthcoming discussion.
The oldest method for absorption correction in qPXRD applications is a
univariate approach known as the internal standard technique.21 The specimen is spiked
with a known amount of a pure reference phase and subsequently analyzed as a mixture.
The ratio of unknown phase intensity to the internal standard intensity can be used to
determine the concentration of the unknown phase, as the ratio of intensity values are
independent of sample absorption. Analyte concentration values are, therefore, obtained
from a single experiment negating the need for a calibration. The weight fraction of a
phase j is given by:

cj = H

I ij

(1.2)

I hs

where Iij is the intensity value for the unknown phase, Ihs is the intensity value for the
internal standard, and H is a constant determined from knowing the weight of the internal
standard. In this analysis, intensity is taken as the peak height or integrated intensity.
In selecting an internal standard, a few considerations must be made. First, the
standard is desired to possess high symmetry, thereby producing a small number of
highly intense Bragg peaks. Additionally, sufficient isolation of the peak(s) used for the
unknown phase from that of the standard is also a necessity. The density of the internal
standard should be close to that of the unknown phase as to permit a homogeneous
distribution upon mixing.27 Finally, the standard material should be chemically stable in
the analytical environment.
The internal standard method is insensitive to unknown phases and therefore may
be implemented to analyze any crystalline material in a multiphase matrix. Lithium
15

fluoride was used to aid in simultaneously quantifying an enantiomeric material and
racemic compound mixture of ibuprofen, where limits of quantification were around
three percent.28 A potential disadvantage involves the physical addition of an internal
standard to the sample matrix. Errors in weighing and inhomogeneous distribution of the
standard may increase the uncertainty associated with the measurement. Further, the
methodology prevents analysis of composite samples intact, as the sample must be
destroyed and blended with the standard.
The most direct method for absorption correction is afforded through knowledge
of the mass absorption coefficient. This may be determined using a simple calculation
from the chemical composition23 or any direct experimental technique, provided the
determination is independent of the diffraction measurement. Born from this approach is
the diffraction-absorption method, where calibrations are created from correlating
standard samples to corrected intensity(s). If it is assumed that the absorption coefficient
for the unknown phase is the same as that for the entire sample matrix, the concentration
of phase j is given by:
(1.3)

c j = χ ij I ij

where Iij is a measured intensity value and χij is a calibration constant obtained by
analyzing any mixture with a known concentration of phase j. The use of a single
intensity value in this application may introduce significant error into the analysis due to
many of the systematic aberrations described previously. Variations in the lattice strain
and particle size, which commonly influence Bragg peak shape, are avoided by using the
integrated intensity.27
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Adaptations for constant and variable absorption coefficients have been
developed for multiphase analysis. Unfortunately, sources of nonlinearity other than
absorption can introduce errors into this type of calibration, including microabsorption,
extinction, and preferred orientation. The effect of preferred orientation may be
substantially different in a composite system than that exhibited by the pure phase, as
powder consolidation has been shown to induce preferred orientation.29 A qPXRD study
by Tiwari et al. to quantify polymorphs of a specific drug showed particle size and
preferred orientation errors significantly affected the number of identifiable peaks and
their respective integrated areas.30 To increase the accuracy and precision of their
method, substantial parameter and sample optimization was required beforehand, thereby
increasing raw material demands and other costly resources.
Full pattern techniques are particularly useful when peak overlap between
components occurs in a mixture. The most popular full pattern method for quantification
of crystalline phases was introduced by Rietveld,31,32 which was originally developed for
crystallographic structure refinement using single-crystal neutron diffraction data. It was
over ten years after its introduction before the Rietveld method was applied to X-ray data.
Once accepted by crystallographers, the number of publications citing this method
drastically increased.33 Under the Rietveld method, a powder pattern is thought of as a
collection of individual profiles the have a peak height, position, breadth, and an
integrated intensity proportional to the square of the structure factor. Being a structure
refinement technique, a starting structural model is refined to fit the experimentally
determined intensity values. Calculated intensity values are determined from the
structure factor (derived from a structural model) that sums neighboring Bragg reflection
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contributions plus a background estimate. Adjustable parameters in the calculation of the
structural model are iteratively altered as to obtain a least-squares minimization between
the calculated and experimental intensity values. No specific effort is made by the
Rietveld method to allocate an observed intensity to a particular Bragg peak or resolve
overlapped peaks, thereby mandating accurate initial model estimation.34 A central part
of Rietveld’s contribution stated information in overlapping peaks (unless coincident) is
not entirely lost when the peak profile function is known.
It was realized some time after the Rietveld method was proposed that the scale
factors derived from the analysis of multiphase diffraction data are proportional to crystal
phase composition when the product of the mass and volumes of the unit cell of each
phase are known.35 This full-pattern analysis proceeds with structural parameters,
experimental parameters, and scale values (weight fractions) that are simultaneously
refined against the experimental pattern. The Rietveld method has been successfully
applied to both inorganic and organic samples, where additional information concerning
preferred orientation may be gained from the analysis.36 This imposes a requirement of
crystallographic structure solutions for all phases present and thus precludes its use for
quantifying multiple amorphous phases, which is not to say that a collective amorphous
content is unavailable through mass balance.
In all of the qPXRD methods mentioned thus far, the overarching limitation, with
respect to pharmaceutical applications, is the inability to quantify multiple amorphous
phases. Although each ostensibly permits the ability to back-calculate the collective
amorphous element of a mixture, they all fail to address the individual contributions
comprising the disordered component. This is particularly important, as an increasing
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number of formulations contain amorphous excipients as well as disordered API, where
differentiation is paramount for claiming sensitivity. In an effort to assert sensitivity to
all components present in a mixture, other full pattern techniques that consider Bragg
diffraction and diffuse scattering have been developed.
The term “full pattern” with respect to qPXRD applications has traditionally
referred to two different types of analyses, one that solely solved the issue of overlapping
peaks and the other addressing the additional issue of multiple amorphous components.
The first approach is generally referred to as profile fitting, as clusters of overlapping
peaks are decomposed into components (i.e. individual peaks). Unlike Rietveld’s method,
structural data is not needed; rather, knowledge of peak shape (i.e. profile) and, less
importantly, position are used to decompose convoluted peaks. Once clusters are
separated, integrated intensity values are assigned to each component.21 These intensity
values can then be used in a calibration-based method, such as the diffraction-absorption
technique, or standard-based methods that do not require construction of a calibration, as
previously described.
The second approach may be tailored to handle the quantification of multiple
amorphous phases in a mixture. The entire powder pattern of a multiphase mixture is
assumed to be the sum of the scaled patterns of the individual phases present. Linear
combinations of each pure component pattern are used to create a simulated pattern that
can be compared with the experimental pattern. The scaling constants serve as estimates
of the mass fraction of each phase in the mixture. To date, it appears as though this
method has only been applied to pharmaceuticals in an effort to quantify the amount of
amorphous lactose in a multiphase mixture.37 The technique, however, could be
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theoretically extended to multiple amorphous phases, provided the diffuse scatter patterns
of each individual disordered component were unique.
For the aforementioned method, the advantage in handling convoluted peaks and
quantification of amorphous phase(s) without the creation of a calibration is contingent
upon a few factors. Diffraction patterns must be obtained for each individual component
comprising the mixture; impurities in the composite pattern or individual component
patterns would introduce error into the analysis. Each pattern in the analysis should be
collected using exactly the same parameters and conditions. Additionally, peak shape
and intensity must be consistent for a given phase to give reliable predictions. Much of
the success of implementing the latter full-pattern technique was attributable to invoking
a pattern normalization method based on Vainshtein’s law.37 This states that total
integrated diffraction intensity in reciprocal space is independent of phase, as total
electron density does not change with solid form, given constant mass. An important
interpretive assumption linked to this law imposes either: (1) the whole sample must be
irradiated throughout the entire angular range of the diffraction experiment; or (2) the
same mass of sample is irradiated throughout the entire angular range of the diffraction
experiment. If violated, the total electron density interrogated between samples would
vary. Issues with preferred orientation, particle size broadening, strain, and
microabsorption, unless uniformly observed between samples, will all introduce error
into the analysis.
From the preceding qPXRD discussion, it may seem apparent that an increased
sensitivity to materials that diffract X-rays at a lower intensity (e.g. amorphous,
disordered, nanocrystalline materials) is afforded through multivariate techniques.
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Recent qPXRD literature has introduced multivariate chemometric linear algorithms as
useful tools in pharmaceutical applications and demonstrated robust modeling
capabilities using classical least squares regression, principal components regression, and
partial least squares regression. The implementation of full-pattern analysis in
combination with creating a calibration, avoids many of the preceding issues. This is the
subject of Chapter 2.
1.3.1.2 Pair Distribution Function
The majority of pharmaceutical applications employing PXRD focus on analysis
of Bragg diffraction peaks only. These diffraction data contain highly useful information
pertaining to the global view of the structure (i.e. long range interatomic correlations).
To be rigorous, one must recognize that structure occurs at a local level (i.e. short- and
intermediate- range interatomic correlations), as well. When considering ideal crystalline
systems, this distinction is rather irrelevant, as the global structure is indicative of the
local structure. Lattice periodicity is a crucial element to the successful implementation
of Bragg’s law. If a material is not perfectly periodic, however, Bragg’s law does not
fully characterize the solid structure and researchers are forced to describe it in different
ways. Therefore, when deviations from average crystallographic order are present,
consideration of local structure packing becomes pertinent.
Given Bragg diffraction peaks contain information pertaining to global structure
only, additional data is required to investigate local structure. Total scattering methods
make use of the entire diffraction pattern and are sensitive to local level structure. The
name “total scattering” comes from intensity values encompassing Bragg peaks (average
structure), elastic diffuse scattering (static local structure) and inelastic scattering
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(atom/molecular dynamics).38 Total scattering analyses make use of the collection of the
aforementioned sources without resolving or differentiating the individual contributions
and are, therefore, sensitive to short- and intermediate-range interatomic correlations.
When an atom, j, is irradiated by an incident wave, the total scattering amplitude
of the wave due to the sample is given by:

ψ(Q) =

1
f

∑f e

iQR j

(1.4)

j

j

where ψ(Q) is the sample scattering amplitude, f is the atomic scattering factor, ‹›
indicates the average, Rj is the position of the jth atom, and Q is the diffraction vector or
momentum transfer.38 The momentum transfer is essentially equivalent to the change in
momentum between the incident wavevector and the scattered wavevector. If it is
assumed that only elastic scattering is considered, the wavelength of each respective
vector would remain constant, and thus the magnitude of the momentum transfer is given
by:
Q =

4 π sin θ
λ

(1.5)

where λ is the wavelength of radiation used, θ = 2θ/2, and 2θ is the maximum scattering
angle interrogated in the experiment. In deriving the sample scattering amplitude
(Equation 1.4), the kinematic approximation was made, thereby only considering single
scattering events.
Since the sample scattering amplitude can not be directly measured, it becomes
highly advantageous that the square of its magnitude is directly related to the intensity of
the diffracted beam. Although PXRD intensity data are collected in “reciprocal space” as
a function of Q, a direct representation of the real structure (i.e. real space domain) may
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be obtained by Fourier transform of scattered intensity. The pair distribution function
(PDF) transform is a total scattering method that exploits the Fourier relationship
between reciprocal space and real space. The basis of this method resides in the structure
function, S(Q), which is the normalized scattering intensity measured from a sample (i.e.
normalized PXRD pattern). The magnitude of the structure function with respect to the
wavevector will be highly dependent on the direction interrogated in Q-space. A
simplification occurs when scattering becomes macroscopically isotropic, as only the
magnitude of the scatter (and not direction) is important. Isotropic scattering is easily
envisioned for liquids, gases, and glassy materials; however, it is also reasonably
assumed for fine crystalline samples, where each individual crystallite is not isotropic,
but the ensemble of scattering is.38 The PDF, G(r), is therefore obtained as follows:

2
G (r ) =
π

∞

∫Q [S (Q ) - 1]sin( Qr )dQ

(1.6)

0

= 4 πr [ρ(r ) - ρ 0 ]

ρ( r ) =

1
4πr 2

fi f j

∑
ij

f

2

(1.7)

δ( r - rij )

(1.8)

where r is the distance between two atoms, ρ(r) is the microscopic pair density, ρo is the
average number density, f and ‹› are defined above, and δ is a delta function. The PDF
gives the probability of finding two atoms separated by a distance, r and is thus
attributable to some atom-atom relationship, or interatomic correlation.39
From Equation 1.6, the integration of the function is taken from Q = 0 to Q = ∞
for an infinitely precise computation of the PDF. The PDF of a perfectly crystalline
material would display constant-amplitude oscillations in G(r) to infinity. In reality,
however, Q can only be measured over a finite range (i.e. Qmax). The result is the
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amplitude of the signal gradually falls off in G(r), not due to the limitation of structural
coherence, but rather a limitation in spatial coherence of the measurement. The finite Qresolution of a PXRD experiment can be the source of termination ripples (λ ~ 2π/Qmax)40
in the PDF, unless treated appropriately.
In a PXRD experiment, substantial corrections need to be made to intensity data
prior to Fourier transformation. Generally speaking, a number of estimates and
approximations are made when calculating the normalized structure function, thereby
inducing some distortion(s) to the intensity data. Fortuitously, inadequacies in the data
normalization result in long-wavelength distortions to the structure function that manifest
as nonphysical features (ripples) at very low r values in the PDF.41 These inadequacies
are often dealt with through an arbitrary mathematical correction, including varying the
sample density during scaling, varying the beam width, or scaling the structure function
itself.
Although the sample density is fairly easy to determine with reasonable accuracy,
it can be varied to produce a structure function consistent with its asymptotic
requirements. Varying sample density applies a predominantly multiplicative correction
to the structure function, as is strongly affects both intensity normalization and absorption
correction. Although the beam size is known from the collimation of the instrument, the
beam may not be homogeneous.41 The effective beam width will be different from the
physical dimensions due to varying intensity across the beam profile. Varying the beam
size is primarily a multiplicative correction to the resulting structure function, as well.
Both corrections can have additive components when multiple scattering manipulations
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are applied. Finally, directly scaling the structure function itself using multiplicative,
additive, or a combination of the two, may be used to optimize the Fourier transform.
The selection of the value(s) to vary is arbitrary if some sort of quality criteria is
implemented to assess the validity of optimization. The PDF is highly sensitive to the
asymptotic behavior of the structure function in the high Q region, which could
ostensibly serve as a quality metric. The density, beam width, or scaling factors would be
varied to produce a structure function that asymptotes one. Alternatively, the greatest
manifestation of improper structure function correction is the introduction of ripples in
the low r region of the PDF, and therefore, a quality criterion derived from this anomaly
is more suitable. The ΔGlow metric is given by:
rlow

∫[ rG ( r ) + 4 π r
Δ G low =

2

ρ fit ] 2 dr

0

(1.9)

rlow

∫( 4 πr

2

2

ρ fit ) dr

0

where rlow is a region in r before the appearance of the first physically possible peak, and
ρfit is the average number density. From the Equation 1.9, the ΔGlow criterion is a
measurement of the magnitude of ripples in the region between r = 0 and r = rlow.
Parameters are varied, as described above, to effectively minimize the ΔGlow metric. A
study by Peterson et al.41 concluded the ΔGlow criterion was more robust than other
options, and the choice of the parameter to vary during optimization (i.e. sample density,
beam width), for all practical purposes, is inconsequential, as all seemingly yielded the
same result.
Justification for using high energy synchrotron radiation for X-ray diffractionbased PDF studies is warranted in the mere definition of the magnitude of the momentum
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transfer. The increase in spatial coherence of the measurement and decrease in
nonsensical artifacts from the Fourier transform are as good a reason as any to use
synchrotron radiation for all PDF studies. It is impractical, however, for the average
researcher to perform all studies using this highly sought, expensive technology. Bruhne
et al.42 showed that PDF transforms obtained from both synchrotron and laboratory

source data on three icosohedral alloys were qualitatively comparable and both suitable
for least squares local structure refinement. This is ultimately attributable to the robust
nature of the PDF transform with respect to errors in the structure function, as previously
discussed.
The PDF has been extensively applied to inorganic-based materials assessment
since its introduction into the literature. One of the largest applications involves material
structure refinement, where successful structure elucidation for atomic amorphous
materials43,44 and intrinsically disordered materials44-46 has been reported. In addition,
size-dependent structure and strain of semiconductor nanoparticles45 and assessment of
thermal motions46,47 in atomic structures are becoming more routine. Although the
number of pharmaceutically-related PDF applications is substantially less, the increased
exposure from recent publications is significantly advancing the interest among scientists
in the field.
Pharmaceutical processing involving high-energy input is commonplace in the
manufacture of solid oral dosage forms. Shear-intensive particle milling, powder
consolidation, and thermal challenging (i.e. fluid bed drying) all have the potential to
affect structural order in pharmaceutical powders. Of the PDF applications published in
the pharmaceutical literature, the overwhelming majority have transformed standard
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laboratory X-ray data. Sheth et al.48,49 used PDF transforms to explain local structure
differences in amorphous phases created from milling different polymorphic forms of
piroxicam. Interestingly, residual long range order in cryogenically milled samples
explained recrystallization habits of different polymorphic forms of the starting material.
A study by Bates et al.50 assessed the potential of the PDF transform to describe the
nature of an amorphous substance. From their analysis, materials were classified as
disordered nanocrystalline or amorphous. Disordered nanocrystalline materials exhibited
peak broadening as a function of increasing introduction of disorder. The final X-ray
amorphous halo had specific correlations to highly intense Bragg peaks displayed by the
crystalline material. Additionally, a comparison between PDF transforms revealed
interatomic probability peak correlations between the disordered nanocrystalline material
and crystalline material. In contrast, PXRD patterns of amorphous materials did not
display peak broadening as a function of continuous disordering. Further, the PDF of
amorphous materials relative to crystalline material displayed significant differences.
Again, from distinguishing different types of disordered materials, information
concerning recrystallization behavior was gained.
Dehydration-initiated crystalline-to-amorphous conversions must be considered
during high-temperature pharmaceutical processing, such as that observed for raffinose
pentahydrate. Authors proposed a quasi-mechanism for this transition using PDF
transforms obtained as a function of drying time.51 The study revealed that a defectmediated process led to the collapse of the crystalline structure, where retention of the
crystalline order was accompanied by significant defect generation during the loss of the
first two water molecules. Additional heating beyond this point resulted in a total
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collapse of the intermediate- and long-rang order of material structure. The ability of the
PDF transform to yield information concerning defect-generated disordering due to
shear-intensive and high energy input processing, as illustrated in the previously
discussed examples, foreshadows its potential use in investigating structural changes
resulting from powder compaction, which is ultimately the subject of Chapter 3.
In addition to the lack of Bragg diffraction peaks exhibited by amorphous
molecular solid dispersions, PXRD patterns have been shown to provide additional
information pertaining to local structure in these systems. The sensitivity of the PDF
transform to interatomic correlations makes it an obvious choice for studying
pharmaceutical systems displaying order on only a short length scale. One of the most
recent applications of the PDF transform to pharmaceutical systems is in the
characterization of co-solidified products to aid in identifying miscibility between a drug
and polymer (Section 1.3.2). Newman et al.52 illustrated the principles behind the use of
PDF transforms to distinguish co-solidified products possessing unique short-range order
relative to the amorphous components that comprise the mixture. The method involved
obtaining PXRD patterns of the amorphous phases comprising the co-solidified product,
as well as, one for the co-solidified product itself. All PXRD patterns were subsequently
transformed by the PDF algorithm and linear combinations of the amorphous component
PDFs were compared to the PDF of the co-solidified product. If the calculated PDF
exacted a “good fit” to the PDF of the composite, the co-solidified product was
categorized as phase-separated, due to the absence of a unique packing pattern. If a good
fit could not be obtained, the co-solidified product was categorized as completely
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miscible, due to formation of unique short-range order (i.e. nearest neighbor and nextnearest neighbor correlations) not explained by the individual amorphous phases.
The power of this method is quickly realized by the scientist charged with the task
of determining miscibility in drug:polymer products, an all too often intangible
distinction. Upon first glance, an initial weakness is the necessity of obtaining
amorphous phase samples for each of the pure components. As the purpose of forming a
solid dispersion is to physically stabilize the amorphous form of a drug, the ability to
isolate and physically maintain a sample to provide sufficient analysis time is not trivial.
A second limitation was the ambiguity with which an assessment of “difference” was
made between linearly combined PDF transforms and the transform of the co-solidified
product. To make the analysis more robust, a method has been proposed to propagate
error estimates for the calculated difference and is the subject of Chapter 4.
1.3.2 Solid Dispersions
Rigorous differentiation between the different composite systems, such as
eutectics (Appendix A) and solid dispersions, is somewhat ambiguously presented across
the breadth of the pharmaceutical literature. This leads to a systematic misclassification
of these products, thereby founding fundamentally irrelevant conclusions from studies
encompassing the subject area. A more accurate approach to defining and contrasting the
individual composites can be realized through a strict materials-based structural
assessment. Analogous to the way in which crystal symmetry defines a crystal system
(and not vice versa) the microstructure of a binary solid composite defines its type. From
these definitions, analytical techniques required for accurate product classification are
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identified, a better fundamental understanding of aqueous solubility enhancement can be
provided, and issues inherent to the underutilization of the technology is established.
1.3.2.1 Structure
The three types of symmetry defining long-range crystallographic order are
translational, orientational, and conformational. Crystalline solids have all three, where
mesophase materials possess one or two.53 In amorphous materials, all three symmetry
operators are characteristically absent; therefore the orientation and position of molecules
relative to one another is random, as similarly observed in liquids, but short-range order
over a few molecular dimensions is present.54,55 The thermodynamic relationship
between crystalline and amorphous phases is best rationalized schematically in the
enthalpy-temperature phase diagram (Figure 1.2). Starting with a crystalline material,
small changes in temperature correspond to minor changes in enthalpy response, where
the slope defines the heat capacity of the solid at constant pressure. Upon further
increase in temperature to Tf, a discontinuity in the diagram is encountered and a sharp
increase in enthalpy is observed. This is the first-order fusion event representing the
crystalline-to-liquid transition. If the melt is rapidly cooled, enthalpy may bypass the
melting/freezing point producing a supercooled liquid. Upon further cooling the glass
transition event is encountered, where a change in heat capacity is observed due to a
higher-order transition from a supercooled liquid to a glass. Any additional cooling is
thought to have very little influence on the microstructure of the material.56 The
Kauzmann temperature (TK in Figure 1.2) represents the temperature at which the
entropy of a supercooled liquid would fall below that of the stable crystalline material.

30

The change in heat capacity that occurs at the glass transition prevents the hypothetical
decrease in entropy to permit this phenomenon.57

Figure 1.2. Enthalpy:temperature phase diagram.
From Figure 1.2, the glass is a higher free energy phase compared to its
crystalline counterpart, and further deviates from equilibrium. The system is said to be
kinetically “trapped” in the solid state, as it exhibits increased molecular mobility relative
to the crystalline phase, but lower than that of the liquid state. The higher free energy
provides for enhanced apparent aqueous solubility, as NBIs maintaining the solid-like
viscosity are weaker than those responsible for crystalline counterpart.58 A corollary of
this solubility enhancement is the thermodynamic driving force to revert back to the
lower energy, crystalline phase. To maintain the amorphous phase and sustain the
solubility enhancements, solid dispersions are formed between an amorphous drug
substance and a polymeric carrier material; although, the exact mechanism of physical
stabilization is largely unknown.
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A binary amorphous molecular solid dispersion is a material consisting of two
components co-solidified such that the short-range order of the product is distinct from
that intrinsic to the amorphous phases comprising the mixture. Since solid dispersions
are macroscopically amorphous systems, it is worthwhile to note that this implies that
they are also non-equilibrium phases. Many of the models founded on equilibrium
thermodynamic principles may be highly inappropriate for solid dispersions. As a
consequence, specific mechanistic explanations describing structural correlations
between solid dispersion co-solidification and observed physicochemical and mechanical
properties of these systems are lacking. This void is also an effect of the random
orientations of the drug and carrier molecules, as well as the heterogeneity of the
interactions between the two components, which ultimately differ between single- and
two-phase systems. Both specific (i.e., hydrogen bonding) and nonspecific (i.e., van der
Waals forces) intermolecular interactions, however, have been characterized in solid
dispersed systems, and are well represented in the pharmaceutical literature.59-62 The
extent of the participation of these interactions in solid dispersion stabilization (or lack
thereof) continues to be a matter of discussion.
The lack of periodic NBI schemes in amorphous materials results in a higher
internal energy, which can provide enhanced physicochemical properties, such as
increased apparent aqueous solubility and/or enhanced dissolution. The random
structural framework of solid dispersed systems and the presence of various combinations
of specific/non-specific bonding schemes, make direct correlations between structure and
enhanced solubility less straightforward than other composite bodies (e.g. eutectics). The
increase in dissolution rate of solid dispersions, however, has been attributed to three
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factors: (1) reduction in drug particle size (i.e., in molecular dispersions, the “particle
size” of the amorphous inclusion is on the order of the dimensions of the API molecule),
(2) decreased drug:water interfacial energy, and (3) establishment of weaker NBIs per
unit volume material relative to the NBIs per unit volume of the drug’s crystalline
phase.19,63 Given the number of possible structural variants, the degree to which each of
these contributes to the optimized physicochemical properties may be dramatically
different. It may seem apparent from the preceding discussion that more rigorous
structural characterization will be required to model physicochemical benefits afforded
through the directed design of solid dispersions. Furthermore, these benefits will vary
with respect to individual systems; a universal model of solid dispersion structurefunction correlation seems impractical.
A review by Craig64 introduced a model that explained the release behavior of
drug molecules from a solid dispersion as being either carrier-mediated or drug-mediated.
A representation of these two schemes is illustrated in Figure 1.3, where drug release
from a two-phase solid dispersion is shown. Initially, a polymer-rich diffusion layer is
formed at the interface between the solid dispersion and the dissolution medium. The
viscosity of this interfacial layer is assumed to be greater than that of the liquid phase. In
carrier-mediated dissolution, the amorphous drug inclusions (assuming a biphasic solid
dispersion) diffuse from the dispersion matrix into the polymer-rich phase, where they
begin to dissolve. Drug is further released from this polymer-rich layer into the
dissolution medium as either solvated molecules, or as amorphous particles having
undergone size-reduction, at a rate dictated by the carrier.
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Figure 1.3. Schematic showing various release modes of amorphous drug inclusions
during dissolution of a solid dispersion (after Craig,64 with modifications); (a) carriermediated dissolution: the carrier forms a polymer-rich phase aiding in initial drug
complex dissolution; (b) drug-mediated dissolution: high solubility of the carrier in the
dissolution medium prohibits formation of a polymer-rich phase; dissolution of the drug
occurs following diffusion of the amorphous complex from the dispersion to the
dissolution medium; (c) Complex aggregation following drug-mediated dissolution:
amorphous inclusions agglomerate upon diffusion into the dissolution medium, resulting
in their higher propensity for devitrification.
In drug-mediated dissolution, the solubility of the polymer in the medium is
considered to be much greater relative to the dissolution time-frame, ultimately resulting
in a polymer-rich layer that is smaller relative to the polymer-rich phase observed in
carrier-mediated dissolution. As the drug inclusions diffuse through the polymer-rich
phase, the rate is sufficient to prevent their dissolution in the polymer layer. The
amorphous drug is, therefore, released intact into the surrounding aqueous medium, and
its dissolution rate is proportional to the aqueous solubility of the amorphous condensed
phase. In both instances, solubility enhancement relative to crystalline materials is
provided owing to either the total breakdown of drug inclusions prior to release in the
medium (carrier-mediated), or to the release of amorphous complexes left to dissolve on
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their own (drug mediated). Craig proposes the application of this model to aid in
identifying the correct strategy to improve dissolution via solid dispersion formulation.
More importantly, the model may assist in understanding the basis for formulation
instability, as related to dissolution, and provide a scientific approach to dealing with
such issues.
A route of physical instability occurring during dissolution that is directly related
to the drug-mediated model for solid dispersions is depicted in Figure 1.3c. When the
amorphous inclusions diffuse through the polymer-rich diffusion layer too rapidly, and
their dissolution rate in the aqueous medium is relatively slow, a time-frame sufficient to
promote recrystallization may be encountered. Nucleation and growth can be thought of
as occurring by, (1) each individual amorphous complex begins the recrystallization
process independent of other amorphous complexes, or (2) agglomeration of amorphous
complexes creates high-energy interfacial boundaries, thereby driving the interfacial term
of nucleation models to favorable values. The latter of these two conditions is expected
to be more prevalent, as reduction in specific surface area upon formation of
agglomerates would slow the dissolution rate even more, permitting a longer time-frame
for recrystallization. This particular mechanism of physical instability illustrates the
importance of excipient selection in solid dispersion formulation; notably, the relative
aqueous solubility of the carrier component may induce physical instability during the
dissolution process. Further, as will be discussed in greater detail, the relationship of
manufacturing methods to resulting solid dispersion structure becomes an important
variable when considering release behavior.

35

The review by Craig was an important step in correlating the release behavior of
solid dispersions to formulation, stability issues, solid dispersion design, etc. However,
the proposed model fails to address structurally-related bases for the proposed differences
in release (e.g., effects of intermolecular interactions between drug and carrier on drug
release mechanism) and focuses specifically on biphasic systems, thereby neglecting
molecularly dispersed solids. Karavas et al.,65 more recently reported that the molecular
interactions between felodipine:polyethylene glycol (PEG) &
felodipine:polyvinylpyrrolidone (PVP) dictate the resulting physical state of felodipine
(crystalline versus amorphous), as well as the size of inclusions in the dispersed matrix.
The additional characterization of the solid dispersion enabled the authors to ascertain the
release mechanism as related to the specific structure of the dispersion and to identify
critical manufacturing attributes which altered the structure and release mechanism.
The preceding discussion demonstrates the size-dependence of the carrier matrixdispersed inclusions on the release mechanism, and the additional implications
concerning physical stability of the material during dissolution. Unfortunately, the
structural heterogeneity of the solid dispersion variants often deters rigorous intrinsic
correlation to physicochemical properties, creating an area having tremendous research
potential.
1.3.2.2 Manufacture
The traditional methods for manufacturing solid dispersions can generally be
broken down into two general categories: (1) fusion-based methods and (2) solvent-based
methods. Sikiguchi and Obi66 were the first to demonstrate the use of a hot-melt
procedure in the production of pharmaceutically-relevant solid dispersions. Subsequently,
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Tachibani and Nakumara67 dissolved both a drug and carrier in a common solvent, which
was then evaporated under vacuum to produce a solid dispersion. In the production of
binary solid composites, each method has its own advantages and disadvantages
stemming from production costs, ease of manufacture, scalability, and other critical areas.
In the last decade, new techniques have emerged which address one or more of these
deterrents. Some of the barriers that complicate the application of each individual binary
composite to pharmaceuticals manifest through investigation of the manufacturing
regimes.
Since solid dispersions are structurally aperiodic, methods not traditionally used
in other solid composite production may be employed in their creation. Spray drying,68,69
lyophilization,63 fluid-bed coating,70 and hot-melt extrusion71,72 have all been used in
pharmaceutically-related manufacturing of solid dispersions, as these processes are
known to result in amorphous products. Current literature shows a trend in development
of new schemes for solid dispersion formation that are fundamentally similar to
traditional techniques; however, the newer methods have been shown to possess various
benefits relative to their conventional counterparts, thereby deserving attention. It may
be worthwhile to note that although these methods are common in the sense that an
amorphous co-solidified product is formed, it has been shown that common
manufacturing methods may, in fact, have an effect on the supersaturation of drug in
polymer.73
In a recent study, Papadimitriou et al.,74 used microwave irradiation in place of
conventional heating to melt the drug and carrier mixtures and then compared the
resulting dispersion with that prepared by the conventional fusion technique. In both
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instances, the resulting dispersions were two-phase systems possessing an element of
periodicity; therefore, neither product would be defined as a solid dispersion according to
the criteria proposed in this paper. The authors claimed a reduction in production time by
using microwave radiation with a slight enhancement in the dissolution profile. However,
the biphasic dispersion produced using this method was shown to result in a smaller
particle size, which may better explain the improvement in dissolution kinetics.
Although the authors attributed the decrease in particle size to the use of microwave
irradiation, this actually appears to be a consequence of the more rigorous mixing regime
employed. The practicality of scale-up for this particular method may also limit its
potential for adoption at the industrial level. In addition to the limitations imposed by
capital investment, since pharmaceutical applications of microwave technology are
relatively new to the industry, considerable attention to issues involving distribution
homogeneity, implications of microwave energy on chemical stability, and other methodrelated topics is required.
Xu et al.,75 developed a pulse combustion dryer system designed from the basic
principles of spray drying. A combustion cycle is repeated at a specific frequency to
produce consecutive high-temperature shock waves used to rapidly dry solutions of drug
material and carrier. Advantages of the system include an increased rate of heat transfer,
decreased drying time, and lower costs compared with conventional spray drying.
Studies show an enhanced apparent dissolution rate for ibuprofen solid dispersions
prepared using the pulse combustion dryer versus conventional spray drying. The
authors failed to present structural characterizations for both products; therefore, the
aforementioned dissolution advantage may be due to the decreased particle size of the
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pulse combustion dryer final product relative to the conventional spray dryer product.
Once again, the cost of developing a pulse combustion dryer system for large scale
production may outweigh the benefits afforded by this technology.
Supercritical fluid processing was shown to be a valid alternative to the solventevaporation method resulting in lower residual organic solvent, co-precipitates possessing
smaller particle sizes, and better flowability. In the work by Sethia and Squillante,76 the
authors showed that solid dispersions prepared by supercritical fluid processing (SCP)
had an enhanced intrinsic dissolution rate relative to dispersions made via conventional
solvent evaporation (SE) augmented with amphiphilic carriers, thereby eliminating the
stability issues associated with lipid carriers. Powder X-ray diffraction analysis of
products prepared by both SCP and SE augmented with an amphiphilic carrier revealed
highly disordered materials; however, a closer look at the PXRD pattern of the SE
product reveals some Bragg diffraction peaks attributable to the amphiphilic carrier. The
solubility advantage of this material is most likely due to considerable amorphous content;
however, the presence of phase-separated crystalline solid suggests incomplete
preparation of an amorphous dispersion via the SE method. As with the other novel
methods suggested above, although this technology holds some advantages, industrial
scale-up may present a major cost-related barrier to its adoption.
Many of the authors presenting the manufacturing alternatives above advocate the
cost-effectiveness of their respective processes in terms of efficiency (primarily
decreased processing time) yet do not present a cost analysis to support their claims. As
a supplement to structural and physicochemical comparisons, contrasts in small-scale
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research costs as well as large-scale manufacture should be considered when suggesting
the viability of a new manufacturing technology.
Typically, studies involving the structural characterization and assessment of the
physicochemical properties of solid dispersions only consider solids produced by a single
manufacturing scheme. In contrast, Dong et al.,77 published results that compared the
solid state properties of dispersions prepared both by hot-melt extrusion and solvent coprecipitation. In this study, a proprietary compound was evaluated for its potential
development as a solid dispersion formulation. Dispersions were prepared using
hypromellose acetate succinate (HPMC-AS) as the carrier molecule, via hot-melt
extrusion and solvent co-precipitation. Both methods were observed to yield a singlephase (molecularly dispersed) amorphous dispersion. Differential scanning calorimetry
(DSC) analysis of each product showed them to have a single glass transition event,
occurring at comparable temperatures. The co-precipitation product, however, was
determined to be more porous than the hot-melt extrusion product, thereby resulting in a
larger specific surface area. The co-precipitation product had a faster dissolution profile,
but a slower intrinsic dissolution rate relative to the hot-melt extrusion product. Though
the authors did not suggest a reason for this observation and noted that it was unexpected,
a possible explanation may be drawn from classical Noyes-Whitney dissolution theory:
dM
DS
=
(C s - C )
dt
h

(1.10)

where M is the mass of the drug dissolved in time t, D is the diffusion coefficient of the
drug in the dissolution medium, S is the surface area of the exposed drug, h is the
thickness of the diffusion layer, Cs is the solubility of the drug, and C is the concentration
of the drug in the bulk solvent at time t.2 Traditional dissolution profiles were generated
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by suspending the product in an aqueous vehicle and transferring it to a United States
Pharmacopeia (USP) type II apparatus (paddles). In these experiments, the coprecipitation product reached its plateau dissolution value possibly attributable to the
increased value of S relative to the hot-melt extrusion product. Intrinsic dissolution
studies were conducted by compressing each product at 2000 lbs. force to form a pellet
having a constant exposed surface area. Given that one of the principle steps in
consolidation is a reduction in void volume, or porosity, it is not unexpected that the
surface area enhancement gained by employing the solvent co-precipitation method was
lost. Normalization of the final compacted pellets to their solid fraction may explain the
enhanced intrinsic dissolution observed for the hot-melt extrusion product.
The authors also showed an enhanced physical stability of the hot-melt extrusion
product over the dispersion produced from the co-precipitation process, which once again,
may be related to a specific surface area argument. The co-precipitation product, having
a larger specific surface area, possesses more accessible sites for water molecules relative
to the hot-melt extrusion product. The presence of water on the surface of amorphous
materials can create supersaturated microenvironments which serve as nucleation sites.
Additionally, water may act as a plasticizer,78 thereby theoretically increasing the
molecular mobility.
Though this study illustrates that the various physicochemical properties of solid
dispersions may be dependent upon the manufacturing method, it fails to address specific
structural differences which may contribute to these properties. For example, a powder
X-ray diffraction pattern was shown for both products to illustrate an absence of Bragg
diffraction peaks inherent of a crystalline material, which may be a result of the material
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being truly X-ray amorphous or an artifact of inappropriate sensitivity to adequately
detect diffraction. Advanced methods in diffraction pattern processing (e.g. pair
distribution function transformation) may have been applied to delineate local structure
differences between the two products, where a correlation to these differences may be
established. Creation of models to explain and predict these types of phenomena will be
imperative to understanding and applying these systems for commercial manufacturing
and may ultimately result in the increased use of solid dispersions in pharmaceuticals.
1.3.2.3 Stability
The amorphous state possesses a higher free energy relative to its crystalline
counterpart, which should result in enhanced thermodynamic properties (i.e. solubility)
and molecular motion. A consequence of this increased molecular motion is the tendency
to revert back to a stable crystalline phase (devitrification).56 Thermodynamically,
amorphous substances will inevitably devitrify; however, the time frame of this process is
at the heart of research directed at stabilizing these materials. In addition to physical
drivers for recrystallization, environmental factors, such as water, must be considered for
dispersion systems, where the hygroscopicity of the polymeric carrier may be a
significant factor.79 Oftentimes strategies to deal with physical stability issues in
pharmaceutical products do not require elimination of the source for the mechanism of
instability; rather, the kinetics of the transformation are manipulated to prolong a
product’s shelf life.
Molecular mobility is frequently described as a key factor in the physical stability
of amorphous phases.80 The glass transition, commonly represented as a single value (Tg),
actually occurs over a temperature range delineating high and low molecular mobility
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within the material. Evidence of increased resistance to recrystallization in solid
dispersions has been attributed to antiplasticization when polymeric carrier components
having a higher Tg relative to that of the drug are used.81 However, other reports show
examples where differences in Tg values between carrier components and API were not
correlated to the physical stability of the dispersions studied.59,82 Both specific and
nonspecific intermolecular bonds have been shown to occur in stable solid disperse
systems. This includes direct bonding interactions between carrier and drug molecules
and/or the disruption of drug:drug interactions (e.g. dimer formation)48 by the carrier.48,83
In conflicting reports, however, these interactions are shown unnecessary in the
prevention of recrystallization.81 Consequently, the preceding points illustrate the
difficulties with identifying and the limited understanding of the physicochemical
properties of the carrier necessary for inhibiting drug devitrification.
The Gordon-Taylor equation,84 based on the mechanistic approach of free volume
and related densities, has been successfully applied to predict Tg of molecular dispersions
and is given by:
T g12 =

w 1T g1 + Kw 2T g 2
w 1 + Kw 2

(1.11)

where w1 and w2 are the weight fractions of each component, Tg1 and Tg2 are the
respective glass transition temperatures, and K = (Tg1ρ1)/(Tg2ρ2), where ρ is the density of
the component. A variation of Equation 1.11, where K = ΔCp1/ΔCp2 and derived from
more thermodynamic assumptions, was later identified by Couchman and Karasz.85
Although the Gordon-Taylor equation has been shown to be highly useful when both
components are large polymeric materials, it has been shown to poorly predict SMOpolymer systems. Additionally, since many of the empirical parameters of each equation
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are determined using thermodynamic techniques (e.g. DSC), it is somewhat more
appropriate to use the Couchman-Karasz version of the equation.86
Recall that formation of solid molecular dispersions assumes complete
drug:polymer miscibility in the liquid phase, which, as previously interpreted, means that
adhesive interactions must be comparable to cohesive interactions (in the liquid phase).
In the case of antiplasticization, some intermolecular interactions between the polymer
and drug would be anticipated to decrease the molecular mobility of the amorphous
system. This definition suggests a correlation between the two proposed mechanisms of
stabilization, where this combination has been reported in studies as the underlying
mechanism of stabilization.83
In order to maintain the advantage of drug substance solubility enhancement
provided by its preparation in the amorphous state, methods to preserve its physical
stability over a pharmaceutically-relevant time scale must be employed. Water-soluble
polymers such as PEG, PVP, and cellulose derivatives (e.g. hydroxypropylmethyl
cellulose) are commonly incorporated as carriers in pharmaceutical solid dispersions.
Much of the current research investigates the specific stabilization mechanisms afforded
by polymers in pharmaceutical solid dispersions. For amorphous molecular solid
dispersions, it is recognized that devitrification is preceded by amorphous drug:polymer
phase separation, in the case of nucleation and growth.87 In a study by Konno and
Taylor59 the ability of three polymers to inhibit the recrystallization of felodipine was
investigated. PVP, HPMC, and HPMC-AS were combined with felodipine to create
molecularly dispersed systems. To study both antiplasticization effects and drug-polymer
molecular interactions, the polymers were selected to span a range of Tg values and had
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different potentials for hydrogen bonding. PVP showed both increased hydrogenbonding interactions with felodipine as well as a greater antiplasticization effect relative
to the other polymers. All three polymers, however, were found to prolong the time to
nucleation of amorphous API to a similar extent, given an equivalent weight fraction.
The mechanism proposed by the authors ascribed the increase in physical stability to
result from the provision of a kinetic barrier to nucleation by the polymeric carriers, with
the magnitude of the effect being related to the polymer concentration (w/w).
The important distinction between drug:polymer miscibility and physical stability
needs to be drawn. The thermodynamic term “miscibility,” in a strict sense, is taken out
of context when applied to drug:polymer systems. Rather than associating miscibility to
the equilibrium solubility between a drug and polymer, it more accurately describes the
ability of a drug and polymer to form a supersaturated metastable phase. Although
miscibility between a drug and polymer is indicative of the compatibility between a drug
and polymeric material, it does not, however, give any insight into the timeframe (extent)
of physical stability.
Predicting drug:polymer miscibility at various concentration ranges, as well as
differentiation from partial miscibility,88 has become the focus of recent studies. The use
of interaction parameters (e.g. derived from group contribution theory) and FloryHuggins theory to predict drug:polymer miscibility has recently appeared in the literature.
One study89 concluded that the majority of SMO compounds will be supersaturated with
respect to solubility in a polymer, providing a thermodynamic driving force for
recrystallization. Additionally, the physical stabilization was predominantly attributable
to a kinetic barrier; however, molecular level miscibility was still shown to be an
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important factor as molecularly dispersed systems have altered molecular level
environments. In an unrelated report, an attempt to predict dispersion potential from
physical properties (melting point, molecular weight, etc.) and functional groups of 20
compounds was described. Although none of the physical properties probed were
predictive of miscibility, compounds with hydrogen bonding potential were shown to be
favorable candidates.90
From the background supplied herein on the subject of PXRD structural and
quantitative analyses, an appreciation for the necessity of accurately characterizing
amorphous systems and the local structure deviations in a crystalline material is gained.
The ability to successfully model predictability for overall aperiodic systems, such as
amorphous molecular solid dispersions, will be discussed in great detail and ultimately
hinged on the credibility of differentiating co-solidified products at the local structure
level.
A general consensus among the pharmaceutical community concerning
appropriate characterization methods for studying solid dispersions is sufficiently lacking.
Characterization inconsistencies between research groups have yielded conflicting reports,
thereby complicating the advancement in understanding of solid dispersion systems.
Vibrational spectroscopy has been successfully used to identify specific/non-specific
interactions developed between a drug and polymer in co-solidified systems.59-62
Unfortunately, the level of mixing between materials is not available from spectral
changes. Further, cohesive interactions are either so subtle or absent altogether that
changes to molecular vibrations may not be detected.81 Traditional PXRD analyses only
confirm a lack of detectable crystallinity in a co-solidified product and fail to provide
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information concerning the extent of mixing between the components, as well. Although
DSC has served as the conventional method for identifying an overall phase-separated
system, forthcoming sections will aim to illustrate instances where it is not sensitive to
phase separation and the use of multiple characterization techniques is imperative. To
this end, the successful completion of the theoretical portion of this dissertation (i.e. solid
dispersion potential) was afforded by the analytical optimization comprising Chapters 2,
3, and 4.
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Chapter 2: Chemometric Applications in Quantitative Powder
X-ray Diffraction (PXRD) of Intact Multi-Component
Consolidated Samples
2.1 Introduction
Powder X-ray diffraction (PXRD) of intact, consolidated samples is an important
technique for pharmaceutical materials and drug product characterization. Quantitative
PXRD methods are the most universal of the structure-sensitive methods for phase
analysis of multi-phase systems.20,23 The foundation of quantitative PXRD techniques for
analyzing mixtures was originally developed by Alexander and Klug,26 and some
examples applied to pharmaceutical mixture analyses are reported in the literature.52-57
Traditional quantitative PXRD methods can be subcategorized into those which
incorporate a standard and those which are standardless. Standardless techniques, such as
whole-pattern fitting and Rietveld refinement, are particularly useful because they permit
quantification without the use of specific calibration standards. These methods have the
ability to assess and account for physical phenomena (such as preferred orientation);
however, selecting an appropriate function, is not trivial.36 Standardless quantification
has also been limited to uses with crystalline materials. Further, they require a known
crystal structure, which is often obtained from the literature/online databases.
Numerous quantitative PXRD methods exist to incorporate a standard material
into mixtures for analysis,21 the use of which permits correction for matrix absorption.
The most commonly employed of these is the internal standard technique. Incorporation
of a standard within a sample, however, prevents analysis of intact, marketable drug
products, for which the inclusion of an analytical dopant would be prohibited. Moreover,
finding a standard that is stable, has approximately the same absorption characteristics as
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the sample, does not exhibit preferred orientation, and possesses isolated peaks which do
not overlap with sample peaks are all potential barriers to using this method.21
Diffraction-absorption calibrations are created through empirical linear regression
modeling of component concentration against single diffraction peak intensity, a few
diffraction peak intensities, or the integrated area under diffraction peak(s). These
techniques assume constant mass attenuation across the sample, and therefore, are
susceptible to errors resulting from diffraction intensity attenuation. Anisotropic
intensity reduction due to microabsorption and extinction often result in non-linearities
observed in quantitative PXRD calibrations.26,36 The largest contributor to intensity
attenuation, however, is preferred orientation, which can be particularly problematic in
consolidated samples.36 Problems with preferred orientation in powdered samples are
traditionally resolved by optimizing the particle size used for PXRD analysis, which may
add significantly to method development and execution,30 as well as the potential for
induction of experimental artifact owing to conversions elicited by triturative particle
sizing.20
By using only Bragg diffraction intensities, the traditional methods are limited to
quantification of crystalline materials. Many solid oral dosage forms are developed using
excipient materials having no long range order. The physicochemical benefits afforded
by incorporating amorphous active pharmaceutical ingredients in formulations of solid
oral dosage forms has resulted in increased interest in the use of these systems;56 however,
for PXRD to be sufficiently sensitive to quantify disordered materials, a method that
models both diffuse scatter and Bragg diffraction is required.
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Many of the aforementioned issues are addressed through the use of multivariate
calibrations.91 In quantitative chemometrics, a multivariate relationship is sought
between input data (e.g., diffraction patterns) and output data (e.g., composition, various
physical phenomena). Applications of chemometric-based analyses in PXRD are starting
to surface in the literature. Examples of applications of partial least squares regression
(PLS),92 principal components analysis (PCA),93,94 and advanced techniques such as
artificial neural networks (ANN)95,96 to PXRD data have all been reported. The possible
benefits of incorporating entire diffraction patterns into empirical models include
enhanced signal-to-noise, analyte sensitivity and selectivity.97 The objective of this work
was to investigate applications of different multivariate calibrations used to quantify both
crystalline and amorphous components in consolidated samples. Intact compact analysis
using PXRD was used to determine which algorithm was most suitable for intact
quantification of multi-phase consolidated pharmaceutical systems.
Quaternary mixtures composed of two crystalline materials and two disordered
materials were compressed at multiple compaction pressures and subjected to intact
PXRD analysis using two different instrumental optics setups. Quantitative calibrations
were created using the traditional (univariate) diffraction-absorption technique, and three
multivariate algorithms commonly employed in spectroscopy. Calibration linearity,
precision, and prediction error were calculated for assessing model suitability.

2.2 Materials and Methods
Four-component mixtures comprised of anhydrous theophylline (Lot No. 92577,
Knoll AG, Ludwigshafen, Germany), Lactose 316 Fast Flo NF Monohydrate (Lot No.
8502113061, Hansen Labs, New Berlin, WI), microcrystalline cellulose (Avicel PH 200,
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Lot No. M427C, FMC BioPolymer, Mechanicsburgh, PA), and soluble starch GR (Lot
No. 39362, EMD Chemicals, Inc., Gibbstown, NJ) were prepared. The design matrix
was fully balanced for compact concentration, having values ranging from 0 – 60% w/w.
Approximately 800 mg of each mixture was compressed at 67.0 MPa, 117.3 MPa, 167.6
MPa, 217.8 MPa, and 268.1 MPa using a single station Carver Press (Carver, Inc, Model
3887.1SDOA00, Wabash, IN) equipped with a 13 mm flat-faced punch.
2.2.1 Powder X-ray Diffraction Analysis of the Four Component Compacts
PXRD data were collected using an X’Pert Pro MPD system (PANalytical B.V.,
Alemlo, the Netherlands) equipped with a copper anode (λ = 1.5406 Å), programmable
divergence slit, and X’CeleratorTM detector. The operational voltage and amperage were
set to 45.0 kV and 40.0 mA, respectively, and diffraction patterns were acquired using an
angular step size of 0.02° 2θ over a range of 2 – 60° 2θ. Data were collected with the
instrument set in both Bragg-Brentano reflectance geometry (equipped with a spinning
sample stage) and transmission geometry (equipped with a vertical spinner sample stage
with the sample sandwiched between Kapton® film), optically fitted with an auxiliary
elliptical mirror used to expose the sample to quasi-parallel beam radiation.
All chemometric routines were performed in the Matlab programming
environment (v7.1, MathWorks, Natick, MA) using the PLS_Toolbox (v3.0, Eigenvector
Research, Manson, WA), together with several analysis routines developed in-house.
2.2.2 Data Preprocessing
Prior to the application of chemometric algorithms, sample diffraction patterns
were corrected for anisotropic peak (axis) shift using an iterative program that tested for
correlations between a reference pattern and the sample pattern as a function of

51

incremental calculated shifts. Corrected shifts that resulted in the highest correlation
were ultimately selected. Additionally, the diffraction pattern of an empty sample holder
(geometry dependent) was used to correct for scatter from that sample holder by pattern
subtraction. Sample absorption correction was also performed according to published
equations specific to the geometric setup of the instrument,38 and finally, a modified
version of the Rachinger method98 was used to mathematically correct for Kα2 radiation.
2.2.3 Inverse Least Squares (ILS) Regression
Inverse least squares (ILS) regression assumes that component concentration is a
function of diffraction intensity. The standard ILS univariate model for a single
component is calculated by:

y = xb + e

(2.1)

where y is the reference concentration value, b is the regression coefficient, x is the
diffraction value at a specific peak position (i.e. a single peak intensity, a calculated peak
area, ratio of intensities, etc.), and e is the error, which is assumed to be attributed to the
concentration values. One of the features of ILS regression is that quantitative analysis
can be performed even when the concentration of only a single component is known in
the calibration mixture. In multiple linear regression (MLR), several independent
variables are used, and the regression vector is calculated as follows (in matrix notation):

B=

X' Y
X' X

(2.2)

where Y is a matrix of concentration values, X is a matrix of intensity values, B is an
matrix of regression coefficients. MLR is limited, in that the number of variables
selected can not exceed or equal the number of samples in the calibration set. For
example, a calibration set having nvars = nsamples only possesses enough statistically52

independent information to estimate the mean; a larger sample set provides additional
degrees of freedom to estimate other statistical parameters. Although statistical methods
are available to assist with variable selection (i.e. stepwise regression), calibrations
created with suboptimal selections can introduce modeling errors such as noise inflation
from collinearity and over-fitting.99
2.2.4 Classical Least Squares (CLS) Regression
Classical least squares (CLS) regression is often used in spectroscopic
quantitative modeling owing to its agreement with Beer’s law. Under some conditions,
PXRD intensity will be a linear function of the number of diffracting planes present,
which qualifies the application of CLS regression in PXRD data modeling. CLS assumes
a linear combination of pure component sensitivities, where each component is weighted
by concentration. Unique to this technique is the feature that the regression vectors can
be used as estimates of the pure component diffraction patterns. CLS regression models
can be generated using PXRD data provided all reference constituent concentrations are
known (Equation 2.3):

X = KY + E c

(2.3)

where X is a matrix of diffraction intensities, K is a matrix containing the regression
vectors (pure component estimates), Y is a matrix of concentration values for all
constituents, and Ec is the error matrix. Model error is attributed to diffracted intensities
(i.e., microabsorption, extinction, preferred orientation, etc.). The calculation of the
regression vector (estimated pure components) is as follows:

K = Y+ • X

(2.4)
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where the superscript “+” indicates the Moore-Penrose pseudoinverse. The effectiveness
of CLS regression in multivariate modeling is limited when the concentrations of all
constituents contributing to signal (in the case of PXRD, diffract or cause diffuse scatter)
are not known, or when non-linearities are present.99
2.2.5 Principal Components Regression (PCR)
Principal components regression (PCR) is the ILS regression of “scores”
calculated from principal components analysis (PCA) against a dependent variable(s).
The objective of PCA is to maximize the variation contained in a data matrix with as few
underlying “factors” as possible.100 The PCA model has the form of:

X = TP'+ E

(2.5)

where X is a data matrix of k sample-independent variables (diffraction intensities), for n
samples, T is a matrix of component “scores” in vector form for each component, P is a
matrix of component “loadings,” and E is a matrix containing the residuals (the prime
indicates the transpose of the matrix). Principal component scores and loadings are
calculated using singular value decomposition.101 The algorithm proceeds through a least
squares fit of a straight line through the data in a k-dimensional hyperspace.102 New
components are fitted to the data until an adequate amount of the variance has been
explained. In PCR, the dependent variable(s) (i.e., reference concentration values) are
linearly regressed against the scores. The regression coefficients are calculated as
follows:

B=

T' Y
•P
T' T

(2.6)

where Y is a matrix of concentration values. A full-length regression vector is obtained
by projecting the regression coefficients onto the loading vector(s). Calibrations may be
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created with fewer samples than variables. Reviews of PCA and PCR can be found
elsewhere.99,102
2.2.6 Partial Least Squares (PLS) Regression
The PLS and PCR algorithms, being factor-based analysis methods, have similar
goals. The objective of PLS is to maximize the amount of co-variation explained
between dependent variables and independent variables using the fewest number of
factors. Contrary to PCA where only the independent variables are used to calculate the
basis set, PLS incorporates both dependent and independent variables in the basis set
calculation. It may be envisioned that this method is particularly powerful when the
dependent variable set contains low noise. Generally speaking, PLS explains the total
variance in fewer factors relative to PCR. In this study, the SIMPLS algorithm was used
to directly calculate factors as linear combinations of the original variables, while
constrained to orthogonality and normalization restrictions.103 The PLS algorithm used
herein,104 and representative reviews can be found elsewhere.99,102

2.3 Results and Discussion
The fully balanced concentration design matrix used for this study is shown in
Table 2.1 and contains five concentration points (0,20,25,40,60% w/w) for each of the
four constituents. The concentration points were added to the design matrix in a one-byone fashion, followed by a calculation of the matrix covariance; each point was adjusted
to minimize this covariance. It should be noted that separate experimentation concerning
instrument sensitivity, selectivity, and signal-to-noise has been previously reported in
Moore et al.,.97 At each concentration point, mixtures were compacted using 5 different
pressures (67.0 MPa, 117.3 MPa, 167.6 MPa, 217.8 MPa, and 268.1 MPa), resulting in a
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calibration sample size of 145 compacts. Recognizing that consolidation may induce
changes to diffraction intensity105,106 and diffuse scatter, samples compacted at different
pressures were included in the calibration set to incorporate pattern variability into the
model approximation. An additional sample at each concentration point, compacted
using a randomly-assigned pressure, was used to test the calibrations.
Table 2.1. Sample composition design matrix.
Tablet
#
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29

Theophylline
wt/wt
0.600
0.400
0.200
0.400
0.200
0.200
0.600
0.400
0.200
0.600
0.400
0.200
0.000
0.400
0.200
0.000
0.200
0.000
0.400
0.200
0.400
0.200
0.000
0.200
0.000
0.200
0.200
0.000
0.250

Lactose
wt/wt
0.200
0.400
0.600
0.200
0.400
0.200
0.200
0.400
0.600
0.000
0.200
0.400
0.600
0.000
0.200
0.400
0.000
0.200
0.200
0.400
0.000
0.200
0.400
0.000
0.200
0.200
0.000
0.200
0.250

MCC
wt/wt
0.200
0.200
0.200
0.400
0.400
0.600
0.000
0.000
0.000
0.200
0.200
0.200
0.200
0.401
0.400
0.400
0.600
0.600
0.000
0.000
0.200
0.200
0.200
0.400
0.400
0.000
0.200
0.200
0.250

Starch
wt/wt
0.000
0.000
0.000
0.000
0.000
0.000
0.200
0.200
0.200
0.200
0.200
0.200
0.200
0.200
0.200
0.200
0.200
0.200
0.400
0.400
0.400
0.399
0.400
0.400
0.400
0.600
0.600
0.600
0.250

Univariate calibrations were created by regressing a single intensity value for
each individual component (i.e., the largest Bragg peak for crystalline materials and the
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largest overall intensity for the disordered materials) against constituent concentration
(nominal value from the design). The PCR and PLS regression vectors for each
constituent were estimated individually from a component-specific orthogonal basis set.
Selection of the ideal number of principal components/latent variables (shown in Table
2.2) was performed through minimization of both the root mean square error of
calibration (RMSEC) and the root mean square error of cross validation (RMSECV).
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Table 2.2. Selected statistical values for the different quantitative PXRD calibrations relative to the collection geometry.

Method
Univariate

CLS
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PCR

PLS

Component
Theophylline
Lactose
MCC
Starch
Theophylline
Lactose
MCC
Starch
Theophylline
Lactose
MCC
Starch
Theophylline
Lactose
MCC
Starch

LV
N/A

N/A
1
3
4
5
1
3
3
3

2

R
0.961
0.927
0.809
0.292
0.972
0.963
0.955
0.946
0.972
0.968
0.751
0.941
0.972
0.978
0.955
0.950

Transmission
SEP
Precision
(%)
(%)
3.79
0.00024
5.70
0.00081
9.70
0.00324
15.30
0.00935
2.90
0.00027
3.48
0.00076
3.69
0.00237
5.24
0.00413
2.92
0.00027
3.16
0.00062
9.77
0.00346
4.98
0.00133
2.91
0.00028
2.48
0.00110
3.84
0.00210
4.88
0.00256

Reflectance
2

R
0.898
0.911
0.940
0.006
0.942
0.939
0.958
0.866
0.926
0.919
0.875
0.868
0.933
0.943
0.937
0.804

SEP (%)
5.09
4.95
5.81
18.18
3.57
3.63
5.47
4.91
4.81
4.82
7.49
5.00
4.49
3.71
6.23
7.15

Precision
(%)
0.09491
0.03195
0.04044
0.07608
0.16771
0.12726
0.07263
0.01797
0.07780
0.02580
0.03176
0.10102
0.08007
0.02915
0.03226
0.07829

Traditionally, it is not common to use a univariate PXRD calibration to predict the
concentration of a disordered component in a mixture; however, it was performed in this
study as a means to illustrate the practicality of different multivariate methods. In
general, data collected in transmission geometry provided better linearity, precision and
lower concentration prediction error relative to reflectance geometry for both the
crystalline and disordered components. In transmission geometry, the entire sample
volume is irradiated, whereas only a fraction of the sample is interrogated in reflectance
analysis. Therefore, data collected in transmission mode is less susceptible to errors
derived from analyzing inhomogeneous “regions” within a sample matrix.
The data in Table 2.2 indicate that the standard error of prediction (SEP) for
theophylline in most instances is greater when using data collected in reflectance
geometry relative to that in transmission. This indicates a correlation between instrument
geometry and prediction error; more than likely a result of the diffraction pattern
anomalies related to specific analytical optics setup modes. Barring microabsorption,
extinction, and other anomalies, regression vectors should mimic pure component
diffraction patterns. In Figure 2.1, the pure component pattern and the calculated
regression vectors for all three multivariate theophylline prediction models are shown for
data collected in reflectance geometry. There is good agreement between all regression
vectors and the pure component pattern, as would be expected. For PCR and PLS,
negative correlations are observed at ~18º 2θ, which specifically corresponds with the
location of Bragg peaks resulting from lactose monohydrate diffraction. Therefore, the
PCR and PLS models are sensitive to the changes in both theophylline and lactose
concentration at this angle. In Figure 2.2, the theophylline regression vectors calculated
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from data collected using transmission geometry are identical to the pure component scan.
Further, the negative correlations observed at ~18º 2θ in the reflectance geometry
regression vectors are nearly absent from transmission data. The calculated regression
vectors from the transmission geometry are, therefore, more highly correlated to only
changes in theophylline concentration, thereby resulting in enhanced theophylline
sensitivity and decreased prediction errors.

Figure 2.1. Calculated regression vectors for each multivariate calibration used in the
prediction of anhydrous theophylline from data collected in reflectance geometry.
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Figure 2.2. Calculated regression vectors for each multivariate calibration used in the
prediction of anhydrous theophylline from data collected in transmission geometry.
When considering disordered materials, the diffuse scatter that produces the
characteristic “amorphous halo” may not be linearly related to constituent concentration.
Non-linear relationships may manifest as negative correlations in regression vectors as a
result of modeling the decrease in concentration of other components. In Figure 2.3, the
calculated regression vectors for the three multivariate starch prediction models and the
corresponding pure component scan are shown for data collected in reflectance geometry.
The CLS regression vector bears the highest correlation with the pure component
diffraction pattern, thereby affording enhanced linearity and decreased prediction error
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relative to PCR and PLS (from Table 2.2). Although they possess the same positive
correlations as the starch pure component scan, the regression vectors from both PCR and
PLS once again exhibit negative correlations attributable to changes in the concentrations
of other mixture components at angles corresponding to their respective peaks of
principal diffraction: theophylline (~12º 2θ), lactose (~18º 2θ) and MCC (~22º 2θ). This
same trend is also observed for the transmission data, as shown in Figure 2.4, where both
the PLS and PCR regression vectors exhibit the same negative correlations seen in
reflectance. Additionally, the CLS regression vector of transmission data representing
diffraction by the starch component possesses negative correlations at ~12º 2θ and ~18º
2θ. These regression vector similarities resulted in near-equal linearity and prediction
error for the PCR, PLS, and CLS starch calibrations created from data collected in
transmission. The negative correlations observed in the disordered component regression
vectors, therefore, could quite possibly be a result of the non-linear relationship between
constituent concentration and diffuse scatter intensity.
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Figure 2.3. Calculated regression vectors for each multivariate calibration used in the
prediction of starch from data collected in reflectance geometry.
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Table 2.3. The effects of various powder pattern corrections on linearity and the standard error of prediction of the univariate and
PLS calibrations for prediction of both crystalline and disordered components using data collected by reflectance geometry.

R2

Univariate
PLS

SEP
(%)

Univariate
PLS

Crystalline
Disordered
Crystalline
Disordered
Crystalline
Disordered
Crystalline
Disordered

No
corrections
0.723
0.493
0.906
0.864
7.61
11.41
4.39
5.97

Axis
shift
0.898
0.489
0.936
0.890
5.59
11.19
4.45
6.40

Kα2
subtraction
0.759
0.484
0.906
0.866
6.75
11.54
4.40
5.98

Absorption
correction
0.729
0.486
0.908
0.849
7.34
11.76
4.11
6.42

Background
subtraction
0.723
0.493
0.906
0.864
7.61
11.41
4.39
5.97

All
0.904
0.473
0.938
0.871
5.02
11.99
4.10
6.69
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Figure 2.4. Calculated regression vectors for each multivariate calibration used in the
prediction of starch from data collected in transmission geometry.
In Table 2.3, linearity and SEP are reported as a function of applied pattern
corrections using data collected in reflectance geometry. Statistics are reported as an
average of the two crystalline components and an average of the two disordered
components. The importance of correcting for axis shift prior to creating a univariate
calibration in the prediction of crystalline components is supported by the observed
increased linearity and decreased prediction error. When modeling a single intensity, or
the area of a single peak, anisotropic peak distortions may build errors into the calibration
and result in inaccurate predictions. Interestingly, in multivariate calibrations (such as
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PLS) the linearity and predictability are not significantly affected by corrections to the
powder patterns relative to univariate modeling. By modeling multiple intensities having
correlation with constituent concentration, the anisotropy of error-related variance is
compensated for through increased correlation at unaffected variables. Further, through
maximization of the explained covariance between diffraction intensity and constituent
concentration, variability due to anisotropic peak aberrations is modeled in the regression
vectors.
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Table 2.4. The effects of various powder pattern corrections on linearity and the standard error of prediction of the univariate and
PLS calibrations for prediction of both crystalline and disordered components using data collected by transmission geometry.

R2

Univariate
PLS

SEP
(%)

Univariate
PLS

Crystalline
Disordered
Crystalline
Disordered
Crystalline
Disordered
Crystalline
Disordered

No
corrections
0.940
0.260
0.968
0.770
4.24
16.30
3.07
8.07

Axis
shift
0.947
0.590
0.972
0.948
4.10
10.72
2.89
4.17

Kα2
subtraction
0.937
0.260
0.968
0.772
4.42
16.30
3.07
8.10

Absorption
correction
0.939
0.186
0.971
0.771
4.47
16.49
2.96
8.17

Background
subtraction
0.941
0.260
0.968
0.770
4.15
16.30
3.07
8.07

All
0.944
0.551
0.975
0.952
4.75
12.50
2.70
4.36
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Table 2.4 shows the effects of PXRD pattern corrections on linearity and
prediction error using data collected in transmission geometry. Comparison with Table
2.3 (reflectance geometry collection) indicates that performance statistics are superior for
transmission data, particularly for disordered (weakly diffracting) materials. This is not
unexpected, given that transmission experiments interrogate the entire compact sample
volume. Although the low mass attenuation coefficients of pharmaceutical materials
permit some sample penetration (on the order of mm), reflectance experiments
interrogate a much smaller volume compared to transmission experiments. For the
crystalline components, both models are invariant to all of the applied corrections.
However, the SEP for the disordered components using PLS shows significant
dependence on axis shift correction. Figure 2.5 illustrates the effects of applied pattern
corrections on the calculated PLS regression vectors. The calculated regression vectors
of raw diffraction patterns, patterns corrected for absorption only, patterns corrected for
Kα2 only, or background subtraction only are highly correlated to one another. Further,
these regression vectors exhibit differences from the regression vector calculated from
patterns corrected for axis shift. The dashed boxes highlight the main differences
observed between the aforementioned group of regression vectors and those for which
axis shift was corrected. These differences represent uncertainties correlated to peak
aberrations and result in modeling concentration changes of other components.
Ultimately, the prediction error was larger due to the error in modeling the concentration
changes in multiple components.
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Figure 2.5. The effects of various corrections on the PLS calibration regression vectors
as applied to data collected in transmission geometry.
For many spectroscopic methods, building quantitative models that include
variability associated with compression force is imperative. However, the variability in
diffraction intensity observed to have resulted from consolidation was minimal because
the materials used in this study have low mass-attenuation coefficients and require few
applied absorption corrections. Admittedly, creating a calibration and test sample matrix
the size of the set presented in this work (n = 174) may be impractical in a multi-product
industrial development group. Given the results of the present data, however, efficient
calibrations could have been created using fewer samples. This was tested by
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compressing a single sample from each concentration point (Table 2.1) at 268.1 MPa in
order to re-create the calibrations (29 samples total), while the remaining samples (n =
145) were used to test the models generated from this reduced data set. The graph in
Figure 2.6 shows prediction error as a function of component, as modeled by each
calibration method for differently sized calibration sets relative to the experimental optics
utilized. Linearity statistics (not shown) were not affected by the reduction of the dataset
used for calibration. The data in Figure 2.6 illustrate that prediction error associated with
transmission geometry is relatively unaffected by the size of the calibration set employed.
Reflectance geometry, however, indicates that a slight increase in prediction error occurs
when using the smaller calibration set, possibly due to the decreased signal-to-noise.
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Figure 2.6. The effects of the number of samples in the calibration set on the standard error of prediction for both collection
geometries.

The starch and theophylline calculated CLS regression vectors for reflectance and
transmission geometry are shown in Figure 2.7 and Figure 2.8, respectively. When
comparing the starch regression vectors as calculated from data collected in reflectance
geometry, the smaller calibration set vector exhibits increased noise (rougher) and larger
peak/trough correlations ultimately attributable to increased uncertainty. Though the
starch regression vector (as calculated from data collected in transmission geometry) for
the smaller calibration set is “rougher” relative to the vector from the larger set, the
overall shape is the same for both. The regression vectors calculated from the smaller
calibration set using data collected in transmission mode demonstrated increased
correlation to the regression vectors calculated from the larger calibration set relative to
the reflectance data. Therefore, this enhanced correlation results in nearly identical error
statistics independent of calibration sample size (shown in Figure 2.6).
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Figure 2.7. The effects of the number of samples in the calibration set on the starch and
theophylline CLS regression vectors for data collected from reflectance geometry.
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Figure 2.8. The effects of the number of samples in the calibration set on the starch and
theophylline CLS regression vectors for data collected from transmission geometry.
Based on the results presented herein, calibrations via PLS, created from the data
collected in transmission geometry can be recommended as optimal for quantitative
PXRD of similar systems. The calibrations created using this algorithm exhibited
optimal linearity values of 0.972, 0.978, 0.955, and 0.950 for theophylline, lactose, MCC,
and starch, respectively. The calibrations created in the present work stem from a
quaternary design using the design matrix concentration values. Given that each nominal
design value is likely to differ slightly from the actual concentration, each component
reference concentration value has some random error. Overall, a cumulative 2-3% error
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in content uniformity of all the constituents may be anticipated; linearity values
approaching 0.98 in this design are, therefore, statistically acceptable. Additionally,
minimum prediction error and enhanced precision for both crystalline and disordered
components in complex, intact compacts was achieved. Furthermore, PLS models were
observed to be less susceptible to errors associated with diffraction pattern anomalies and
effects related to the size of the calibration set.

2.4 Conclusions
The ability to analyze intact compacts makes PXRD an important analytical tool
for non-destructive pharmaceutical characterization. The structure-sensitivity afforded
by PXRD enables quantitative applications having the ability to discriminate between
different chemical components, polymorphs, and other phase mixtures. It has been shown
in this work that the traditional univariate calibrations are affected by peak distortion,
variable selection, and applied powder pattern corrections. Multivariate calibrations,
however, provided enhanced linearity, decreased prediction errors, and exhibited less
susceptibility to errors attributable to peak distortions relative to single-point calibrations.
Further, calibration errors related to pattern anomalies were minimized through empirical
modeling of the entire diffraction pattern (i.e. both Bragg diffraction and diffuse scatter
intensities). As an increased amount of mixed amorphous/crystalline systems are
formulated into dosage forms, the need for discriminative and sensitive quantitative
analytical tools for intact analysis will become more prevalent.
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Chapter 3: A Structural Investigation into the Compaction
Behavior of Pharmaceutical Composites Using Powder X-ray
Diffraction and Total Scattering Analysis
3.1 Introduction
The US Food and Drug Administration’s Critical Path Initiative to New Medical
Products maintains the need for industry to continue investigation and development of
analytical methods capable of fundamentally characterizing pharmaceutical systems. The
availability of more effective analysis techniques will facilitate product and process
understanding, and reduce drug product failures.107 Challenges encountered during drug
product development are often the result of unpredicted changes to the physicochemical
and mechanical properties of materials used in manufacturing. Characterization during
small-scale research should predict performance modifications that may occur at
commercial scale. This goal is contingent upon accurate detection and quantification of
specific changes in material structure that can be linked with product performance. Some
such changes (i.e. dissolution rate, friability, etc.) can be traced to very subtle structure
modifications, where the largest limitation in detection and quantification is inadequate
analytical sensitivity, particularly in the context of complex mixtures of materials. At
present, research in this area is heavily focused on active pharmaceutical ingredients
(API), with substantially fewer reports concerning responses of excipients or composites
to processing. As the pharmaceutical industry moves forward, it is imperative that the
synergistic functions of both API and excipients be considered as the basis for claiming
product understanding at the level of specifically engineered delivery platforms.
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Powder X-ray Diffraction (PXRD) is universally applied for detecting phase
changes and assessing material structure and order. Industrial applications of PXRD rest
in the ability to analyze materials from all stages of powder processing, without prior
destructive sample preparation. Traditional uses of this technique have focused on
analysis of prominent, high-intensity Bragg diffraction peaks that are characteristic of a
given crystalline phase. In addition to long-range order, the powder diffraction pattern
contains information pertaining to intermediate and short-range order. Specifically,
diffuse scatter, which occurs between and superimposed on Bragg diffraction peaks,
offers additional information pertaining to the short- and intermediate-range structure of
materials, when treated appropriately.
In the present work, the compaction behavior of anhydrous theophylline was
investigated. Binary composite compacts were also prepared and analyzed, using either a
common tablet filler (α-lactose monohydrate), or a common tablet compression aid
(microcrystalline cellulose; MCC) in combination with anhydrous theophylline. PXRD,
in combination with total scattering computational methods, was used to assess the
effects of powder compaction without reversion of compacts to powders. Furthermore,
the use of PCA as an alternative to the traditional weighted agreement factor in
comparing PDF transformed diffraction data was explored.

3.2 Materials and Methods
Binary mixtures comprised of anhydrous theophylline (Lot No. 92577, Knoll AG,
Ludwigshafen, Germany) and either crystalline α-lactose monohydrate, referred to as
lactose for the remaining discussion, (Lot No. 125090020, Acros Organics, Geel,
Belgium) or microcrystalline cellulose, referred to as MCC for the remaining discussion,
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(Avicel PH 200, Lot No. M427C, FMC BioPolymer, Mechanicsburgh, PA) were blended
and compacted using an automatic single-station Carver Press (Carver, Inc, Model
3887.1SDOA00, Wabash, IN) equipped with a 13 mm flat-faced punch. The
approximate median particle size of theophylline was 90 μm. A circumscribed central
composite experimental design102 was used for sample preparation, in which both
excipient concentration (0 – 75% w/w) and compaction pressure (67 – 503 MPa) were
varied. Consolidation at each pressure resulted in composite solid fractions ranging from
0.85 – 0.98. The central point was repeated five times to build precision into the design.
3.2.1 Powder X-Ray Diffraction (PXRD)
PXRD data were collected using an X’Pert Pro MPD system (PANalytical B.V.,
Almelo, the Netherlands) equipped with a copper anode (λ = 1.5406 Å), an auxiliary
elliptical mirror, and X’CeleratorTM detector. The operational voltage and amperage
were set to 45.0 kV and 40.0 mA, respectively, and diffraction patterns were acquired
using an irradiation time of 101.42 seconds per step and an angular step size of 0.017° 2θ
over a range of 2 – 100° 2θ. Data were collected with the instrument set in transmission
geometry, using intact compact samples, sandwiched between two layers of X-ray
transparent kapton film and placed on a spinning vertical sample stage (16 rpm).
3.2.2 Pattern Separation
PXRD analysis of binary compacts produced diffraction patterns containing
information from both components. To study the effects of powder compaction on a
specific constituent, a method for accurately separating diffraction events attributable to
each individual component was required. The pattern subtraction technique,108
commonly reported for this purpose, often leaves residual artifact in separated patterns

78

attributable to diffraction by component(s) that are not of interest, or negative peak
intensities as a result of overcompensation. An alternative approach for isolating single
constituent diffraction patterns from multi-component data has been recently reported in
the literature.97
Generalized Least Squares (GLS) pre-processing has been reported in the nearinfrared spectroscopy literature as a multiplicative orthogonalization technique used to
make spectra “blind” to interferants, while retaining sensitivity to the main analyte.109
Signal pre-processing using this covariance-weighted technique reduces the
dimensionality of final models by including prior knowledge. The scaling matrix, T, is
calculated as follows:
∑L = d L2 LL'+ I

(3.1)

T = inv ( ∑1/2
L )

(3.2)

where d is a scalar covariance-scaling constant, L is an m × n noise matrix, L' is the
transpose of L, and I is an n × n identity matrix. In the case of PXRD, the matrix L
would be comprised of diffraction information from material(s) that are not of interest to
a given evaluation. The final scaling of the multi-component diffraction patterns, X, is
given by:
(3.3)

X FIN = XT

where T multiplicatively suppresses diffraction in X displaying covariance with the noise
matrix. A problem is encountered with this particular method when components that are
not of interest (noise) diffract at the same angle (2θ) as the component of interest. This
issue results in the suppression of diffraction events from the component being isolated.
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The method was, therefore, modified to account for covariance between the “noise”
component(s) and the component of interest by creating a second scaling matrix:
∑R = d R2 RR '+ I

(3.4)

where R is an m × n matrix of the reference material (i.e. a pure component diffraction
pattern of the constituent of interest) and the remaining variables are defined above. The
scaling matrix, ΣR, was used to suppress angular variables in the noise matrix, which are
covariate with the component of interest as follows:
∑FIN = ∑L •inv ( ∑R )

(3.5)

T = inv ( ∑1/2
FIN )

(3.6)

where T is substituted back into Equation 3.3. By compensating for angular variables
(2θ) of the noise matrix that are covariate with those of the constituent of interest, a more
accurate separation is obtained. All data manipulations in this study were performed
using programs written in-house in the Matlab programming environment (v7.1,
MathWorks, Natick, MA).
3.2.3 Pair Distribution Function (PDF)
The PDF is a total scattering method that exploits the Fourier relationship
between X-ray diffraction intensity and the real-space arrangement of atoms, given
appropriate data treatment. This method has received extensive attention in the inorganic
literature;39,43,44,110 however, few pharmaceutical applications have been reported.48,51,52
In the present work, the PDF was calculated for (a) compacts formed from pure
components, and (b) mathematically isolated diffraction attributable to a single
component, detected from PXRD patterns of binary compacts. This provided a sensitive
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method to assess the structure-specific compaction behavior of theophylline, individually
as well as in a consolidated mixture. The PDF, G(r), is defined as:
G (r ) = 4 πr [ρ(r ) - ρo ]

(3.7)

where ρ(r) and ρo are the local and average atomic number densities, respectively, and r
is the inter-atomic separation distance.111 The PDF calculates the probability of finding
atom pairs separated by a distance r, and is obtained by transformation of the reciprocal
space structure function, S(Q), according to:
G (r ) =

2
π

Q max

∫Q [S(Q)

- 1 ]sin( Qr ) dQ

(3.8)

0

where S(Q) is obtained from a diffraction experiment, and Q is the magnitude of the
scattering vector.41 The term Qmax is the resolution of the diffraction experiment, which
is dependent on the wavelength of radiation used and the maximum diffraction angle (°2θ)
of data collection. Corrections were made to the intensity data to obtain a structure
function normalized to the total-scattering cross-sectional area, consistent with the
assumptions of Egami and Billinge.38
For a crystalline material, a theoretical PDF may be calculated from a solved
crystal structure. The mathematical corrections applied to a theoretical PDF, including
compensations for limited Q-resolution and broadening of probability peaks as a result of
thermal motion are detailed elsewhere.38,47 Theoretical modeling of the PDF, G(r)c, for a
crystalline material is achieved by:

G (r ) c =

fm fn
1
δ(r - rm,n ) - 4πrρo
∑
∑
r m n f 2

(3.9)

where fm and fn are the atomic form factors for the individual atoms, ‹f› is the mean
atomic form factor for the structure, and rm,n is the separation distance between atoms m
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and n (from the crystal structure), where the delta function is assessed out to a userdefined radial distance rmax.
Reviews of the PDF, both experimental and theoretical, are found elsewhere.38,111
All intensity corrections and PDF calculations were performed using software developed
in-house in the Matlab programming environment based on published equations.
Theoretical PDF patterns for anhydrous theophylline were calculated using the solved
Cambridge Structural Database (CSD) crystal structure, (refcode: BAPLOT01).
3.2.4 Principal Components Analysis (PCA)
PCA is a multivariate, bilinear decomposition technique used to identify the
orthogonal basis set, which explains the maximum amount of variance in a data matrix, X;
where X is n observations of an m-dimensional vector. PCA decomposes data into
loadings and scores, where loadings represent the weight of each variable for a given
principal component (PC), and scores represent the weight of the PC for each sample.
Vectors comprising a data matrix, X, possessing comparable score values for a given PC
are similar; dissimilar score values indicate differences between vector features. Reviews
of principal components analysis may be found elsewhere in the literature.99,112 PCA
models were calculated in the Matlab programming environment using the PLS_Toolbox
(v3.0, Eigenvector Research, Manson, WA).
Traditional comparison of PDF transforms have involved calculation of a
weighted agreement factor, Rwp, between the properly scaled sample PDF and a reference,
albeit a theoretically calculated or empirically derived pattern.38 In this study, PCA was
used to assess variations among PDF patterns as an alternative to the weighted agreement
factor commonly employed for this purpose. This method may be preferable to the Rwp
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calculation when there are a large number of PDFs to compare, as in this study. PCA is
also applicable when a reference pattern is not available or comparison to a reference
pattern is inappropriate for a given analysis.

3.3 Results
3.3.1 Pure Theophylline Compaction
In Figure 3.1, the PXRD patterns (average of 3 samples) for theophylline
compacted at 67 MPa and 503 MPa are shown as blue and red solid lines, respectively.
The original patterns were normalized and were corrected for absorption, Laue
monotonic scattering, Compton scattering, etc.38 to remove physical artifacts (i.e., sample
thickness and solid fraction). The red and blue dashed lines in Figure 3.1 respectively
represent one standard deviation (n=3) for diffraction from theophylline compacts
prepared at 67 MPa and 503 MPa. The Bragg peak positions of samples compacted at
higher pressures occur at the same diffraction angle (°2θ) relative to the sample
compacted at 67 MPa, indicating low probability of uniform residual strain. Moreover,
additional PXRD peaks, which would be indicative of a polymorphic conversion, are not
observed. One noticeable difference between the patterns, however, is increasing diffuse
scatter over the 23-30 º2θ range for samples compacted at higher pressures.
Figure 3.2 (solid lines) shows the average PDF pattern (n=3) for each of the
corresponding samples in Figure 3.1. The dashed lines represent one standard deviation
as calculated from the three replicates. At lower radial distances in the PDF (r < 30 Å),
peak positions and intensities are highly correlated, irrespective of compaction pressure.
In contrast, the Figure 3.2 inset, which focuses on r > 40 Å, shows a dampening of the
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probability peaks, as well as peak shifts, which become significant with increased
compaction pressure.

Figure 3.1. Mean PXRD patterns (average of n=3) for anhydrous theophylline
compacted at 67 MPa (blue, solid line) and 503 MPa (red, solid line). The red and blue
dashed lines correspond to 1 standard deviation from the mean of samples compacted at
67 MPa and 503 MPa, respectively.
In an attempt to arrive at a possible materials-based explanation for the alterations
observed in the PDF of anhydrous theophylline upon compaction at high pressures,
simulations based on reverse Monte Carlo39,113 refinement were performed. Briefly, as
unit cell translation and expansion was calculated from the crystal structure solution,
spatial permutations were applied to randomly selected atomic coordinates. These
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permutations included linear deviations from periodicity, as well as alterations to axial
orientation (e.g., the molecule may be rotated 120° with respect to the c-axis). The fully
translated model, calculated to a defined rmax, therefore contained a certain percentage of
atomic coordinates that varied from their original positions defined by the average
structure. PDF patterns for computationally altered structures were subsequently
calculated, and the data were mathematically compared with experimentally derived PDF
patterns using an agreement factor.

Figure 3.2. Mean PDF patterns (average of n=3) of theophylline compacted at 67 MPa
(blue, solid line) and 503 MPa (red, solid line). The red and blue dashed lines correspond
to 1 standard deviation from the mean of samples compacted at 67 MPa and 503 MPa,
respectively.
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When simulating atomic displacements from average structure, it is important to
define the proper constraints to yield physically-meaningful simulations. One of the
constraints incorporated in the models calculated for this study was the rigid body
assumption; i.e, the molecule was held rigid such that permutations to atomic coordinates
could not result in changes to intra-molecular bond distances, angles, or conformations.
An additional constraint prevented atomic overlap of coordinates resulting from
simulated displacements. The final constraint allowed only atomic coordinates residing
at r values comprising long-range order (r > 40 Å) to be randomly selected for
permutation, as this region defines the marked differences between the PDFs presented in
Figure 3.2.
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Figure 3.3. (a) Experimental PDF pattern for theophylline compacted at 67 MPa (black), calculated PDF pattern from the crystal
structure (blue circles), and the difference plot (green, below); (b) Experimental PDF pattern for theophylline compacted at 503 MPa
(red), a simulated PDF pattern from reverse Monte Carlo refinement (blue circles), and the difference plot (green, below).

The experimentally derived PDF pattern for theophylline compacted at 67 MPa
(blue line) and the PDF pattern calculated from the crystallographic structure of
theophylline (black circles) are shown in Figure 3.3a. Generally speaking, the difference
plot indicates pattern similarity, especially at longer r values. This result is expected as
the compaction pressure is insufficient to induce large deviations from the average
crystallographic structure.
Recall from Figure 3.2 that the PDF of the high pressure sample shows
dampening and shifts in peak position relative to the lower pressure sample at r > 40 Å.
An acceptable fit between the PDF of the sample compacted at high pressure and the
theoretical PDF will require alterations to the original calculated PDF to accommodate
the probability peak aberrations. Figure 3.3b shows the experimentally derived PDF for
theophylline compacted at 503 MPa (red line), a refined PDF from the Monte Carlo
simulation (black circles), and the difference between the two PDFs (green line, shown
below Figure 3.3b). The simulated PDF shows the same probability peak shifts and
dampening as the experimental PDF of the sample compacted at a high pressure. The
goodness of fit between the calculated PDF and the experimental PDF can be seen in the
difference plot (green) shown below Figure 3.3b. The simulated PDF was modeled by
pseudo-randomly selecting molecules in the defined spherical volume (radius = 60 Å)
and inducing a deviation from the average crystallographic structure. The number of
molecular permutations was converted to a percentage of total molecules probed in the
simulation. Therefore, the simulated PDF in Figure 3.3b (black circles) differs from the
calculated PDF in Figure 3.3a (black circles) as a result of 0.928% of the molecules
deviating from the defined average structure.
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3.3.2 PDF of Mathematically Isolated Theophylline
Figure 3.4a shows the PXRD pattern of a sample (blue, circles) comprised of
25% w/w theophylline and 75% w/w MCC, compacted at 118 MPa. Diffraction data
attributable only to theophylline (red) are superimposed over the diffraction pattern of the
aforementioned sample. Most of the diffuse scatter observable in the diffraction pattern
of the original binary sample (blue, circles) is absent when theophylline diffraction was
isolated (red data). In Figure 3.4b, the PDF transform of the mathematically isolated
theophylline (red) is shown superimposed with the calculated theoretical PDF pattern for
theophylline (black, circles).
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Figure 3.4. (a) PXRD pattern (zoomed) of a compact containing 75% MCC and 25%
theophylline (sample3) compressed at 67 MPa (blue, circles) and the isolated diffraction
attributable to theophylline (red); (b) The calculated pair distrubtion function of
anhydrous theophylline (crystal structure ref: BAPLOT01) (black, circles), the pair
distribution function of isolated theophylline from sample 3 (red), and the difference
between the calculated and experimental (green).
Figure 3.5a shows the diffraction pattern of a sample (blue, circles) containing
25% w/w theophylline and 75% w/w lactose, compacted at 118 MPa. Mathematically
isolated theophylline diffraction (red) is superimposed over the total diffraction data from
this sample. Many of the Bragg diffraction peaks observed in the original sample pattern
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(blue, circles), which are strictly attributable to lactose, are absent from the isolated
theophylline diffraction pattern. In Figure 3.5b, the PDF transform of the isolated
theophylline (red) is shown with the calculated PDF pattern for theophylline (black,
circles).
3.3.3 PCA of PDF Transformed Data
As introduced, PCA is a bilinear decomposition method, where principle
components (PCs) are calculated in a manner to explain the maximum amount of
variance such that PCn and PCn+1 are orthogonal. Similar PDF patterns will have similar
scores for a given PC, while dissimilar PDF patterns will have drastically different score
values for the same PC. Examples employing PCA score cluster analysis to ordinary
PXRD patterns are found in the pharmaceutical literature;45,114 however, the authors are
unaware of the existence of previous applications of PCA cluster analysis to PDF data.
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Figure 3.5. (a) PXRD pattern of a compact containing 75% lactose and 25%
theophylline (sample 19) compressed at 67 MPa (blue, circles) and the isolated
diffraction attributable to theophylline (red); (b) The calculated PDF pattern for
anhydrous theophylline (crystal structure ref: BAPLOT01) (black, circles), the PDF
pattern for isolated theophylline from sample 19 (red), and the difference between the
calculated and experimental (green).
Three different PCA models were calculated, where each varied in the
number/type of samples included. The first analysis incorporated PDF patterns for pure
theophylline and theophylline mathematically isolated from binary mixtures with MCC.
The resulting scores plot is shown in Figure 3.6. First, in the dimension of the first PC,
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where 36.28% of the overall variance is explained, the score values for pure theophylline
samples compacted at low pressures are drastically different than those for samples
compacted at high pressures. The variance explained by the first PC, therefore, is
weighed differently in PDF patterns for samples compacted at low pressures relative to
samples compacted at high pressures. Secondly, PDF patterns for theophylline data
mathematically isolated from binary samples containing MCC compacted at low
pressures had similar score values for the first PC relative to those calculated for pure
theophylline compacted at low pressures. This indicates that PDF patterns of samples
compacted at low pressures were similar in the dimension of the first PC, regardless of
MCC concentration. Additionally, all samples containing MCC compacted at higher
pressures had score values similar to pure theophylline compacted at high pressures in the
dimension of the first PC. Overall, it was observed that scores of PDF data from samples
compacted at low pressures formed one general cluster, while those from samples
compacted at higher pressures formed another cluster.
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Figure 3.6. PCA scores plot corresponding to the first and second principal components
for analysis of PDF patterns from pure theophylline samples (black, closed symbols) and
PDF patterns from theophylline mathematically isolated from binary compacts containing
MCC (blue, open symbols). Black, dashed line circles surround the replicate samples.
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Figure 3.7. PCA scores plot corresponding to the first and second principal components
for analysis of PDF patterns for pure theophylline samples (black, closed symbols) and
PDF patterns for theophylline mathematically isolated from binary compacts containing
lactose (red, open symbols). Black, dashed line circles surround the replicate samples.
The second PCA performed incorporated PDF data obtained from theophylline
mathematically isolated from binary mixtures containing lactose, as well as pure
theophylline compacts. The PCA scores plot for these data is shown in Figure 3.7,
where the dimension of the first PC explained 46.88% of the overall variance. Score
values for PDF patterns from pure theophylline samples compacted at low pressures were
considerably different relative to PDF patterns from pure theophylline compacted at high
pressures. Samples compacted at low pressures tended to cluster together, regardless of
lactose content; as did samples compacted at high pressures. A particularly interesting
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sample was the compact containing 75% w/w lactose compacted at 268 MPa, which
clustered with the samples compacted at low pressures. These data indicate that the PDF
pattern resulting from the isolated theophylline diffraction data of this sample is more
similar to PDF data for samples compacted at low pressures than samples compacted at
high pressures.

Figure 3.8. PCA scores plot corresponding to the first and second principal components
for analysis of all samples, including: PDF patterns for pure theophylline samples (black,
closed symbols), PDF patterns for theophylline mathematically isolated from samples
containing MCC (blue, bold open symbols), and PDF patterns for theophylline
mathematically isolated from samples containing lactose (red, un-emboldened open
symbols).
The final PCA performed incorporated data from PDF patterns obtained from all
samples in the circumscribed central composite experimental design, resulting in the
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scores plot shown in Figure 3.8. In Figures 3.6 and 3.7, scores of samples compacted at
low pressures formed one cluster while samples compacted at high pressures formed a
separate cluster in the dimension of the first PC. In Figure 3.8, delineation between
score values is not as obvious, and merit further explanation. Beginning with the pure
theophylline compacts (filled symbols), the score values in the dimension of the first PC,
where 33.89% of the overall variance is explained, are drastically different for samples
compacted at low pressures versus those compacted at high pressures. The scores in the
dimension of the first PC of PDF data from samples containing MCC (blue, unfilled
symbols) again tended to cluster with pure theophylline samples compacted at similar
pressures, irrespective of MCC concentration. Contrary to the previous analyses of PDF
data for samples containing lactose, a clear-cut boundary delineating clusters of similarly
compacted samples in the dimension of the first PC is not observed. Interestingly, almost
all samples containing lactose (red, unfilled symbols) resulted in PDF patterns having
score values (in the first PC) that were most similar to all other samples compacted at low
pressures. The score values for all lactose samples compacted at the intermediate
pressure (268 MPa) clustered around samples compacted at low pressures. Further, a
lactose-containing sample compacted at 419 MPa clustered in the same area.

3.4 Discussion
3.4.1 Pure Theophylline Compaction
The PXRD patterns of pure theophylline compacted at different pressures exhibit
an increase in diffuse scatter over the 23-30 º2θ range. With a median particle size of 90
μm, it is anticipated that the effects on pattern features and further mathematical
manipulations will be minimal, as peak broadening and increased diffuse scatter tend to
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occur for particle sizes in the nanometer scale. Replicate samples (n=3) of pure
theophylline compacted at 67 and 503 MPa were analyzed to estimate contributions of
sample variability to the PXRD patterns. At both compaction pressures, the standard
deviation intervals (Figure 3.1, dashed lines) indicate that the increase in diffuse scatter
is not attributable to random sample variations, as the magnitude of the standard error is
not sufficient to explain the scattering deviations between the PXRD patterns of the
samples compacted at two different pressures (Figure 3.1, solid lines).
The previously discussed pattern distortion can be associated with many different
physical and structural anomalies;45,111 however, a discussion of each is beyond the scope
of this manuscript. Rather, it is proposed that the introduction of disorder into a
crystalline material may result in the alterations observed in the average diffraction
patterns (solid lines) in Figure 3.1. The PDF method is relatively sensitive to instances
where materials exhibit long-range order; however, significant structural distortions may
also be present that would not be representative of the average crystallographic structure.
These “crystallographically challenged materials” result in dampened PDF features as a
function of increasing radial distances relative to their pure crystalline counterparts.39 It
may, therefore, be suggested that the features observed as a function of increasing
compaction pressure in Figure 3.2 are the result of increasing deviations from the
average crystallographic structure of anhydrous theophylline. Replicate samples at each
compaction pressure were carried through the PDF transformation to assess the effect of
sample variability on the resulting PDF patterns. As shown by the standard deviation
intervals (Figure 3.2, dashed lines), the probability peak dampening and shifting can not
be adequately explained by sample-to-sample variability, as the magnitude is not
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sufficient to justify the pattern distortions. This is further supported by data in Figure 3.3.
Key features in the experimental PDF and the pattern generated by simulating distortions
to 0.928% of the molecules from their defined average position (Figure 3.3b), agree well
with one another. This agreement further supports the observation that compactionrelated structural distortions resulted in the types of probability peak changes observed in
Figure 3.2.
It is worthwhile to note that the PDF is a one-dimensional representation of a
three- dimensional structure; therefore, multiple simulated models may result in the same
one-dimensional PDF representation. Though the simulations in this study were properly
constrained to prevent physically meaningless solutions, other random structure
permutations may give an acceptable or better answer than the one yielded in Figure
3.3b. The proposed model is presented only to show that the PDF differences associated
with compaction are consistent with compaction-induced disorder.
3.4.2 PDF of Mathematically Isolated Theophylline
The significant disorder of MCC presents a potential problem with respect to
separation of diffuse scatter specifically attributable to MCC from the diffuse scatter from
theophylline introduced as a result of compaction. The green difference plot in Figure
3.4b shows that theophylline diffraction data mathematically isolated from the
theophylline:MCC mixtures agrees well with the theoretical PDF of theophylline. Given
the low compaction pressure used to prepare the samples for Figure 3.4b, significant
changes to the anhydrous theophylline structure were not anticipated, and accurate
mathematical isolation of theophylline diffraction was, therefore, expected.
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Different issues with isolation of scattering from theophylline:lactose compacts
occurs owing to the crystallinity of the excipient. Specifically, isolation of theophylline
diffraction from regions in the PXRD pattern where both components have peak overlap
may result in multiple anomalies with the isolated pattern, including inaccurate peak
intensity values, peak shape distortions, and/or the disappearance of theophylline peaks
altogether. The green difference plot in Figure 3.5b shoes that PDF-transformed
theophylline diffraction data mathematically isolated from the theophylline:lactose
mixtures agrees well with the theoretical PDF of theophylline. Again, considering the
low pressure used to prepare compacts for Figure 3.5b, significant structural changes to
anhydrous theophylline were not anticipated.
3.4.3 PCA of PDF Transformed Data
The circumscribed central composite design of experiments used in the present
work directly built sample variability into each model through replication of the center
point (n=5), which corresponded to a compaction pressure of 268 MPa and an excipient
concentration of 48% w/w. The variance in the PDF attributable to sample variation is
therefore susceptible to explanation by PCA. In the dimension of the first PC, however,
the replicate samples are observed to cluster together (dashed circles in Figures 3.6, 3.7),
thereby precluding sample variability from acting as the sole contributor to the data
segregation observed in each plot.
The data-segregation correlated to compaction pressure observed in Figure 3.6
occurred regardless of the concentration of MCC present. As described above, longrange atomic correlation dampening (r ≥ 40 Å) was concluded to be most likely
attributable to structural differences arising from compaction. Ultimately, these data
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strongly support that the variance explained by the first PC is correlated to the probability
peak dampening observed in PDF data (Figure 3.2).
The same data segregation observed in the first analysis (Figure 3.6) was also
observed in the second PCA model (Figure 3.7), which suggests that clustering
corresponds with the same probability peak dampening explained above. Recall that the
point representing the binary sample containing 75% w/w lactose compacted at 268 MPa
clustered with the samples compacted at low pressures. Interpretation of this behavior
suggests that the presence of this much lactose may provide some degree of “protection”
against the theophylline structural changes interpretable from the PDF; however, this
warrants further investigation.
Almost all samples containing lactose (Figure 3.8, red, unfilled symbols) had
PDF patterns with score values (in the dimension of the first PC) that were most similar
to all other samples compacted at low pressures. The score values for all lactose samples
compacted at 268 MPa clustered around samples compacted at low pressures, as did a
lactose-containing sample compacted at 419 MPa. The clustering of this particular
sample with others compacted at low pressures may not seem intuitive given that the
remaining two lactose samples (containing less % w/w lactose) compacted at a high
pressure did not. When sample composition is taken into consideration, however, a trend
in the dimension of the first PC is observable. At a compaction pressure of 419 MPa, as
the amount of lactose is decreased (Figure 3.8, red triangles), the sample score values
became increasingly similar to the rest of the samples compacted at high pressure.
Overall, every sample containing lactose (with the exception of the two compacted at 419
MPa having low % w/w concentrations), resulted in PDF patterns similar to all samples
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compacted at low pressures. These PDF data, therefore, did not exhibit the probability
peak dampening displayed by PDF-transformed data of (a) pure theophylline samples
compacted at high pressures, and (b) PDF-transformed data of mathematically isolated
theophylline from samples containing MCC compacted at high pressures. Hence, the
samples containing > 50% w/w lactose did not demonstrate any detectable structural
modifications as a function of compaction pressure in the range investigated.

3.5 Conclusion
In this study, the effects of powder consolidation on solid structure were
examined. Simulated data suggest that the compaction-related changes observed in realspace analyses (PDF) of theophylline are primarily attributable to molecular deviations
from average crystalline order. The analysis of pharmaceutically relevant, intact
consolidated systems was performed using PXRD, which afforded structure-sensitive
capabilities without the introduction of artifacts arising from traditional sample
preparation (e.g. subsequent grinding to revert to powder samples). The application of
the PDF transform to an individual constituent, in the presence of an excipient, was
successfully accomplished as a result of a novel, accurate mathematical pattern separation
technique. Ultimately, this permitted practical real-space structural analysis of a single
component in the presence of another material, thereby enabling the investigation of
compound consolidation effects (i.e. the affect a material has on the compaction behavior
of another). The use of PCA as an alternative to the weighted agreement factor for
comparing multiple PDF patterns was successfully demonstrated. Relative to binary
compacts formed with microcrystalline cellulose, structural changes to theophylline in
the presence of α-lactose monohydrate were not observed (except in the two samples
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compacted with the least amount of lactose). This suggests the inclusion of lactose
provides protection to theophylline from structural changes that would otherwise occur at
high pressures. Further exploration of this particular conclusion, however, deserves
additional attention and will be the focus of future experiments.
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Chapter 4: Structural Interpretation in Composite Systems
Using Powder X-ray Diffraction: Applications of Error
Propagation to the Pair Distribution Function
4.1 Introduction
Advanced analytical techniques used to characterize pharmaceutically-relevant
materials properties are becoming increasingly sensitive to changes in short-range order
of material structure. At the forefront of these advancements is a total scattering powder
X-ray diffraction (PXRD) method adapted from the inorganic materials science literature,
commonly referred to as the atomic pair distribution function (PDF). The PDF transform
exploits the Fourier relationship between powder diffraction intensity and the real space
arrangement of atomic species. It has been used extensively to study crystalline,
nanocrystalline, and amorphous inorganic materials, and its application in the
pharmaceutical literature has increased substantially in the last decade.
Recent applications of the PDF in the pharmaceutical literature include the
investigation of dehydration mechanisms in excipients,51 phase differentiation,48,115
assessing structural changes during pharmaceutical manufacturing,116,117 and
characterization of solid dispersions.52,118,119 An unfortunate occurrence in recent
analyses incorporating PDF transforms involves drawing subjective conclusions with
little to no statistical support. Additionally, errors made to pre-Fourier transformed
intensities manifest as pattern anomalies oftentimes mistaken for structural phenomena,
thereby further detracting from the merit of the study. Deriving an error estimate for a
PDF pattern would largely increase the value of PDF-related conclusions.
Experimental errors in the PXRD experiment may arise from quantum counting
inefficiencies, experimental imprecision, sample inhomogeneities, etc. and should be
104

propagated and accounted for when interpreting PDFs. In addition to uncertainties in the
PXRD experiment, the lack of infinite momentum transfer resolution, as well as
inaccurate data corrections applied to intensity data affect the degree of uncertainty in the
resulting PDF. The inherent artifacts incurred as a result of Fourier transforming lower
energy X-ray source data to real-space representation are well known and when treated
appropriately41 are less significant contributors to errors in the PDF. An appropriate
estimate of error at the outset of the experiment and subsequent propagation through the
entire mathematical transformation would significantly aid in drawing meaningful
conclusions from PDF studies.
The use of error propagation methods in assessing the fit between a theoretical
PDF calculated from a known crystal structure and experimental PDF has been developed
and applied in the materials sciences literature.120,121 As it is becoming routine to
compare two experimentally derived PDFs (i.e. two individual components versus
composite materials), a question arises as to appropriate treatment of each individual
error source in combined comparisons. In this study, the propagation of initial PXRD
error estimates through the PDF transform is presented. Monte Carlo simulations were
performed to assess the validity of applying traditional error propagation algorithms to
accurately estimate uncertainty in the resulting PDF. The propagated error estimates for
individual experimentally-derived PDFs were mathematically combined to define
uncertainty intervals around difference plots. Statistical hypothesis inferences were
drawn from these intervals to aid in identifying differences between experimental PDF
patterns attributable to structure as opposed to those resulting from random error. The
aforementioned principles were applied to co-solidified products in an attempt to assess
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drug:excipient miscibility, an area where differentiation between structural information
and error in the PDF is of the utmost importance.

4.2 Materials and Methods
Ketoconazole was purchased from Spectrum Chemicals (New Brunswick, NJ),
polyvinyl pyrrolidone:vinyl acetate (PVPva) was purchased from BASF (Ludwigshafen,
Germany), terfenadine was purchased from Sigma-Aldrich (St. Louis, MO) and
felodipine was purchased from Tecoland (Edison, NJ). Molecular structures for the
compounds used in this study are shown in Figure 4.1.

Figure 4.1. Molecular structures for felodipine, ketoconazole, terfenadine, and PVPva.
4.2.1 Solid Dispersion Preparation
Co-solidified products were prepared using the melt-quench method.66 Briefly,
the powdered components were physically mixed in a scintillation vial and added to a
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crucible heated in a silicone oil bath at a temperature sufficient to melt the mixture. The
molten mixture was held isothermally for 30 minutes. The molten mixture was quenched
using an ice water bath. Individual amorphous phases were produced by holding the
sample above the melting temperature for 10 minutes followed by quenching in an ice
bath. All samples were removed from the bottom of the crucible intact for analysis.
4.2.2 Powder X-ray Diffraction (PXRD)
The PXRD data were collected in transmission geometry using an X’Pert Pro
MPD system (PANalytical B.V., Almelo, the Netherlands) equipped with a copper anode
(λ = 1.5406 Å), an auxiliary elliptical mirror, and X’CeleratorTM detector. The
operational voltage and amperage were set to 45.0 kV and 40.0 mA, respectively.
Diffraction patterns were acquired on intact samples, sandwiched between two layers of
Kapton® film and subsequently placed on a spinning vertical sample stage (16 rpm).
Experimental parameters include an irradiation time of 51.04 seconds per step and an
angular step size of 0.02° 2θ over a 2-100° 2θ range.
4.2.3 Differential Scanning Calorimetry (DSC)
Glass transition temperatures (Tg) were measured using a Q100 DSC (TA
Instruments, New Castle, DE) under constant nitrogen purge (~50mL/min). A threepoint enthalpy and temperature calibration was performed at 20 °C/min using o-terphenyl,
indium, and tin standards. In an attempt to avoid artifacts arising from grinding samples,
approximately 5 mg intact “sample chips” were hermetically sealed in aluminum pans.
To normalize thermal history, samples were first heated at 20 °C/min to 105 °C, held
isothermally for 2 minutes, and subsequently cooled to -20 °C at 20 °C/min. Samples
were then cycled through Tg at 20 °C/min for temperature determination. Ideal glass
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transition temperatures for drug:polymer amorphous molecular solid dispersions were
calculated using the Couchman-Karasz equation85 and are listed in Table 4.1.
Table 4.1. Summary of DSC and PDF analyses.
DSC Analysis

felodipine:PVPva
terfenadine:PVPva

Ideal Tg
(°C)
62.1
77.48

Tg (°C)
66.9 (0.015)
60.7 (0.21)

PDF Analysis

R value
0.2126
0.0864

Drug
Conc.
(w/w)
0.81
0.73

Polymer
Conc.
(w/w)
0.19
0.27

Conclusion
miscible
phase-separate

4.2.4 Pair Distribution Function (PDF)
The PDF is a total scattering method that exploits the Fourier relationship
between X-ray diffraction intensity and the real-space arrangement of atoms, given
appropriate data treatment.38,111 This method has received extensive attention in the
inorganic literature with an increasing number of pharmaceutical applications reported
recently. The PDF, G(r), is defined as:
G ( r ) = 4 πr [ρ( r ) - ρ o ]

(4.1)

where ρ(r) and ρo are the local and average atomic number densities, respectively, and r
is the inter-atomic separation distance. The PDF calculates the probability of finding
atom pairs separated by a distance r, and is obtained by Fourier transform of the
reciprocal space structure function, S(Q), according to:
G (r ) =

2
π

Q max

∫
0

Q [S ( Q ) - 1]sin( Qr ) dQ

(4.2)

where S(Q) is the structure factor obtained from a diffraction experiment and Q is the
magnitude of the scattering vector. The term Qmax is the momentum transfer resolution of
the diffraction experiment, which is dependent on the wavelength of radiation used and
the maximum diffraction angle (°2θ) of data collection. Corrections consistent with those
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outlined by Egami and Billinge38 were made to the measured diffraction data leading to
the calculation of the structure function. All intensity corrections (e.g. background due to
Kapton® film scattering, absorption, etc.) and PDF calculations were performed using
software developed in-house in the Matlab programming environment (v7.1, MathWorks,
Natick, MA) based on published equations. The PDF transforms were optimized using
the Glow quality criteria introduced by Peterson, et al.41
4.2.5 Error Propagation
The method of error propagation through the PDF transform has been derived and
applied in previous work.38,121 If it is assumed that the measurement of each individual
observation is statistically independent of all others (i.e. the count intensity at a given
diffraction angle is independent of all others), the covariance between observations is
eliminated. It is worthwhile to note that the aforementioned assumption is appropriate in
PXRD experiments provided the mathematical manipulations to the raw diffraction
pattern do not introduce statistical correlation among individual data points (i.e.
windowed smoothing, interpolation). When a quantity T is the sum of two independent
observations, X1 and X2, each having their own error estimate, σ(X1) and σ(X2), the
estimated error σ(T) is:
σ (T ) =

(σ ( X 1 )) 2 + (σ ( X 2 )) 2

(4.3)

The quantity T calculated from the product of a constant value, c, and X has an estimated
error given by,
(4.4)

σ (T ) = c • σ ( X )

When a quantity T is the product of two independent observations, X1 and X2, each
having their own error estimate, σ(X1) and σ(X2), the estimated error σ(T) is:
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σ (T ) σ ( X 1 ) σ ( X 2 )
=
+
T
X1
X2

(4.5)

Error propagation was performed by setting up two data vectors. The first data
vector contained the raw PXRD intensity values for a given powder pattern. The second
vector contained the initial error estimates for each intensity value. The vectors were
propagated side-by-side through to the calculation of the structure function using the
principles outlined in Equations 4.3, 4.4, and 4.5 for the mathematical manipulations to
the error vector.
The final step of the PDF method involves the sine Fourier transform of the
structure function, S(Q), into real-space representation. Given accurate propagation of
error up through calculation of the structure factor and no introduction of statistical
correlation among the independent scattering events, a good estimate of the standard
uncertainty in the PDF, σ(G(r)), is given by:
σ (G ( r j )) =

4
π2

∑(Q

i

sin(Q i r j )ΔQ i ) 2 σ ( S (Q i )) 2

(4.6)

i

where σ(S(Q)) is the error estimate of the structure function.
4.2.6 Monte Carlo Simulation
The term Monte Carlo refers to a broad class of methods that employ generation
of random numbers as a starting point for solving a complicated numerical problem.
Monte Carlo methods are often used to simulate physical and mathematical systems.
They are especially useful for modeling phenomena having significant uncertainty. The
simulation typically begins with defining a distribution of possible inputs. An input
generated from the distribution is used to perform deterministic computations to obtain an
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individual result. Finally, the results from individual computations are compiled and
interpreted.122
The raw PXRD counts go through a number of mathematical manipulations when
transformed using the PDF algorithm; oftentimes optimized according to specific quality
criteria.41 In order to confirm the appropriate propagation of an initial raw count error
estimate, Monte Carlo simulations were employed. The simulations began with a defined
distribution of intensity values at each °2θ. The distribution at each specific scattering
angle (°2θ) was formed by using the raw intensity (i.e. counts) as the distribution mean
and the error estimate as the spread. Simulated PXRD patterns were formed by randomly
selecting an intensity value from the previously defined distributions at each °2θ angle.
Each simulated PXRD pattern was subsequently transformed into real-space
representation using the PDF. After ten-thousand iterations, a matrix of PDF patterns
spanning the variance of the simulated PXRD patterns was formed. The minimum and
maximum G(r) at each r-value in the PDF was compared to the error vector calculated
using the previously defined equations.

4.3 Results
The count of scattered intensity within a given time interval obtained from the
PXRD experiment is subject to an unavoidable, random uncertainty due to statistical
variation in quantum counting.123 This stochastic variation best follows a Poisson
probability density function a discrete distribution that possesses unique statistical
properties. Assuming that n counts occur in a specific time interval, the distribution
possesses a mean and variance equal to n, when n is a positive integer.38 The standard
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deviation for n counts at the scattering angle x° 2θ is, therefore, equal to the square-root
of n and will serve as the initial error estimate.
Figure 4.2a shows the diffraction pattern for amorphous ketoconazole (black,
solid line) and ±3 standard deviations (blue, solid line). The subsequent PDF transform
of the PXRD pattern is shown in Figure 4.2b (zoomed, black, solid line). To confirm the
appropriate propagation of error through the transform, Monte Carlo simulations were
performed as previously described. The calculated error (blue, dashed lines) and
simulated error (red, dashed lines) is shown as intervals in Figure 4.2b and as absolute
error values in Figure 4.2c.

Figure 4.2. (a) The diffraction pattern for amorphous ketoconazole (black, thick line)
and ±3σ (blue, thin line); (b) the PDF transform of (a) (black, thick line), calculated ±3σ
(blue, dashed line), and simulated ±3σ (red, dashed line); (c) absolute representation of
calculated 3σ (blue) and simulated 3σ (red).
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It is common practice to compare an experimentally obtained PDF to one
calculated from a structural model. Previous studies have illustrated the advantages of
error propagation to this particular application. Recently, an increasing interest to
compare multiple experimental PDFs has emerged. Difference plots with error intervals
calculated from experimental PDFs may assist in delineating random errors from true,
structural variations. Figure 4.3a shows the PDF transform of a 50 wt% physical
mixture of amorphous felodipine and PVPva (black, solid line) with an overlay of a linear
combination of PDFs from amorphous felodipine and PVPva (blue, line with circles).
Figure 4.3b shows the difference plot (black, solid line) obtained from the two traces in
Figure 4.3a. Additionally, the estimated combined error contribution (±3σ) calculated
from the propagation through each transform is also shown as an interval around the
difference (red, dashed lines). That is to say, an interval calculated from the combination
of the two amorphous component PDFs comprising the blue trace and the physical
mixture PDF represented by the black trace.
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Figure 4.3. (a) The PDF of a 50 wt% physical mixture of amorphous felodipine and
PVPva (black) and the refined linear combination of the amorphous component PDFs
(blue, circles); (b) the difference between the PDFs (black) and ±3σ (red, dashed line).
To illustrate the potential to differentiate random error from true structural
differences, the error propagation principles were applied to the method outlined by
Newman et al.52 that was proposed to identify miscibility between a drug and excipient.
Briefly, the PDF of a co-solidified product is compared to the linear combination of the
PDFs obtained from the amorphous components comprising the mixture. The scaling
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constants serve as concentration estimates for each amorphous phase in the co-solidified
mixture. If the linear combination of the PDF for each amorphous component describes
the PDF of the co-solidified sample, it is reasonable to conclude that the system is at least
partially phase-separated as the short-range order (i.e. the static local structure) of the cosolidified product can be described by the intrinsic distances found in the amorphous API
and polymer. Substantial differences between the PDF calculated from linear
combination of the individual amorphous component PDFs and the PDF of the cosolidified sample are indicative of short-range order not presented in the individual
components, (i.e. that of a unique packing pattern). Figure 4.4a shows the PDF
transform (black, solid line) for a 75 wt% felodipine and PVPva co-solidified product.
The superimposed trace (blue, circles and line) is the best refined linear combination of
the amorphous component PDFs. Figure 4.4b shows the difference between the two
PDFs (black, solid line) with the calculated ±3σ error estimates.
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Figure 4.4. (a) The PDF of a 75 wt% co-solidified product of felodipine and PVPva
(black) and the refined linear combination of the amorphous component PDFs (blue,
circles); (b) the difference between the PDFs (black) and ±3σ (red, dashed line), where
the green dots are indicative of the error interval not containing zero.
As a point of comparison, Figure 4.5a contains the PDF (black, solid line) for a
75 wt% terfenadine and PVPva co-solidified product. Superimposed is the best refined
linear combination of the amorphous component PDFs. Figure 4.5b shows the
difference between the two PDF traces (black, solid line) with the calculated ±3σ error
estimates. The Tg for the co-solidified products in Figure 4.4 and Figure 4.5 are shown
in Figure 4.6 and Figure 4.7, respectively. In both products, a single Tg event is
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observed (middle traces in Figure 4.6 and 4.7) intermediate to the Tg observed for the
pure components (top and bottom traces in Figure 4.6 and 4.7). Table 4.1 summarizes
the DSC and PDF results.

Figure 4.5. (a) The PDF of a 75 wt% co-solidified product of terfenadine and PVPva
(black) and the refined linear combination of the amorphous component PDFs (blue,
circles); (b) the difference between the PDFs (black) and ±3σ (red, dashed line).
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Figure 4.6. The DSC thermograms for felodipine:PVPva systems (as labeled).
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Figure 4.7. The DSC thermograms for terfenadine:PVPva systems (as labeled).

4.4 Discussion
The PXRD experiment is traditionally regarded as robust. Fluctuations in
scattering intensity attributable to experimental geometry (Lorentz factor) and radiation
polarization are assumed to be insignificant contributors to the overall variance due to
their precision.23,123 The uncertainty due to statistical variation in quantum counting,
therefore, serves as an appropriate initial error estimate (Figure 4.2a). Although this
estimate does not contain all possible sources of error, it does enable the ability to rule
out changes that are too small to be taken seriously.
By randomly selecting scattering intensities spanning the defined error interval for
each scattering angle (°2θ) over ten-thousand iterations, the Monte Carlo simulation
creates a matrix of diffraction patterns that possess the overall variance contained within
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the initial uncertainty estimate. The simulated patterns were individually transformed
using the PDF algorithm. Since the simulated PXRD patterns span the total variance of
the estimated uncertainty in reciprocal space, the resulting PDF patterns span that same
variance in real-space. The propagated PDF uncertainty interval (Figure 4.2b, blue,
dashed lines) is in good agreement with the simulated PDF uncertainty interval (Figure
4.2b, red, dashed lines). For a point of reference, the absolute PDF errors derived from
propagation and simulation are given in Figure 4.2c. The agreement between simulated
and propagated errors confirms the appropriate propagation of the initial error estimate
through the PDF transform.
Comparisons and modeling between multiple experimentally obtained PDFs is
becoming increasingly common. Similar to comparing an experimental PDF to a
calculated PDF from a structural model, the premise in these analyses is to identify
correlations between PDFs while maintaining the ability to differentiate pattern
dissimilarities attributable to structural differences from those attributable to random
error. To do this, it is proposed that error intervals are estimated for the difference plot
calculated between experimental PDFs of interest. In Figure 4.3a, the PDF transform of
a PXRD pattern obtained from a 50 wt% physical mixture of amorphous felodipine and
PVPva is represented by the black, solid line. The blue line with circles in Figure 4.3a
represents the refined linear combination of amorphous component PDFs. The difference
between the calculated and physical mixture PDF is given in Figure 4.3b (black, solid
line). The uncertainty interval around the difference plot was obtained from the
combined propagated error of the two PDF patterns. The PDF transform of a PXRD
pattern of an amorphous felodipine:PVPva physical mixture would be expected to be the
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same as a linear combination of a PDF transform of a PXRD pattern of pure amorphous
felodipine and a PDF transformed of a PXRD pattern of pure PVPva. This expectation is
founded on the principle that a physical mixture of two amorphous materials would not
alter the short-range order intrinsic to the two materials comprising the blend.
A null hypothesis may be formed stating that the difference between the two
PDFs is equal to zero (ho: μa – μb = 0). The alternative to the null hypothesis states the
difference between the two PDFs is not equal to zero (hA: μa – μb ≠ 0). If, at any value of
r, the ±3σ interval around the difference plot contains zero, then the null hypothesis is

accepted. If, however, the ±3σ interval at a value r does not contain zero, then the
difference between the two PDFs can not be explained simply by random error and the
null hypothesis is rejected. The ±3σ interval shown in Figure 4.3b contains zero for
every value of r, and therefore, reflects that all differences between the two PDFs is
attributable to random error. Defining a threshold below ±3σ would lead to conclusions
of structural differences between the two PDFs, as the entire range of r would not contain
zero. As a result of this finding, ±3σ difference plot intervals that do not include zero are
assumed to be indicative of statistically significant structural dissimilarities between
experimental PDFs for the remainder of this manuscript.
It is worthwhile to point out that the aforementioned conclusion concerning the
±3σ threshold is not universal; rather, it is dependent on the PXRD experimental
parameters. Longer irradiation times or different experimental geometries may result in
better counting statistics, hypothetically producing relative initial error estimates orders
of magnitude less than the ones illustrated herein. The principles surrounding error
propagation and the conclusions drawn from statistical hypotheses testing outlined
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previously, however, are valid and warrant application when drawing inferences from
differences between multiple analytical results.
The DSC data for 75 wt% felodipine and PVPva co-solidified product, as well as
75 wt% terfenadine and PVPva co-solidified product are shown in Figure 4.6 and 4.7,
respectively. From Table 4.1, the calculated ideal Tg for a 75 wt% felodipine:PVPva
amorphous molecular solid dispersion is 62 °C. The experimentally determined Tg for
the co-solidified product, cycled through the event three times, was 67 ± 0.02 °C and in
good agreement with the ideal value. The ideal Tg for a 75 wt% terfenadine:PVPva
(Table 4.1) is 77 °C. The experimentally determined Tg for the co-solidified product was
60 ± 0.2 °C. In both instances, a single Tg intermediate to the individual amorphous
phase Tg that remains constant upon cycling was observed for the co-solidified products
(Figures 4.5 and 4.6). From purely thermal analyses, both co-solidified products may be
classified as amorphous molecular solid dispersions due to the presence of only a single
Tg intermediate to the pure amorphous phase Tg events.

In Figure 4.4a, the PDF of the PXRD pattern for the felodipine:PVPva cosolidified product (black, solid line) is shown with the refined linear combination of the
amorphous component PDFs. The scaling constant-derived concentrations of 81 % and
19 % drug and polymer, respectively (Table 4.1) deviate substantially from the
theoretical values of 75 % drug and 25 % polymer. The sum-of-squares agreement factor
(R) shows an error estimate of 21 % between the calculated PDF and the co-solidified
product PDF. From the difference plot in Figure 4.4b, variations between the two
patterns are observed within the range of 6 – 9Å that are not explained by random error
as indicated by portions of the error interval not encompassing zero (green dots). As
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previously suggested, this result would be indicative of a true amorphous molecular solid
dispersion, as the product would have short-range order (i.e. nearest neighbor and next
nearest neighbor interatomic distances) not explained by either pure component PDF.
The PDF for the terfenadine:PVPva co-solidified product (black, solid line) is
shown with the calculated PDF in Figure 4.5a. The scaling constant-derived
concentrations of 73 % and 27 % drug and polymer, respectively (Table 4.1) are close to
the theoretical values of 75 % drug and 25 % polymer. The sum-of-squares agreement
factor (R) shows an error estimate of only 8 % between the calculated PDF and the cosolidified product PDF (Table 4.1). Upon inspection of the difference plot uncertainty
interval in Figure 4.5b, it was found that zero is contained within the ±3σ interval over
the entire range of r. The short-range order displayed in the PDF of the co-solidified
product is well explained by that found in the individual amorphous components and
thereby negates formation of a unique packing pattern. The terfenadine:PVPva
dispersion product, therefore, is phase-separated.
A plausible explanation as to why a second Tg was not observed for the
terfenadine co-solidified product was extrapolated from Newman, et al.52 Close
inspection of Figure 4.7 shows the Tg of the dispersion product to be nearly equal to the
Tg of amorphous terfenadine. Since terfenadine represents the major phase of the

dispersion (75%), PVPva only constitutes 1.25 mg of a 5 mg sample. As the
concentration of the PVPva amorphous domain decreases with respect to that of the
amorphous terfenadine, the heat capacity change at the PVPva glass transition becomes
so subtle relative to that of amorphous drug that it is not detectable using standard DSC.
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4.5 Conclusion
The successful propagation of an initial error estimate through the PDF transform
enabled statistically-based conclusions to be drawn from multiple pattern comparisons. It
was found that difference plots calculated from linear combinations of amorphous phase
PDFs and co-solidified product PDFs could be used to differentiate between phaseseparated systems and amorphous molecular solid dispersions. The calculation of error
intervals on the difference plot assisted this classification scheme by providing statistical
thresholds to define structural dissimilarities as opposed to subjective interpretation.
Though this study does not define a universal threshold for differentiation of random
errors and structural dissimilarities, the principles developed herein may be adapted and
applied accordingly.
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Chapter 5: Informatics Calibration of a Molecular Descriptors
Database to Predict Solid Dispersion Potential of Small
Molecule Organic Solids
5.1 Introduction
The aqueous solubility of a small molecule organic (SMO) solid is one of the
principle physicochemical properties considered when evaluating the developability of a
new chemical entity (NCE) for pharmaceutical use. Although a number chemical- and
physical-based approaches are available for enhancing the apparent aqueous solubility of
active pharmaceutical ingredients (API), it is still estimated that more than 40% of highly
potent compounds fail to reach clinical trials due to the inability to overcome poor
aqueous solubility.15 It is proposed that this statistic is somewhat inflated, not necessarily
due to the inefficacy of available methods, but rather the raw material requirements
associated with empirically assessing the potential of each. Formulation scientists are
ultimately forced to investigate only a fraction of the existing technology, where
unsuccessful outcomes may deem a therapeutically efficacious API undevelopable. The
development of predictive models to optimize these methods in an attempt to preserve
early stage raw material supplies is thus imperative.
Stabilization of an API as an amorphous solid phase through the formation of
binary amorphous molecular solid dispersions has received increasing attention yielding
up to a four-fold enhancement of apparent aqueous solubility relative to the crystalline
form.58 Binary amorphous molecular solid dispersions are created through the rapid cosolidfication of an API and a pharmaceutically acceptable excipient, such as a polymer, at
loadings sufficient to achieve a physically stable amorphous API. Due to the kinetic
nature of the formation, spray drying,69 super-critical fluid processing,76 lyophilization,63
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and hot-melt extrusion72 have all been successfully implemented in the preparation of
amorphous molecular solid dispersions. Successful formation has been attributed to the
presence of specific and/or nonspecific adhesive interactions,62,83 as well as
antiplasticization effects intended to reduce molecular mobility.81
Predictive models for API:polymer miscibility have been introduced and are
largely derived from solution thermodynamics. Lattice based solution models, such as
Flory-Huggins theory, can be used to assess miscibility in API:polymer blends. In
addition to developing methods for estimating the Flory-Huggins interaction parameter,
Marsac et al.89 developed a model that predicted the solubility of an API in a polymer
based on a combination of interaction variables and Flory-Huggins theory. Janseens et
al.73 applied the similar theory to model solid dispersion preparation method effects on

the solubility of API in polymer. Friesen et al.68 showed physical properties of APIs,
such as hydrophobicity (i.e. log P), thermodynamic parameters (e.g. melting temperature)
and kinetic parameters (e.g. glass transition temperature) to provide insight concerning
formulation strategies for solid dispersion systems. In addition to ionic interactions,
when applicable, Yoo et al.124 also observed a correlation between hydrophobicity values
of APIs and miscibility with a given polymer. Despite the recent advances, explicit
universal criteria for API:polymer miscibility are still lacking.
Quantitative structure property relationships (QSPR) were derived from the
fundamental concept that a compound’s behavior is a result of its chemical structure. In
QSPR models, molecular descriptors, single integer indices that encode specific structural
information for a given compound, are typically regressed against some physical,
chemical, or mechanical property. Applications of molecular descriptors in QSPR
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modeling include predicting pharmacokinetic performance,125 describing physical
properties of alkanes,126 and prediction of soil sorption coefficients of pesticides.127
Coupled with characterization techniques to classify the co-solidified composites
containing a given API, molecular descriptors have the potential to provide insight to
API:polymer miscibility using a materials informatics approach.
In this study, 12 model compounds were prepared by a melt-quench procedure
using polyvinylpyrrolidone:vinyl acetate (PVPva) copolymer as a stabilizing agent with
useful thermoplastic properties and the potential (i.e. miscibility) for generating an
amorphous molecular solid dispersion. Each co-solidified sample was characterized by
thermal analysis, powder X-ray diffraction (PXRD). and a pair distribution function (PDF)
method recently introduced into the literature.52 Rather than attempting to quantify the
extent of miscibility between API and polymer to afford a continuous dependent variable,
each sample was classified as a successful formation (i.e. completely miscible) or an
unsuccessful formation (i.e. partially miscible or immiscible) based upon conclusions
drawn from the analyses. Molecular descriptors were calculated for each of the 12 model
compounds comprising the library and tested for correlation to dispersion potential using
logistic regression. A univariate model was created that predicted solid dispersion
potential from a single molecular descriptor and challenged using three compounds not
included in the calibration.
At the outset, it should be noted that the model developed herein is not proposed
to be universally applicable across all SMO compounds nor is it predictive of the time
course of physical instability (i.e. devitrification). Rather, a significant portion of the
discussion will attempt to highlight the limitations associated with the model and define
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the pertinent variance space for its applicability. The central objective of this work was
to illustrate the potential of in silico calculations to create models that may one day
provide the means for intelligent selection of stabilizing agents in the design of
amorphous molecular solid dispersions. This possibility is ultimately afforded by the
ability to classify co-solidified samples to compliment the interpretation that is possible
from solid-state characterization methods alone.

5.2 Materials and Methods
Cloperastine, terfenadine, propranolol, chlorpropamide, nifedipine, melatonin,
and quinidine were all purchased from Sigma-Aldrich (St. Louis, MO). Ketoconazole
and itraconazole were purchased from Spectrum (Gardena, CA). Indomethacin,
cimetidine, and tolbutamide were purchased from MP Biomedicals (Solon, OH).
Felodipine was purchased from Tecoland Corporation (Edison, NJ), sulfanilamide was
purchased from Acros Organics (Geel, Belgium), bicalutamide was purchased from Altan
(Orange, CT), and Kollidon VA64 (PVPva) was a gift from BASF (Ludwigshafen,
Germany). All model and test compounds are shown in Table 5.1.
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Table 5.1. Molecular structures and Cambridge Structural Database Codes for
compounds used in this study.
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5.2.1 Solid Dispersion and Amorphous Phase Preparation
Solid dispersion samples were manufactured using a melt-quench method.66
Briefly, each API and PVPva was weighed and dispensed into a scintillation vial at 75
wt% API loading. The powders were physically mixed for a period of 5 minutes by
manual agitation. To avoid sub-sampling, the entire mixed sample was added to a
crucible heated in a silicone oil bath. The oil bath was maintained at a temperature equal
to the fusion temperature of the API (Tf,API) + 10°C. In the instance where Tf,API was less
than 150 °C (e.g. the temperature at which PVPva liquefies), the mixture was held
isothermally at 160 °C. The isothermal hold time was between 10-20 minutes to provide
sufficient time for mixing. The hold time was determined using thermogravimetric
analysis and was defined as the time (at a given preparation temperature) where ≥2%
weight loss occurred. The molten mixture was subsequently quenched in an ice water
bath. Amorphous samples of each component were produced by holding the crystalline
API above its melting temperature for approximately 10 minutes followed by quenching
in an ice bath. The melt-quench samples were removed from the crucible intact and
examined. All preparations were repeated twice (n=3).
5.2.2 Differential Scanning Calorimetry (DSC)
Glass transition temperatures (Tg) for amorphous preparations of each model
compound, PVPva, and the co-solidified samples were measured using a Model Q100
DSC (TA Instruments, New Castle, DE) under constant nitrogen purge (~50 mL/min). A
three-point enthalpy and temperature calibration was performed at 20 °C/min using oterphenyl, indium, and tin standards. In an attempt to reduce artifacts arising from
sample preparation procedures (i.e. grinding), approximately 5 mg intact “sample chips”
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were hermetically sealed in aluminum pans. To normalize thermal history, samples were
first heated at 20 °C/min to 105 °C, held isothermally for 2 minutes, and subsequently
cooled to -20 °C at 20 °C/min. Samples were then cycled from -20 °C to 120 °C at 20
°C/min for Tg determination.
The expected Tg assuming an intimate mixture was calculated using the
Couchman Karasz85 equation given by:

Tg =

w API Tg API + Kw pTg p

(5.1)

w API + Kw p

where wAPI and wp and the weight fractions of API and polymer, respectively, TgAPI and
Tgp are the glass transition temperatures of amorphous API and polymer, respectively,

and K = ΔCpAPI/ΔCpp, where ΔCpAPI and ΔCpp are the heat capacity step change through
the glass transition region of the API and polymer, respectively. Experimental Tg values
were determined from the measured DSC heat flow signal as the onset of the step change
in heat capacity.
5.2.3 Powder X-ray Diffraction (PXRD)
The PXRD data were collected in transmission geometry using an X’Pert Pro
MPD system (PANalytical B.V., Almelo, the Netherlands) equipped with a copper anode
(λ = 1.5406 Å), an auxiliary elliptical mirror, and X’CeleratorTM detector. The
operational voltage and amperage were set to 45.0 kV and 40.0 mA, respectively.
Diffraction patterns were acquired on intact samples, sandwiched between two layers of
Kapton® film and subsequently placed on a spinning vertical sample stage (16 rpm).
Experimental parameters include an irradiation time of 51.04 seconds per step and an
angular step size of 0.017° 2θ over a 2-100° 2θ range.

131

5.2.4 Pair Distribution Function
The PDF is a total scattering method that exploits the Fourier relationship
between X-ray diffraction intensity and the real-space arrangement of atoms, given
appropriate data treatment.38,111 The PDF gives the probability of finding atom pairs
separated by a distance r, and is obtained by Fourier transform of the reciprocal space
structure function, S(Q), according to:
G (r ) =

2
π

Q max

∫
0

Q [S ( Q ) - 1]sin( Qr ) dQ

(5.2)

where S(Q) is the structure function obtained from a diffraction experiment and Q is the
magnitude of the scattering vector. The term Qmax is the momentum transfer resolution of
the diffraction experiment, which is dependent on the wavelength of radiation used and
the maximum diffraction angle (°2θ) of data collection. Corrections consistent with those
outlined by Egami and Billinge38 were made to the measured diffraction data leading to
the calculation of the structure function. All intensity corrections (e.g. background due to
Kapton® film scattering, absorption, etc.) and PDF calculations were performed using
software developed in-house in the Matlab programming environment (v7.1, MathWorks,
Natick, MA) based on published equations.38,111 The PDF transforms were optimized
using the Glow quality criteria introduced by Peterson, et al.41
The PDF has been shown to be useful in characterizing co-solidified composite
samples in differentiating phase-separated from completely miscible systems.52,118
Briefly, the PDF transform for a co-solidified sample is compared to the linear
combination of the PDF transforms obtained for each amorphous component comprising
it. Scaling coefficients are multiplied by the amorphous component PDFs and serve as
estimates of each component concentration in the co-solidified product. If the linear
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combination of the PDF for each amorphous component describes the PDF of the cosolidified sample, it is reasonable to conclude the system is at least partially phaseseparated, as short-range order (i.e. the static local structure) of the co-solidified product
can be described by the intrinsic distances found in the amorphous API and polymer.
Large deviations between the calculated PDF determined by linear combination of the
PDFs for the individual amorphous components and the PDF of the co-solidified sample
are indicative of short-range order not presented in the individual components, (i.e. that
of a unique packing pattern). A statistically-founded protocol based on principles of error
propagation has recently been introduced to aid in drawing conclusions from the
aforementioned method (Chapter 4). A sum-of-squares difference, R, between the
calculated PDF and PDF of co-solidified sample was also determined for comparative
purposes.123
5.2.5 Molecular Descriptors
The term molecular descriptor refers to a broad class of indices calculated under
the principal objective of representing a 3-dimensional molecule as a simple number(s).
Their successful use in QSPR studies, relating the structure of a compound to how it
behaves, provides impetus to modeling amorphous molecular solid dispersion potential.
By employing graph theory,128 a branch in discrete mathematics dealing with the way
objects are connected and the consequences of connectivity, single integer indices may be
calculated that encode structural information for a given molecule. Molecular graphs are
a 2-dimensional depiction of molecules, where atoms are represented by vertices and
bonds by edges. Two molecular graphs are isomorphic if there is a one-to-one
correspondence between their vertex sets and edge sets. For a given molecular graph, U,
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a graph invariant is a quantity that has the same value for any graph that is isomorphic
with U.128
From the molecular graph, important theoretical matrices may be calculated. The
vertex-adjacency matrix is a square symmetric matrix having off-diagonal values of one
for adjacent vertices and zero for non-adjacent vertices. Similarly, the edge-adjacency
matrix is a square symmetric matrix having off-diagonal values of one for adjacent edges
and zero for non-adjacent edges. The distance matrix is a square symmetric matrix
having off-diagonal values describing the shortest topological distance between two
vertices. Single integers may be obtained from the mathematical manipulation of these
matrices, thereby generating a class of molecular descriptors called topological indices.
These indices are graph invariants and do not possess atom identities, thereby lacking
heteroatom differentiation and stereochemical features of the molecule.126
To combat this issue, indices are calculated from weighted graph invariants,
where atomic mass, atomic number, van der Waals volumes, and atomic polarization
constants have all been implemented. These descriptors are much more powerful and
have seen an increasing exposure to structure-property relationships studies. In this study,
molecular descriptors were calculated using the EDRAGON online program.129-131
Three-dimensional coordinates and atom connectivity was obtained from the Cambridge
Structural Database (CSD),132,133 where the CSD code for each model and test compound
are listed in Table 5.1.
5.2.6 Logistic Regression
The intent of this study was to introduce a novel method for modeling the
potential of a compound to successfully form an amorphous molecular solid dispersion
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with PVPva using a common method of preparation. Attempting to define and quantify
the extent of miscibility between API compounds and PVPva would likely confound the
results of the analysis, as errors in this determination would propagate into the regression
modeling. Therefore, the response in this analysis is a discrete, dichotomous variable
taking a value of 1 for successful formation of an amorphous molecular solid dispersion
(i.e. completely miscible) or a value of 0 for unsuccessful formation (i.e. partially
miscible or immiscible) based upon conclusions drawn from the analyses. The inclusion
of a dichotomous dependent variable unfortunately violates many of the assumptions of
general linear regression.134 Logistic regression was, therefore, used for modeling
purposes in this study.
Logistic regression was performed using maximum likelihood (ML) estimation to
calculate the regression coefficient for each molecular descriptor. Initial regression
coefficients are estimated and the ML is calculated. The regression coefficient is
iteratively adjusted until the maximum value of the ML (Equation 5.3) is achieved. To
avoid multiplication of probabilities, the natural logarithm of the ML function is used and
given by:

ln( ML) =

∑[Y

i

* ln Pi ] + [(1 - Yi ) * ln(1 - Pi )]

(5.3)

where Yi is the observed value (i.e. 0 or 1) and Pi is the estimated probability as obtained
by:
Pi =

e b0 + b1 X i
1 + e b0 +b1 X i

(5.4)

where b0 + b1Xi is the general linear model.134-136 The effect of individual variables on
model significance was tested by comparing the change in deviance (D), which is
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Equation 5.3 multiplied by -2. The likelihood ratio (LR) test statistic, corresponds to the
arithmetic difference between the deviance values for two models (e.g., with and without
a particular variable included), and follows a χ2 distribution. The significance of the
calculated regression coefficient for each molecular descriptor was evaluated by
comparing the reduction of deviance value of the full model against using only the model
intercept.
The error of cross-validation was assessed using the leave-one-out (LOO) method.
Briefly, one of the compounds comprising the calibration library was removed from the
data set. The remaining compounds were used to construct a calibration and a
subsequent prediction on the compound removed from the library was performed. This
was iteratively repeated for all compounds, where the sum of the total error was reported.

5.3 Results
5.3.1 Co-solidified product characterization
Amorphous molecular solid dispersions are formed as a result of the miscibility
between the components comprising the sample. To enable model estimation, DSC and
PDF analyses were used to characterize and classify the co-solidified samples according
to the extent of miscibility. To achieve this, both DSC and PDF analyses were employed.
To support the implementation of multiple characterization methods, three examples will
be examined. The first example will illustrate a co-solidified sample categorized as an
amorphous molecular solid dispersion, the second will detail identification of a phaseseparated system according to both DSC and PDF results, and the final will showcase a
phase-separated system identified by PDF results. A compilation of calculated
parameters associated with each example are given in Table 5.2.
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Table 5.2. DSC and PDF analyses results.

felodipine:PVPva

DSC Analysis
Ideal
Tg2
Tg1
Tg
(°C)
(°C)
(°C)
63.4
64.9
--

PDF Analysis
Drug
Polymer
R
Conc.
Conc.
value
(w/w)
(w/w)
0.213
0.81
0.19

quinidine:PVPva

76.8

59.7

81.9

0.069

0.73

0.27

terfenadine:PVPva

77.2

60.6

--

0.086

0.73

0.27

Conclusion
miscible
phaseseparated
phaseseparate

The DSC thermogram for amorphous felodipine, PVPva, and the 75 wt% cosolidified sample is shown in Figure 5.1a. A single Tg at 64.9 ºC was observed for the
co-solidified sample. The PDF analysis and respective difference plot for this system is
shown in Figure 5.1b. From Table 5.2, the calculated Tg for an ideal 75 wt% mixture is
63.4 ºC, which is in good agreement with the experimentally determined 64.9 ºC shown
in Figure 5.1a. The difference plot for the PDF analysis (Figure 5.1b) exhibits regions
in r where the confidence intervals do not contain zero. An R of 0.2126 (Table 5.2)
corresponds to 21% error between the two PDF patterns. Refined API and polymer
concentrations (scaling coefficients) of 0.81 and 0.19 (Table 5.2) deviate substantially
from theoretical concentrations of 0.75 and 0.25, respectively. Based on a single Tg and
the large deviations between the calculated and measured PDF of the co-solidified sample,
the system is an amorphous molecular solid dispersion.
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Figure 5.1. (a) DSC thermogram for amorphous felodipine (blue), PVPva (red), and 75 wt% co-solidified product (black); (b) PDF
analysis (as labeled).
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Figure 5.2. (a) DSC thermogram for amorphous quinidine (blue), PVPva (red), and 75 wt% co-solidified product (black); (b) PDF
analysis (as labeled).

The DSC thermogram for amorphous quinidine, PVPva, and the 75 wt% cosolidified sample is shown in Figure 5.2a. Glass transition events at 59.7 ºC and 81.9 ºC
were observed for the co-solidified sample. Although the DSC results alone provide
conclusive evidence of phase-separation, the PDF analysis was performed and is shown
in Figure 5.2b. The difference plot (Figure 5.2b) for the PDF analysis shows confidence
intervals that contain zero through the entire r region. In addition to this, a satisfactory R
value of 0.0689 and refined API and polymer concentrations of 0.73 and 0.27 (Table 5.2),
respectively, were also observed. The system is phase-separated based on evidence of
two Tg events and the agreement between the calculated and measured PDF for the cosolidified sample.
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Figure 5.3. (a) DSC thermogram for amorphous terfenadine (blue), PVPva (red), and 75 wt% co-solidified product (black); (b) PDF
analysis (as labeled).

The DSC thermogram for amorphous terfenadine, PVPva, and the 75 wt% cosolidified sample is shown in Figure 5.3a. A single Tg event at 60.6 ºC was observed for
the co-solidified sample, albeit relatively close to the Tg observed for the amorphous
terfenadine. The difference plot (Figure 5.3b) for the PDF analysis shows confidence
intervals that ultimately contain zero through the entire r region. In addition to this, a low
R and refined concentration values (Table 5.2) that are close to the theoretical

concentrations were also observed. It is concluded that the system is phase-separated as a
result of a single, Tg value near that of the amorphous API and the good agreement
between the calculated and measured PDF for the co-solidified sample.
The final results of the co-solidified sample analyses are listed in Table 5.3. Of
the 12 compounds comprising the calibration library, DSC and PDF analyses revealed six
successfully formed an amorphous molecular solid dispersion (i.e. miscible with PVPva)
and six formed phase separated systems. Propranolol, cloperastine, and sulfanilamide all
exhibited Bragg diffraction peaks (PXRD analysis), a clear indication of phase separation,
following preparation. Nifedipine and terfenadine both displayed a single Tg but were
shown to be phase-separated using the PDF analyses.
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Table 5.3. Calibration library generation results.
Compound
Felodipine
Indomethacin
Ketoconazole
Itraconazole
Tolbutamide
Chlorpropamide
Nifedipine
Quinidine
Propranolol
Cloperastine
Terfenadine
Sulfanilamide

Miscible?
YES
YES
YES
YES
YES
YES
NO
NO
NO
NO
NO
NO

Comments
---Could not obtain amorphous itraconazole; No PDF test
--PDF confirmation only; crystallinity day 1 for repeats
Detectable phase separation from DSC and PDF
Detectable crystallinity (PXRD) on day 1
Detectable crystallinity (PXRD) on day 1
PDF confirmation only; crystallinity day 1 for repeats
Detectable crystallinity (PXRD) on day 1
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5.3.2 Calibration
Univariate logistic regression was performed by estimating regression coefficients
for each of the calculated molecular descriptors. Subsequently, a model containing the
regression coefficient for a given molecular descriptor was compared with a model
containing only the mean using the LR test statistic. From this metric, the significance of
the descriptor was determined. Molecular descriptors with a significance ≥ 0.999 (i.e. α
= 0.001) were retained for further analysis. The results of the univariate screening are
given in Table 5.4. Along with the regression equation, deviance, LR, and error of crossvalidation are shown. From each of these parameters, the atomic mass-weighted thirdorder R autocorrelation index, R3m, appears to be the most significant. Other significant
molecular descriptors include the topological distance between oxygen and chlorine
atoms (T(O…Cl)), the sum of the eigenvalues of an atomic number-weighted distance
matrix (SEigZ), the sum of the eigenvalues of an atomic mass-weighted distance matrix
(SEigm), first-order H autocorrelation weighted by atomic mass (H1m), the total H
autocorrelation weighted by atomic mass (HTm), and the maximum of the fourth-order R
autocorrelation weighted by atomic mass (R4m+). The R3m index will be described in
detail later; however, an explanation of other indices is beyond the scope of the paper and
interested readers are directed elsewhere.137
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Table 5.4. Model parameters for the seven best univariate models.

Molecular
Descriptor

Deviance

LR

LOO CV

logit P(Y) = -1.927 + 0.208T(O…Cl)

6.513

10.86

0.3841

SEigZ

logit P(Y) = -12.33 + 7.37SEigZ

4.889

12.49

0.4208

SEigm

logit P(Y) = 12.57 + 7.50SEigm

4.813

12.56

0.4199

H1m

logit P(Y) = -17.78 + 12.31H1m

6.314

11.06

0.3964

HTm

logit P(Y) = -13.25 + 1.14HTm

5.992

11.39

0.3720

R3m

logit P(Y) = -88.54 + 135.18R3m

0.039

17.34

0.0565

R4m+

logit P(Y) = -15.2 + 346.22R4m+

3.253

14.12

0.2637

T(O..Cl)

Regression Equation
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Following univariate screening, both forward and backward elimination
multivariate screening were performed at a significance level of 0.8 (i.e. α = 0.2). The
R3m index was the only remaining variable, and therefore, served as the final model.
Predicted probabilities of amorphous molecular solid dispersion potential using the R3m
model are shown graphically in Figure 5.4. The results from testing the R3m model with
three compounds not used in the calibration are shown schematically in Figure 5.5. A
description of the R3m index and explanation of its potential significance will be
addressed in the discussion section.
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Figure 5.4. Predicted dispersion potential probabilities for each of the 12 model compounds. Red indicates a correct prediction for
unsuccessful formation and blue indicates a correct prediction for successful formation.
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Figure 5.5. Predicted dispersion potential probabilities for each of the three test compounds. Red indicates a correct prediction for
unsuccessful formation and blue indicates a correct prediction for successful formation.

5.4 Discussion
As stated in the introduction, the central objective of this research was to illustrate
the potential of using in silico molecular calculations to create predictive models for
assessing miscibility between a compound and polymeric material, afforded by the ability
to classify co-solidified samples using advanced solid-state characterization methods. A
further interpretation of this hypothesis states that some underlying molecular property is
responsible for its ability to form a unique phase when intimately mixed with a carrier
material. It is assumed that API:polymer miscibility is represented by the formation of
short range order possessing physical, structural, and other intrinsic properties distinct
from either individual amorphous component. It is further assumed that a completely
miscible system will need to undergo phase separation as a pre-requisite to crystallization.
The extent of miscibility between a given compound and polymer is sensitive to
many different variables. The method of preparation, drug loading, and environmental
factors may all affect the outcome of this determination. The process of heating the
materials to prepare co-solidified may introduce chemical impurities into the system. As
shown elsewhere,138 the presence of impurities can provide resistance to crystallization in
co-solidified products by itself. This is recognized as a potential confounding factor to
the analysis presented herein, where TGA impurity assessment limits quantification to
volatile degradants only. It is assumed that the identification of miscible co-solidified
products is a result of the compatibility between the API and polymer and not a
consequence of thermal degradation. Therefore, conclusions concerning miscibility in
this study will be with reference to the melt-quench method used, the fixed concentration
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range interrogated, and assumptions derived from direct observation of characterization
data.
5.4.1 Co-solidified product characterization
The purpose of showing the three examples was to illustrate the requirement for
using multiple solid-state characterization techniques in order to classify the co-solidified
samples. Although the two techniques are often complimentary, instances occur when
results are contradictory. In the first example, a single Tg (Figure 5.1a, black line)
intermediate to each of the amorphous component Tg events was observed for the cosolidified felodipine:PVPva sample. Since the experimental Tg of 64.9 ºC is relatively
close to the predicted 63.4 ºC (Table 5.2), this may support classification as an
amorphous molecular solid dispersion on its own accord.
Instances arise where DSC may not be sensitive to the presence of multiple Tg
events. Possible explanations include convolution of two Tg events into a single Tg, the
magnitude of the heat capacity change associated with an additional phase(s) is below the
sensitivity of the instrument, the Tg event is superimposed over some other thermal
transition, or the glass transition event unexpectedly occurs outside of the temperature
range interrogated. In addition, heating the sample during the measurement may
consequently force miscibility in a phase separated system. Each instance warrants the
application of an alternative characterization technique, such as the PDF method using
error propagation estimates, to examine the co-solidified sample.
For the felodipine:PVPva co-solidified sample, the high R value of 21.26%,
concentrations inconsistent with theoretical values, and the presence of confidence
intervals for r-values not containing zero (Figure 5.1b and Table 5.2) all serve as
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indicators that the co-solidified product exhibits a packing pattern different than that
produced by the local structure of each individual amorphous component. From Figure
5.1b, the difference plot indicates a significant difference between the calculated PDF
and the co-solidified PDF around 8-9Å.
From Equation 5.2, the integration of the PDF is taken to Qmax, which ostensibly
serves as the resolution of the calculation. In this study, Cu Kα radiation was used as the
source in the PXRD experiments, which produces a Qmax of approximately 7Å-1. Fully
resolved PDFs require a Qmax much greater than 7Å-1, often achieved using synchrotron
radiation sources. Due to the limited Q-resolution afforded by laboratory source X-ray
data, each probability peak in the PDF represents a convolution of many different delta
peaks. With infinite Q-resolution, the formation of a new phase in the co-solidified
sample would result in the appearance of unique delta peaks representing newly formed
interatomic distances. The limitations imposed by using Cu Kα radiation call for
considering the distributions of delta peaks in the convoluted probability peaks.
Distribution changes manifest as alterations to the shape of the probability peak, as
observed for the felodipine:PVPva co-solidified sample (Figure 5.1b, black line) relative
to the combine amorphous components (Figure 5.1b, blue circles). It may be concluded
that this sample has unique interatomic distances formed around 8-9Å not found in either
amorphous component, and therefore, is an amorphous molecular solid dispersion. This
conclusion is consistent with those found elsewhere.79
In the second example, the thermogram of the quinidine:PVPva co-solidified
sample (Figure 5.2a, black line) displays a Tg event near that of the amorphous quinidine
(Figure 5.2a, blue line) and a second intermediate to each amorphous component. Given
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the detection of two Tg events, it is reasonable to conclude that the co-solidified sample
has phase-separated. In an effort to illustrate an instance where the PDF method supports
the conclusions drawn from DSC, an analysis was performed on the quinidine:PVPva
system. From Figure 5.2b, agreement between the calculated PDF and the co-solidified
sample was obtained as evidenced in the difference plot. The inclusion of zero
throughout the entire r range, low R value, and experimentally determined concentration
values close to theoretical (Table 5.2) all support the conclusion of phase separation.
The final example is unique due to the disagreement in conclusions drawn from
each characterization technique. In Figure 5.3a, the thermogram for the
terfenadine:PVPva co-solidified sample (black line) shows a single detectable Tg of 60.6
ºC close to the Tg of 59.8 ºC for amorphous terfenadine (blue line). Although this is
likely indicative of the presence of amorphous terfenadine, unfortunately, a definitive
conclusion is not readily available. Deeming this analysis as inconclusive, an additional
characterization technique is required.
In Figure 5.3b, the linearly combined amorphous component PDF patterns are
superimposed over the co-solidified sample PDF. From the difference plot, it is shown
that the confidence intervals include zero throughout the entire range of r values.
Additionally, the refined concentration values and low R value (Table 5.2) indicate a
good fit between the two PDF patterns. The aforementioned PDF data supports the
conclusion that the terfenadine:PVPva co-solidified sample is phase-separated.
Table 5.3 summarizes miscibility determination between the 12 model
compounds comprising the calibration library and PVPva, where a few noteworthy points
deserve some discussion. Propranolol, cloperastine, and sulfanilamide all exhibited
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Bragg diffraction peaks in PXRD patterns obtained following co-solidification, thereby
indicating phase separation. Nifedipine and terfenadine were identified as phaseseparated using the PDF method, where their respective co-solidified sample
thermograms displayed single Tg events. This conclusion was indirectly confirmed when
the repeat co-solidification samples were analyzed. In their subsequent preparations,
PXRD patterns from both compounds displayed Bragg diffraction peaks immediately
following sample preparation, thereby corroborating the previous conclusions.
Itraconazole was deemed to successfully form an amorphous molecular solid
dispersion. From Table 5.3, amorphous itraconazole was not obtained thereby
preventing the PDF analysis; a definite shortcoming of the PDF method. It may be
expected that making conclusions solely on DSC data increases the probability of a
misclassification. In the previous discussion, terfenadine and nifedipine were classified
as phase separated by PDF analysis. It was shown that subsequent preparations were
prone to different levels of devitrification as evidenced in PXRD analyses. The inability
to procure amorphous itraconazole was attributable to the tendency for instantaneous
crystallization upon quench cooling. Given this characteristic, phase-separated
itraconazole would be expected to instantaneously crystallize upon quenching. Three
different itraconazole:PVPva preparations consistently produced a single Tg event with
PXRD patterns lacking any detectable Bragg diffraction. The combination of all
information supports a classification of complete miscibility between itraconazole and
PVPva, which is further founded on conclusions drawn elsewhere.139
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5.4.2 Calibration
From Table 5.4, the most promising molecular descriptor appears to be the R3m
index. Deviance is the natural logarithm of the likelihood value multiplied by negative
two and serves as an estimate of error. As the deviance is minimized (approaches zero),
therefore, the predictions approximate experimental values and the model becomes more
significant. With a deviance of 0.039 for the R3m model, it is two orders of magnitude
lower than that of the next best index. The LR approximates a χ2 statistic, where a larger
value is indicative of greater significance. The R3m index has the greatest LR value for
all molecular descriptors tested. Finally, the error of cross-validation (LOO CV) is a
metric for determining the robustness of the model. By iteratively removing a compound
from the library, creating a calibration, make a prediction on the compound removed, and
calculating the error, the extent to which each sample influences the calibration is
assessed. The LOO CV for the R3m is an order of magnitude less than that of the next
best value, thereby confirming the robustness of the R3m model.
It is important to consider the possibility of over-saturating a model constructed
from only 12 samples. With this in mind, multivariate logistic regression at a
significance level of α = 0.2 was performed. Both forward- and backward-elimination
yielded the same conclusion; the R3m index was the single most significant descriptor.
Shown in Figure 5.4 are the R3m predicted probabilities for each calibration sample with
an estimated confidence interval in bar graph form. Interestingly, 10 of the 12
compounds were predicted perfectly, while quinidine and tolbutamide only slightly
deviated. The estimated confidence intervals (α = 0.05) for all 12 predictions indicated
the predictions are reliable.
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The R3m index is part of a class of molecular descriptors known as GETAWAY
(Geometry, Topology, and Atom-Weights AssemblY).140,141 The GETAWAY indices
link 3-D geometry to atom relatedness, while retaining specific chemical information.
The first part of calculating any GETAWAY descriptor is to calculate the molecular
influence matrix, H, given by:
(5.5)

H = M• inv(M' M) • M'

where M is the molecular matrix comprised of A rows (number of atoms in molecule)
and three columns (Cartesian atomic coordinates). The molecular influence matrix is
equivalent to a leverage matrix, ostensibly describing the Euclidean distance of atoms
from the geometric center of the molecule. The diagonal elements of H, hii, are called
leverages and represent the “influence” of each atom in determining the whole shape of
the molecule. Interestingly, lower leverages are found for atoms in molecules of
spherical shape, while higher leverages for atoms in more linear compounds. Each offdiagonal element of H represents the accessibility of the ith atom to interactions with the
jth atom, where negative elements represent a low degree of accessibility. From the

molecular influence matrix, various R-GETAWAY descriptors can be calculated,
including the w-weighted kth order autocorrelation index, Rk(w) , given by:

Rk ( w ) =

∑∑
i =1 j > i

hii h jj
rij

• w i • w j • δ( k; d ij )

k = 1,2...d

(5.6)

where h is the element of the molecular influence matrix, r is the geometric interatomic
distance, w is the chemical weighting, k is the path length, d is the topological interatomic
distance, and δ is equal to 1 when k = d and 0 when k ≠ d. From this equation, the R3m
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descriptor may be interpreted as follows: “R”-GETAWAY “3rd”-order autocorrelation
index weighted by the atomic mass, “m”.140
A direct physical interpretation of the correlation between the R3m index and
amorphous molecular solid dispersion potential is not readily apparent. From equation
5.6, some key conceptual attributes of this index are evident. Larger values are obtained
for two peripheral atoms (i.e. further from the geometric center of the molecule) that are
in close proximity to each other (rij). Additionally, as the atomic masses of the two atoms
increase, so does the index; ultimately attributable to a larger number of electronegative
atoms (i.e. oxygen, sulfur, chlorine) in SMO compounds. In this study, it was observed
that as the index increases, the probability of successful solid dispersion formation
increases, as well. From the previous discussion of the R3m index, it is reasonable to
state that a molecule having electronegative atoms along its periphery that are
conformationally positioned such that their interatomic distances are minimized results in
an increased probability of dispersion formation.
One of the most intriguing comparisons is that of felodipine and nifedipine.
Commonly prescribed calcium channel blockers, their structural similarities are readily
apparent in Table 5.1. It has been previously reported that the nucleation rate in
amorphous nifedipine, both as a pure phase and as a 3 wt% amorphous molecular solid
dispersion with PVP, is substantially greater than that of felodipine in the equivalent
state.142 In this study, felodipine was shown to be completely miscible with PVPva,
whereas the co-solidified product of nifedipine and PVPva exhibited detectable phase
separation. The benzene flanking the dihydropyridine in nifedipine contains a nitro
group, where the same benzene contains two chlorine atoms in felodipine (Table 5.1).
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This substituent change causes a marked increase in the R3m index from 0.579 for
nifedipine to 0.813 for felodipine.
Since the R3m includes specific information concerning 3D molecular geometry
provided by the molecular influence matrix, atom relatedness by molecular topology, and
chemical information by using the atomic mass weighting scheme, it’s difficult to
simplify the relationship between this sophisticated index and the mechanism of
API:polymer miscibility. The mere increase in the R3m index can be attributable to
multiple molecular features (i.e. increasing amount of electronegative atoms, large
number of atoms distant to the geometric center, or intramolecular interactions three
topological units apart). Any further extrapolation, at present, concerning this correlation
would be unfounded and is the subject of ongoing research.
The R3m model was challenged with three compounds not used in the calibration.
The results are shown in Figure 5 as a bar plot. Both cimetidine and melatonin were
accurately predicted to not form an amorphous molecular solid dispersion with PVPva.
Bicalutamide, however, was accurately predicted and identified to be completely miscible
with the polymer. It was important, when selecting compounds to test the model, that
molecular attributes did not exceed the variance space of the molecules used to construct
the calibration. For example, the fusion temperature for compounds included in the
calibration fell in the range of 120-180°C. Predictions for molecules with fusion
temperatures substantially deviating from this range tended to be incorrect.
As with any materials informatics calibration, the power of the model increases
with the variance spanned by the samples comprising it. Since this calibration only
contained 12 compounds, it may seem apparent that the variance space is relatively small.
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It is anticipated that as more compounds are added to this library, predictions will
become more accurate over a wider range of molecular attributes. Additionally, an
expanded library may identify different/additional molecular descriptors that are
correlated to dispersion potential. This may shed further light onto the specific structural
properties responsible for the correlation to dispersion potential.

5.5 Conclusion
The ability to identify phase-separated co-solidified samples was afforded by
implementing a combination of standard DSC and PDF transforms of PXRD patterns.
Classification of co-solidified samples based on extent of miscibility enabled construction
of a 12 compound library to model amorphous molecular solid dispersion potential.
Logistic regression analysis of a molecular descriptor database identified a GETAWAY
index highly correlated to solid dispersion potential. When the model was tested with
external compounds possessing materials-properties spanning an appropriate variance
space, successful predictions were made. The model developed herein is not universally
applicable across all SMO compounds. The methodology presented outlines a novel
approach to solving the complex issues surrounding API:polymer miscibility, where
pharmaceutical sectors having large compound libraries at their disposal are poised to
benefit from these materials-based models. Future work aims to increase interpretability
of molecular indices to aid in understanding the complex phenomena associated with
API:polymer miscibility requirements.
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Chapter 6: Summary
The plethora of recent pharmaceutical literature devoted to the topic of solid
dispersion technology is a testament to its appeal for enhancing aqueous
solubility/dissolution rate of poorly soluble NCEs. Despite the large amount of work
focused on the miscibility between a drug and polymer, there remains a lack of consensus
concerning specific properties underlying this phenomenon. As an alternative to case-bycase studies of specific intermolecular interactions to arrive at an explanation for
miscibility, it was hypothesized that some structural characteristic(s) of a compound may
be indicative of dispersion potential, when the polymer, concentration, and
manufacturing method are all held constant. The approach to testing this hypothesis,
calibrating a material informatics database of molecular descriptors, is novel to the best
of the author’s knowledge.
One of the central themes to this dissertation work, mentioned in the introduction,
states that “innovation in the areas of pharmaceutical pre-formulation and formulation
development are often precluded by advancements in materials characterization.” As
illustrated in this work, the types of materials used as/in medicinal products and inherent
issues surrounding their implementation in pharmaceutical dosage forms are becoming
increasingly complex. Although PXRD as an analytical method serves as the mainstay
for assessing material structure, traditional data processing techniques neglect to benefit
from the information in the entire diffraction pattern and, therefore, are unable to provide
the scale of scrutiny required for analyzing highly disordered systems.
To accommodate sensitivity to “local” environments, full pattern PXRD
techniques have emerged. Total scattering analysis coupled with multivariate
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chemometric linear modeling was successfully shown to provide enhanced quantitative
selectivity to multiple amorphous/disordered components in composite samples over
traditional univariate diffraction-absorption processing. Additionally, the selection of
transmission geometry, combined with multivariate modeling, further enabled a reduction
in calibration size with little effect on standard error of prediction.
The pertinence of using PDF transformed PXRD data to study short-range
structure in complex materials was described in great detail. The sensitivity of PDF
transforms of laboratory PXRD data to local order of material structure deviations in
composite pharmaceutical materials was successfully investigated. It was shown that
high-energy input processing, such as powder compaction, induced structural alterations
to average crystallographic molecular location and orientation relative to the raw
crystalline material as evidenced by changes in PDF transforms. Additionally, these
structural modifications were modeled using reverse Monte Carlo simulations and were
shown to be consistent with deviations to long range order. Further, composite
diffraction data was accurately separated permitting PDF transform of componentspecific isolated diffraction. The conclusions drawn from this work are significant
because they show the minor PXRD pattern aberrations resulting from subtle structural
changes manifest as substantial modifications to interatomic correlations. Ultimately,
this was important in supporting the use of our X-ray data to study solid dispersion
systems, as low-frequency features in PXRD patterns of amorphous/disordered
pharmaceutical materials that may not be interpretable as-is, become considerable in the
PDF transform.
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The published method for using PDF transforms to detect phase-separated cosolidified products was scientifically rigorous in its inception; however, it failed to
provide a statistically-robust approach for drawing conclusions. As the actual PDF
transform itself was adapted from the inorganic materials science literature, principles of
error propagation using initial error estimates from the PXRD experiment were, as well.
The novelty of the approach is the application of these algorithms to comparing multiple
experimental PDF patterns. By developing a characteristic threshold to distinguish
significant differences between experimental PDF transforms from insignificant, the
conclusions drawn from analyses were consistent.
An alternative to circumvent one of the aforementioned limitations to the PDF
method is possible. As previously described, the requirement of producing an amorphous
standard of the drug substance to use in the analysis can be a difficult task. With the
increasing power of structural simulations, akin to those used in some of the preceding
work, and the knowledge of local structure in disorder systems, a simulated amorphous
PDF transform for drug substances may be possible to model. This would be
advantageous as it would bypass the difficulty in producing an amorphous phase of the
drug, as well as decrease the raw material supplies associated with the task.
The final segment of this work tied together all of the analytical development to
support a study to predict solid dispersion potential from in silico modeling. Given the
ability to identify phase-separated co-solidified systems from true amorphous molecular
solid dispersions, a compound library was generated for calibration. The ability to
calculate molecular descriptors from the 3-dimensional coordinates of the atoms
comprising the compound affords a wealth of information with no raw material costs.
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The implementation of a material informatics calibration for correlating dispersion
potential to structural attributes (via molecular descriptors), to the best of the author’s
knowledge, is the first attempt at this approach. A significant correlation between
dispersion potential and the R3m GETAWAY index was observed. A direct physical
meaning of the correlation between R3m and dispersion potential, however, was not
readily identifiable or interpretable.
The informatics calibration largely suffered from an inadequate sample size, as
accuracies in screening a large number of multi-scale independent variables increase as
the sample size increases. The addition of compounds to the library that span further
variance space may result in other selected significant molecular indices. These
additional molecular descriptors may further provide information into structural
characteristics responsible for dispersion potential. Analysis of molecular-level
interactions, as by vibrational spectroscopy, may supplement some of the conclusions
drawn from future work. Coupling structural features with information pertaining to
local interactions may yield a complete picture of these complex systems.
The ability to optimize NCE properties, dosage form selection, and formulation
characteristics using little-to-no raw material supplies is highly imperative to decreasing
escalating development costs. The principles outlined throughout this dissertation may
be adapted within the pharmaceutical setting, where the large libraries of drug compound
information and advanced technological capabilities render them imminent. With the
push for complete product understanding by the Food and Drug Administration,
pharmaceutical companies are set to benefit from adapting and applying these
computational methodologies to their standard development programs.
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Appendix A: Eutectics
The distinction between solid dispersions and eutectics is important, as the
structural, physicochemical, and other intrinsic properties are vastly different. A large
number of pharmaceutical references inappropriately use these terms interchangeably;
therefore, the following sections develop the materials properties of eutectics and how
they limit preparation methods, enhance physicochemical performance, and induce
physical instability.

A.1 Structure
A eutectic solid is a condensed phase formed when a specific composition (χe) of
two miscible liquid phases is co-solidified at a specific temperature (Te), resulting in a
crystalline microstructure that has a lower melting temperature relative to that of either
pure constituent. For eutectic solidification to occur, the components must be mutually
miscible as liquids. From a molecular perspective, this implies that the NBIs between
unlike components must be similar to interactions between like components, in the liquid
phase.
Binary eutectic crystallizations typically proceed as first-order phase transitions,
which mechanistically advance through several stages (i.e. appearance of nuclei, nuclei
growth without replication, Ostwald ripening, etc.).143 Eutectic solid products are,
therefore, crystalline materials. Further, eutectics possess a microstructure-level
component of periodicity different than that of either pure crystalline phase. Without the
microstructural element, the system cannot be accurately classified as a eutectic. This
particular concept is often neglected in the pharmaceutical literature, where accounts of
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eutectic formation are reported without proper supporting thermal and structural
characterization.144-147
An important part of the aforementioned definition of a eutectic surrounds the
newly-formed eutectic microstructure. The effective entropy change and the volume
fraction of the eutectic phase are inter-related during solidification, where the relationship
between them may be used to characterize the microstructure (neglecting kinetics).148
According to Hunt and Jackson,149 the entropy of fusion of the individual pure
components controls the resulting eutectic microstructure. When two materials possess
equivalent entropy of fusion values, both phases grow simultaneously behind a planar
solid/liquid interface resulting in a normal eutectic microstructure (Figure A.1). In
contrast, large differences in entropy of fusion result in faceted growth, producing an
anomalous structure. In normal structures, the phases appear as alternating lamellae or
rods of one phase embedded in the other; anomalous structures, however, exhibit many
variants.16

Figure A.1. A schematic of lamellar growth for a binary eutectic behind a near-planar
solid-liquid interface (from Porter and Easterling, 1981, with modifications).
A.1.1 Structural Interpretation of Physicochemical Benefits
The enhanced aqueous solubility gained through eutectic formation is often
attributed (in the pharmaceutical literature) to the lower temperature of fusion of the
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solidified material.150 A more fundamental reason for this lower fusion temperature, and
the resulting increased aqueous solubility, exists. In Figure A.1, a schematic
representation of normal eutectic solidification is shown. As the saturated α phase
(composed of component A) and β phase (composed of component B) solidify, excess B
and A diffuse laterally to the tips of the β phase and α phase, respectively, promoting
further growth. In this figure, λ represents the interlamellar spacing between the α-phase
and the β-phase and is directly related to the rate of growth (i.e., rapid growth rate results
in small λ). The unique eutectic solid microstructure, which results in incoherent
interphase boundaries (the line between the α-phase and β-phase in Figure A.1), provides
a less thermodynamically stable interface relative to the normal coherent interactions that
comprise the individual crystalline phases. This boundary possesses a higher free energy
because its structural makeup consists of NBIs between different molecules (i.e., a drug
and its carrier, or two different drugs) where these interactions are typically not
energetically equivalent to those between like molecules. Further, the number of
unfulfilled bonds at the interphase boundary is greater relative to either pure component
phase, and the NBIs formed between unlike molecules are not as stable relative to those
involved in maintaining the pure component crystal lattice resulting in an increase in
internal energy. These bonds are, therefore, energetically easier to overcome.

A.2 Manufacture
Application of the fusion technique in the production of eutectics151-156 requires
that a mixture of the two components be heated above the melting temperature of the
highest melting component. The two miscible liquids are mixed until homogenous, and
controlled solidification is facilitated by cooling the liquid mixture through Te. The
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resulting solid may be further processed (e.g. sizing, blending) depending upon the
specific downstream application. Although the fusion method is commonly applied,
additional consideration to temperature must be given when using with pharmaceutically
relevant materials. The temperature at which the onset of thermal degradation occurs
relative to the fusion temperature must be taken into account, as alternative methods of
preparation exist for thermally labile drugs and carriers. Further, the molten state of the
component having the lower melting temperature may adversely affect the fusion kinetics
of the other material. In particular, non-specific and specific interactions between the
molten state of one material and the solid state of the other material during the fusion
process may lead to effective dissolution of the higher melting component in the lower
melting material’s molten phase.157
Solvent-mediated co-precipitation is most commonly used to manufacture
pharmaceutical eutectic solids, serving as the choice for temperature-sensitive
products.158-160 In this process two components are dissolved at the eutectic composition
either in a single medium in which they are mutually soluble, or in separate media that
are eventually mixed together in proportions representing the eutectic composition. The
solvent is then removed in either a controlled or uncontrolled fashion, and the coprecipitated solid is subjected to further processing as above.
Although common, solvent-mediated co-precipitation has several practical
disadvantages. Given a candidate NCE having sufficient hydrophobicity to merit
exploration of solubilization strategies such as eutectic formation, and a second
hydrophilic component, it is may be difficult to find a common solvent capable of
dissolving both solutes. Many organic solvents are highly toxic to humans, imposing
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additional concern with residual solvent levels following precipitation and processing.
Further, the amount of solvent required to perform such a process on a commercial scale
poses a tremendous production cost. Additionally, the method and rate of evaporation
both have implications on the resulting solid microstructure, which may, therefore, alter
product performance. Finally, the amount of time required to evaporate the solvent to
acceptable levels places a constraint on the efficiency of this application. Given these
impracticalities, the fusion method seems to hold an apparent advantage relative to the
solvent technique.
Eutectic growth velocity holds considerable influence on the mechanical
properties of the resulting binary solid material,161 which is of concern particularly if the
eutectic is to be formulated as part of a solid oral dosage form. During growth of a
phase-pure single crystal, the principal faces governing morphology will grow at the
slowest rate, and correspond with planes having the highest intraplanar density and
greatest interplanar spacing (i.e. lowest Miller indices).162 A crystalline lattice is often
weakest coplanar with one of its largest faces, as high d-spacing correlates with weak
interplanar bonding, establishing these as the most likely sites for plastic deformation to
occur.163 The interphase boundary in a eutectic solid represents the source of its weakest
intermolecular interactions. If it is assumed that the interphase boundary has comparable
mechanical implications to weak interplanar bonding in single crystal systems, then these
interphase regions become likely sites for mechanical failure to occur. If it is further
assumed that this boundary becomes weaker as the interlamellar spacing (λ) increases,
then experimental parameters affecting the interlamaller spacing also affect the
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mechanical properties of the material. A binary system co-solidified at its eutectic
composition will display a growth rate (v):
v = k 2 DΔT

λ*
1
(1 - )
λ
λ

(A.1)

where λ is the interlamellar spacing, k2 is a proportionality constant, D is the liquid
diffusivity, λ* is the minimum possible lamellar spacing and ΔT is the degree of
undercooling below Te.16 Therefore, exacting control over the temperature at which a
eutectic solid is grown holds implications for the interlamellar spacing and mechanical
properties of the material.
As addressed above, the eutectic composition (χe) represents the specific
mole/mass fraction concentrations of two mutually miscible liquids at which cosolidification without prior phase separation will result in a microstructure that melts at a
lower temperature than the Tm of either pure component. In Figure A.2, a typical
temperature-composition (T-χ) binary phase diagram is shown. Compositions falling to
the left or right of χe will result in a product having a mixed microstructure, where the
excess phase, will solidify prior to cooling below Te (Figure A.2b). In order to
maximize predictable physicochemical benefits afforded by the unique microstructure,
explicit control of growth parameters at χe and Te is essential, although not easily
established.
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Figure A.2. A T–χ diagram for a mixture of two mutually miscible liquids α and β. a)
Cooling the homogeneous mixture along this trajectory results in eutectic solidification
below Te, resulting in lamellar microstructure (1). b) For χ≠χe, cooling the
homogeneous liquid mixture (2) along the trajectory indicated results in precipitation of β
(3). Continued cooling allows growth of crystalline β (4). At T≤Te, the remaining liquid
(χ=χe) solidifies as eutectic (5) resulting in a mixed microstructure
Currently, χe for simple binary systems is determined empirically, first requiring
assessment of the compatibility of the two components. Eutectic formation requires
complete miscibility of the two components in the liquid state and immiscibility in the
solid state. In the traditional method employed for χe determination, samples spanning
the entire concentration range of the two materials are co-solidified, employing the
fusion-based method discussed above. Samples are subjected to thermal analysis (i.e.,
DSC, hot stage microscopy, etc.,) and the fusion temperature(s) of the co-solidified
mixture is determined and plotted as a function of composition, thereby creating the T- χ
phase diagram. This is where prior characterization of thermal interactions becomes
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critical, as this may affect the accuracy in determination of the true melting
temperature.164 The thermal interactions between components upon heating may
complicate the signal from thermal analysis of mixtures, thus warranting care when
interpreting data. Further, phase-purity must be considered, as this will also affect the
fusion temperature.
Two problematic issues associated with eutectic composition determination via Tχ phase diagram construction are anticipated: (1) the process of creating a T- χ phase
diagram is laborious and (2) phase diagram construction requires the sacrifice of
relatively large amounts of both components. Considering the amount of material
typically available during the early stages of investigating a NCE, determining the
eutectic point via phase diagram is often prohibitive. As a result, a great deal of current
research focuses on the development of methods aimed at determining eutectic
compatibility and eutectic composition in few-to-no experiments.
Law et al.,165 developed a dimensionless index (Ic) used as a screening tool for
predicting PEG-drug eutectic composition based on the van’t Hoff equation:

Ic =

Td f - T pf
R(Td f ) 2 / ΔH df

(A.2)

where Tdf is the fusion temperature of the drug, Tpf is the fusion temperature of the
polymer, R is the ideal gas constant, and ΔHdf is the enthalpy of fusion of the drug.
Though the authors claim to have successfully predicted the eutectic composition for
eight model drug compounds, the index only provided an estimate of χe ± 10-15%.
Further, this index does not consider racemization, phase transitions, decomposition,
incompatibility, etc., as these characteristics would affect the co-solidification process.
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Approximation of χe is, however, not without merit. First, the approach adopted by Law
et al.,165 accurately predicted whether or not a eutectic would form between two

components. During eutectic development, T- χ phase diagrams are created for two
components which occasionally are not able to form a eutectic. The index, therefore,
prevents this costly and time-consuming event from occurring. Also, when the
approximate eutectic point is known, an abbreviated T- χ phase diagram may be prepared,
thereby decreasing initial material requirements.
Two additional details concerning the aforementioned index deserve some
attention: (1) the order of material structure of the carrier PEG and (2) applications of the
van’t Hoff equation. Much of the pharmaceutical literature reports the formation of
eutectics between a drug and the water soluble, synthetic polymer PEG, as is the case in
this example. From a structural standpoint, the formation of a classic eutectic
microstructure between these two components may be difficult to envision, owing to the
fact that the long-chain PEG molecules do not crystallize in the rigorous sense of the
word. Furthermore, the considerable size difference between PEG and any small
molecule is expected to result in significant dimensional mismatch. To visualize the
formation of a eutectic microstructure between PEG and a small molecule drug
compound, PEG needs to be considered in terms of both micro- and macroscopic
structural features. In the solid state PEG molecules are arranged as repeating lamellar
units bridged by tie molecules (molecules arranged in a disordered state). Therefore,
PEGs exhibit a defined Tg due to the tie molecules, as well as having repeating ordered
regions, termed spherulites, which may be conceptualized as a crystalline. Consequently,
PEGs are considered “semicrystalline,” where the relative amount of crystallinity is
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determined by the molecular weight of the PEG chain.166 The crystal lattice for PEG is
often defined as encompassing only portions of the polymeric chains, where the unit cell
dimensions are proportional to that of medicinal organic molecular crystals.
The second issue identified above considers that the index is constructed using the
van’t Hoff equation as its foundation. Models incorporating this equation are typically
bounded by assumptions that may not be rigorously true for real systems (i.e., equivalent
interactions, no change in volume, etc.). The highly idealized assumption of equality of
interactions is invalidated when the incoherent phase boundaries between layers of the
eutectic structure are considered. These boundaries are less thermodynamically stable
relative to bulk lattice regions, specifically due to the difference in interactions between
unlike components across the solid-solid interface. These difficulties may ultimately
detract from the practicality of such tools, limiting their universal application.
The financial and raw material resources required to determine the eutectic
composition appear to represent deterrents of eutectic application in pharmaceutical
systems. Therefore, a key avenue for future eutectics research should include
development of methods designed to decrease the amount of experimentation necessary
for determination of χe and Te, as well as moving towards accurate, predictive
determination of these parameters. Analytical tools used to characterize drug:carrier
compatibility and models designed to predict compatibility are paramount to minimizing
experimental consumption of API, thereby making this strategy more attractive as an
early development tool. Further, as a better understanding of the relationship between
eutectic microstructure and material function is gained, more efficient methodologies for
predicting eutectic composition may result. Characterization of the incoherent
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boundaries formed in eutectics may aide in achieving a better understanding of the
aforementioned relationship. Through characterization, some questions concerning this
boundary need to be investigated: 1) What is the composition at this boundary (i.e. a
single layer of molecules of each phase, multiple, interspersed layers)? 2) Is the boundary
both macroscopically and microscopically isotropic, or does anisotropy exist? and 3)
Does the boundary become increasingly isotropic as the eutectic composition is
approached? If these interfacial boundaries can be modeled structurally through defining
specific intermolecular orientations and interactions, it may enable the macroscopic
composition to be determined theoretically.

A.3 Physical Stability
Eutectics are the most thermodynamically stable of the binary composite
materials covered in this dissertation. Structurally, eutectics are crystalline; the increased
free energy, enthalpy, and entropy are manifestations of the incoherent phase boundaries
formed upon solidification. At χe, the number of incoherent, higher energy regions is
maximized. As explained previously, this is the source from which the enhanced
aqueous solubility of these materials is derived. These high energy regions also result in
the decreased melting temperature that is observed relative to those of each individual
component. If Te is close to ambient temperatures, a limit of physical stability is
represented where the system disproportionates into a mixture of individual phases (i.e.,
phase separation). On the contrary, a lower temperature limit of stability may also be
observed in eutectic solids. In this case, eutectics held at temperatures well below the
eutectic temperature decompose into a mixture of the two phases.167 This most likely
results from the higher energy associated with the interphase boundaries. These regions,

173

over a period of time, are likely to proceed from a metastable state to a more ordered
phase. As a result, the eutectic decomposes into a mixture of the two individual phases.
Both sources of physical instability may ultimately alter the physicochemical properties
of the product, thereby negating the enhanced aqueous solubility that provided the
impetus to engineer the eutectic at the outset of development. Unfortunately, there is a
paucity of literature sources pertaining to the stabilization of eutectics, which may be due
to: (1) the increased thermodynamic stability of eutectics relative to other solid binary
composite systems results in rare occurrences of the aforementioned routes of instability,
(2) traditional stabilizing methods are not applicable to eutectics and alternative
techniques do not exist, (3) research concerning eutectic-based pharmaceutical
formulations is limited relative to their solid-dispersion counterparts, or (4) a combination
of the preceding points.
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Appendix B: PXRD and PDF Analyses
All powder X-ray diffraction (PXRD) patterns were obtained using an X’Pert Pro
MPD system (PANalytical B.V., Almelo, the Netherlands) equipped with a copper anode
(λ = 1.5406 Å), an auxiliary elliptical mirror, and X’CeleratorTM detector. The
operational voltage and amperage were set to 45.0 kV and 40.0 mA, respectively.
Diffraction patterns were acquired on intact samples, sandwiched between two layers of
Kapton® film and subsequently placed on a spinning vertical sample stage (16 rpm).
Experimental parameters include an irradiation time of 51.04 seconds per step and an
angular step size of 0.017° 2θ over a 2-100° 2θ range. From raw powder patterns, if cosolidified products displayed Bragg diffraction peaks, no PDF analysis was carried out
due to the obvious indication of partial crystallinity. Indexed PXRD patterns only are
shown for compounds exhibiting this level of phase separation.
A number of corrections are made to raw diffraction data to obtain a structure
function consistent with those outlined by Egami and Billinge.38 All intensity corrections
and PDF calculations were performed using software developed in-house in the Matlab
programming environment (v7.1, MathWorks, Natick, MA) based on published equations.
The PDF transforms were optimized using the Glow quality criterion introduced by
Peterson, et al.41
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Figure B.1. The PDF assessment for felodpine:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: (top to
bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of
illustration is the actual analysis, as labeled. Due to the lack of agreement between the calculated PDF and co-solidified product PDF
as evidenced by the high R-value, drug and polymer concentration values that deviate from theory, and the regions in r where zero is
not contained in the confidence interval, felodipine and PVPva are concluded to be completely miscible.
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Figure B.2. The PDF assessment for indomethacin:PVPva co-solidified product; left three graphs are corrected PXRD patterns for:
(top to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of
illustration is the actual analysis, as labeled. Due to the lack of agreement between the calculated PDF and co-solidified product PDF
as evidenced by drug and polymer concentration values that deviate from theory and the regions in r where zero is not contained in the
confidence interval, indomethacin and PVPva are concluded to be completely miscible.
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Figure B.3. The PDF assessment for ketoconazole:PVPva co-solidified product; left three graphs are corrected PXRD patterns for:
(top to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of
illustration is the actual analysis, as labeled. Due to the lack of agreement between the calculated PDF and co-solidified product PDF
as evidenced by the high R-value, drug and polymer concentration values that deviate from theory, and the regions in r where zero is
not contained in the confidence interval, ketoconazole and PVPva are concluded to be completely miscible.
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Figure B.4. Raw powder X-ray diffraction pattern for the itraconazole:PVPva cosolidified product. Black delta peaks are indicative of the referenced Bragg intensity
values for itraconazole (CSD reference code: TEHZIP). The PXRD pattern of the cosolidified product does not contain any Bragg peaks attributable to crystalline
itraconazole. Since the PDF analysis was not performed due to inability to produce
amorphous itraconazole, conclusions were made from PXRD and DSC data (Appendix
C) only. Itraconazole was concluded to be completely miscible with PVPva due to lack
of detectable crystallinity in PXRD data and a single detectable Tg from DSC.
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Figure B.5. The PDF assessment for tolbutamide:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: (top
to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of
illustration is the actual analysis, as labeled. Due to the lack of agreement between the calculated PDF and co-solidified product PDF
as evidenced by the high R-value and the regions in r where zero is not contained in the confidence interval, tolbutamide and PVPva
are concluded to be completely miscible.
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Figure B.6. The PDF assessment for chlorpropamide:PVPva co-solidified product; left three graphs are corrected PXRD patterns for:
(top to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of
illustration is the actual analysis, as labeled. Due to the lack of agreement between the calculated PDF and co-solidified product PDF
as evidenced by the high R-value, drug and polymer concentration values that deviate from theory, and the regions in r where zero is
not contained in the confidence interval, chlorpropamide and PVPva are concluded to be completely miscible.

Figure B.7. Raw powder X-ray diffraction pattern for the nifedipine:PVPva co-solidified
product. Blue delta peaks are indicative of the referenced Bragg intensity values for
crystalline nifedipine (ICDD reference code: 00-052-2175). As shown, detectable partial
crystallinity attributable to crystalline nifedipine is present in the co-solidified product.

182

183

Figure B.8. The PDF assessment for quinidine:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: (top to
bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of
illustration is the actual analysis, as labeled. Due to the agreement between the calculated PDF and co-solidified product PDF as
evidenced by the low R-value, drug and polymer concentration values that are close to theory, and confidence intervals that contain
zero for all values of r, quinidine and PVPva are concluded to be phase-separated.

Figure B.9. Raw powder X-ray diffraction pattern for the propranolol:PVPva cosolidified product. Black delta peaks are indicative of the referenced Bragg intensity
values for dl-propranolol hydrochloride (ICDD reference code: 00-051-2107). As shown,
detectable partial crystallinity attributable to crystalline propranolol is present in the cosolidified product.
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Figure B.10. Raw powder X-ray diffraction pattern for the cloperastine:PVPva cosolidified product. Black delta peaks are indicative of the referenced Bragg intensity
values for crystalline cloperastine hydrochloride (ICDD reference code: 00-046-1967).
As shown, detectable partial crystallinity, although not indexed to the crystal structure
shown, is present in the co-solidified product.
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Figure B.11. The PDF assessment for terfenadine:PVPva co-solidified product; left three graphs are corrected PXRD patterns for:
(top to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of
illustration is the actual analysis, as labeled. Due to the agreement between the calculated PDF and co-solidified product PDF as
evidenced by the low R-value, drug and polymer concentration values that are close to theory, and confidence intervals that contain
zero for all values of r, terfenadine and PVPva are concluded to be phase-separated.

α-form
γ-form

Figure B.12. Raw powder X-ray diffraction pattern for the sulfanilamide:PVPva cosolidified product. Black delta peaks are indicative of the referenced Bragg intensity
values for α-sulfanilamide (ICDD reference code: 00-038-1709) and blue delta peaks are
for γ-sulfanilamide (ICDD reference code: 00-038-1710). As shown, detectable partial
crystallinity attributable to crystalline sulfanilamide is present in the co-solidified product.
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Figure B.13. The PDF assessment for cimetidine:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: (top
to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of
illustration is the actual analysis, as labeled. Although the larger R-value and regions in r where zero is not contained in the
confidence interval may indicate a poor fit between the calculated PDF and co-solidified product PDF, the portion of the PDF likely to
contain information pertaining to structure (i.e. r ≥ 5Å) exhibits a good fit between the two PDFs and therefore leads to the conclusion
that terfenadine and PVPva are phase-separated.

189

Figure B.14. The PDF assessment for melatonin:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: (top
to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of
illustration is the actual analysis, as labeled. Due to the agreement between the calculated PDF and co-solidified product PDF as
evidenced by the low R-value, drug and polymer concentration values that are close to theory, and confidence intervals that contain
zero for all values of r, melatonin and PVPva are concluded to be phase-separated.
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Figure B.15. The PDF assessment for bicalutamide:PVPva co-solidified product; left three graphs are corrected PXRD patterns for:
(top to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of
illustration is the actual analysis, as labeled. Due to the lack of agreement between the calculated PDF and co-solidified product PDF
as evidenced by the high R-value, drug and polymer concentration values that deviate from theory, and the regions in r where zero is
not contained in the confidence interval, bicalutamide and PVPva are concluded to be completely miscible.

Appendix C: DSC Analyses
Glass transition temperatures (Tg) for amorphous pure components and cosolidified samples were measured using a TA Q100 DSC (TA Instruments, New Castle,
DE) under constant nitrogen purge (~50mL/min). A three-point enthalpy and
temperature calibration was performed at 20°C/min using o-terphenyl, indium, and tin
standards. In an attempt to avoid artifacts arising from grinding samples, approximately
5 mg intact “sample chips” were hermetically sealed in aluminum pans. To normalize
thermal history, samples were first heated at 20 °C/min to 105 °C, held isothermally for 2
minutes, and subsequently cooled to -20°C at 20 °C/min. Samples were then cycled
through Tg events at 20 °C/min for temperature determination. In each of the following
thermograms, the Tg event for each pure component and Tg for the co-solidified product is
shown. For the co-solidified products, only a single cycle is shown, unless otherwise
noted. The ideal Tg as calculated using the Couchman-Karasz equation,85 Tg,CK, is given
in the figure captions where applicable.
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Figure C.1. The DSC thermograms of felodpine:PVPva systems showing the glass transition event for the individual components and
co-solidified product (as labeled), where Tg,CK = 63.4 °C. The presence of a single Tg in the co-solidified product is indicative of
miscibility between felodpine and PVPva.
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Figure C.2. The DSC thermograms of indomethacin:PVPva systems showing the glass transition event for the individual components
and co-solidified product (as labeled) , where Tg,CK = 66.9 °C. The presence of a single Tg in the co-solidified product is indicative of
miscibility between indomethacin and PVPva.
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Figure C.3. The DSC thermograms of ketoconazole:PVPva systems showing the glass transition event for the individual components
and co-solidified product (as labeled) , where Tg,CK = 63.4 °C. The single, detectable Tg in the co-solidified product is similar to that
of amorphous ketoconazole and therefore, not definitively interpretable.
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Figure C.4. The DSC thermograms of itraconazole:PVPva systems showing the glass transition event for the individual components
and co-solidified product (as labeled) , where Tg,CK = 72.2 °C. The single, detectable Tg in the co-solidified product is similar to that
of amorphous itraconazole and therefore, not definitively interpretable. Due to the inability to perform a PDF analysis, the
repeatability of the Tg across three preparations combined with the lack of detectable Bragg peaks in PXRD patterns provides basis for
concluding miscibility between itraconazole and PVPva.
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Figure C.5. The DSC thermograms of tolbutamide:PVPva systems showing the glass transition event for the individual components
and co-solidified product (as labeled) , where Tg,CK = 34.0 °C. The presence of a single, detectable Tg in the co-solidified product is
indicative of miscibility between tolbutamide and PVPva.
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Figure C.6. The DSC thermograms of chlorpropamide:PVPva systems showing the glass transition event for the individual
components and co-solidified product (as labeled) , where Tg,CK = 41.7 °C. The presence of a single, detectable Tg in the co-solidified
product is indicative of miscibility between chlorpropamide and PVPva.
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Figure C.7. The DSC thermograms of nifedipine:PVPva systems showing the glass transition event for the individual components
and co-solidified product (as labeled) , where Tg,CK = 65.4 °C. The presence of a single, detectable Tg in the co-solidified product is
indicative of miscibility between chlorpropamide and PVPva; however, the PXRD pattern of the co-solidified product (Appendix B)
revealed detectable crystallinity attributable to nifedipine.
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Figure C.8. The DSC thermograms of quinidine:PVPva systems showing the glass transition event for the individual components and
co-solidified product (as labeled) , where Tg,CK = 76.8 °C. The presence of two Tg events in the co-solidified product is indicative of
phase separation.
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Figure C.9. The DSC thermograms of propranolol:PVPva systems showing the glass transition event for the individual components
and co-solidified product (as labeled) , where Tg,CK = 60.5 °C. The lack of a detectable Tg in the co-solidified product is indicative
undetectable amorphous phase.
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Figure C.10. The DSC thermograms of cloperastine:PVPva systems showing the glass transition event for the individual components
and co-solidified product (as labeled) , where Tg,CK = 53.6 °C. The lack of a detectable Tg in the co-solidified product is indicative
undetectable amorphous phase.
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Figure C.11. The DSC thermograms of terfenadine:PVPva systems showing the glass transition event for the individual components
and co-solidified product (as labeled) , where Tg,CK = 77.2 °C. The single, detectable Tg in the co-solidified product is similar to that
of amorphous terfenadine and therefore, not definitively interpretable.
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Figure C.12. The DSC thermograms of sulfanilamide:PVPva systems showing the glass transition event for the individual
components and co-solidified product (as labeled) , where Tg,CK = not obtainable. A thermogram for amorphous sulfanilamide is not
shown due to the inability to produce the amorphous phase. The two Tg events in the co-solidified product is indicative of phase
separation in the amorphous component of the system. Additionally, detectable crystallinity indexed to sulfanilamide was observed in
the PXRD pattern (Appendix B) of the co-solidified product.

204

Figure C.13. The DSC thermograms of cimetidine:PVPva systems showing the glass transition event for the individual components
and co-solidified product (as labeled) , where Tg,CK = 69.9 °C. The single, detectable Tg in the co-solidified product is similar to that
of amorphous cimetidine and therefore, not definitively interpretable.

205

Figure C.14. The DSC thermograms of melatonin:PVPva systems showing the glass transition event for the individual components
and co-solidified product (as labeled) , where Tg,CK = 47.6 °C. The single, detectable Tg in the co-solidified product is similar to that
of amorphous melatonin and therefore, not definitively interpretable
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Figure C.15. The DSC thermograms of bicalutamide:PVPva systems showing the glass transition event for the individual
components and co-solidified product (as labeled) , where Tg,CK = 70.3 °C. The single, detectable Tg in the co-solidified product is
similar to that of amorphous bicalutamide and therefore, not definitively interpretable
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